<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<!-- saved from url=(0053)https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/ -->
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="nihpa"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC2689518/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Human Cannabinoid Pharmacokinetics</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="./Human Cannabinoid Pharmacokinetics_files/jig.min.css"><script type="text/javascript" src="./Human Cannabinoid Pharmacokinetics_files/jig.min.js.download"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Chemistry &amp; biodiversity"><meta name="citation_title" content="Human Cannabinoid Pharmacokinetics"><meta name="citation_authors" content="Marilyn A. Huestis"><meta name="citation_date" content="August 2007"><meta name="citation_issue" content="8"><meta name="citation_volume" content="4"><meta name="citation_firstpage" content="1770"><meta name="citation_doi" content="10.1002/cbdv.200790152"><meta name="citation_pmid" content="17712819"><meta name="DC.Title" content="Human Cannabinoid Pharmacokinetics"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="NIH Public Access"><meta name="DC.Contributor" content="Marilyn A. Huestis"><meta name="DC.Date" content="2007 Aug"><meta name="DC.Identifier" content="10.1002/cbdv.200790152"><meta name="DC.Language" content="en"><meta property="og:title" content="Human Cannabinoid Pharmacokinetics"><meta property="og:type" content="article"><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><link rel="stylesheet" href="./Human Cannabinoid Pharmacokinetics_files/pmc.min.css" type="text/css"><link rel="stylesheet" href="./Human Cannabinoid Pharmacokinetics_files/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="./Human Cannabinoid Pharmacokinetics_files/common.min.js.download">//</script><script type="text/javascript" src="./Human Cannabinoid Pharmacokinetics_files/NcbiTagServer.min.js.download">//</script><meta name="citationexporter" content="backend:&#39;/pmc/utils/ctxp/&#39;"><script type="text/javascript" src="./Human Cannabinoid Pharmacokinetics_files/jquery.citationexporter.js.download">//</script><link rel="stylesheet" href="./Human Cannabinoid Pharmacokinetics_files/citationexporter.css" type="text/css"><script type="text/javascript" src="./Human Cannabinoid Pharmacokinetics_files/MathJax.js.download"></script><script type="text/javascript" src="./Human Cannabinoid Pharmacokinetics_files/large-obj-scrollbars.min.js.download"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/epub/"><link rel="alternate" type="application/pdf" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/pdf/nihms-118643.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="https://www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="8A1A7ABF938A4C2100000000008B0082">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="./Human Cannabinoid Pharmacokinetics_files/4143404.css"><link type="text/css" rel="stylesheet" href="./Human Cannabinoid Pharmacokinetics_files/4157116.css" media="print"><style type="text/css" media="print">.print-log { position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden; }.print-log li { list-style-image: url('https://www.ncbi.nlm.nih.gov/stat?jsevent=print&ncbi_app=pmc&ncbi_db=pmc&ncbi_pcid=%2Farticles%2FPMC2689518%2F&ncbi_pdid=article&ncbi_phid=8A1A7ABF938A4C2100000000008B0082'); }</style><style type="text/css">.print-log { position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden; }</style><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1em; bottom: 1.5em; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 2px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 2px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: 1em}
.MathJax_MenuRadioCheck.RTL {right: 1em; left: auto}
.MathJax_MenuLabel {padding: 2px 2em 4px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #CCCCCC; margin: 4px 1px 0px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: Highlight; color: HighlightText}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-3"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	&lt;p class="nojs"&gt;
	&lt;strong&gt;Warning:&lt;/strong&gt;
	The NCBI web site requires JavaScript to function. 
	&lt;a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank"&gt;more...&lt;/a&gt;
	&lt;/p&gt;
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="https://www.ncbi.nlm.nih.gov/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="./Human Cannabinoid Pharmacokinetics_files/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="https://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="https://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="https://www.ncbi.nlm.nih.gov/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="https://www.ncbi.nlm.nih.gov/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="https://www.ncbi.nlm.nih.gov/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="https://www.ncbi.nlm.nih.gov/account/?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2689518%2F" id="sign_in">Sign in to NCBI</a><a href="https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2689518%2F" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="https://www.ncbi.nlm.nih.gov/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="https://www.ncbi.nlm.nih.gov/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="clone">Clone</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="nucest">EST</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="nucgss">GSS</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="pubmedhealth">PubMed Health</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbook">ToolKitBook</option><option value="toolkitbookgh">ToolKitBookgh</option><option value="unigene">UniGene</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:&#39;pmc-search-autocomplete&#39;,disableUrl:&#39;NcbiSearchBarAutoComplCtrl&#39;" autocomplete="off" data-sbconfig="ds:&#39;no&#39;,pjs:&#39;no&#39;,afs:&#39;yes&#39;" aria-haspopup="true" aria-autocomplete="list" role="textbox"><a class="reset" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#" style="visibility: hidden;"><img src="./Human Cannabinoid Pharmacokinetics_files/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="https://www.ncbi.nlm.nih.gov/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="https://www.ncbi.nlm.nih.gov/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC2689518</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="./Human Cannabinoid Pharmacokinetics_files/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html"><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [&#39;h2&#39;], headingExclude: &#39;:hidden&#39;" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="small"><div class="inline_block eight_col va_top"><div><span role="menubar"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#" role="menuitem" aria-expanded="false" aria-haspopup="true">Chem Biodivers</a></span>. Author manuscript; available in PMC 2009 Jun 2.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=17712819" target="pmc_ext" ref="reftype=publisher&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access&amp;rendering-type=normal"><span class="cit">Chem Biodivers. 2007 Aug; 4(8): 1770–1804. </span></a></div> <span class="doi">doi:&nbsp; <a href="https://dx.doi.org/10.1002%2Fcbdv.200790152" target="pmc_ext" ref="reftype=other&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">10.1002/cbdv.200790152</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2689518</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS118643</span></div></div></div></div></div><h1 class="content-title">Human Cannabinoid Pharmacokinetics</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Huestis%20MA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17712819">Marilyn A. Huestis</a></div></div><div class="fm-panel small half_rhythm"><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140594040118736_ai" style="display:none"><div class="fm-affl" lang="en">Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, NIH, 5500 Nathan Shock Drive, Baltimore, MD 21146, USA</div><div id="CR1">phone: +1−410−550−2711; fax: +1−410−550−2971; e-mail: <a href="mailto:dev@null" data-email="vog.hin.adin.artni@sitseuhm" class="oemail">vog.hin.adin.artni@sitseuhm</a></div></div><div class="togglers"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#" class="pmctoggle" rid="idm140594040118736_ai">Author information <span>►</span></a> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#" class="pmctoggle" rid="idm140594040118736_cpl">Copyright and License information <span>►</span></a></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="fm-cpl-info fm-panel hide half_rhythm" id="idm140594040118736_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="https://www.ncbi.nlm.nih.gov/pmc/about/copyright/">Copyright notice</a>  and <a href="https://www.ncbi.nlm.nih.gov/pmc/about/disclaimer/">Disclaimer</a></div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="small"><div>The publisher's final edited version of this article is available  at <a href="https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=17712819" target="pmc_ext" ref="reftype=publisher&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access&amp;rendering-type=normal">Chem Biodivers</a></div><div>See other articles in PMC that <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="S1" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S1title">1. Introduction</h2><p id="P1" class="p p-first">A multitude of roles for the endogenous cannabinoid system has been proposed by recent research efforts. A large number of endogenous cannabinoid neurotransmitters or endocannabinoids have been identified, and the CB-1 and CB-2 cannabinoid receptors have been characterized. The presence of other receptors, transporters, and enzymes responsible for the synthesis or metabolism of endocannabinoids are becoming known at an extraordinary pace. The complex functions of this novel system have created multiple new targets for pharmacotherapies. Research has focused on separating the behavioral psychoactive effects of cannabinoid agonists from therapeutic effects. These efforts have been largely unsuccessful. Another strategy centers on changing the pharmacokinetics of drug delivery to maximize therapeutic effect and minimize cognitive and subjective drug effects. Development of oral, rectal, and transdermal medications of synthetic Δ<sup>9</sup>-tetrahydrocannabinol (THC)<sup><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#FN1" rid="FN1" class=" fn">1</a></sup>) are examples of this type of approach. Additionally, the potential therapeutic benefits of administering unique combinations of cannabinoids and other chemicals present in the plant <em>Cannabis sativa</em> is being investigated by the oromucosal route. There also is strong interest in medications based on antagonizing endocannabinoid action. </p><div class="figure"><a class="inline_block ts_canvas" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2689518_nihms-118643-f0001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms-118643-f0001.jpg" title="Click on image to zoom" class="tileshop" src="./Human Cannabinoid Pharmacokinetics_files/nihms-118643-f0001.jpg"></a></div><p></p><p id="P2">We have shown that the cardiovascular and subjective effects of cannabis are blocked by rimonabant, the first CB-1 cannabinoid-receptor antagonist, documenting that CB-1 receptors mediate these effects of smoked cannabis in humans. It is clear that the endogenous cannabinoid system plays a critical role in physiological and behavioral processes, and extensive research effort is being devoted to the biology, chemistry, pharmacology, and toxicology of cannabinoids.</p><p id="P3">Cannabis is one of the oldest and most commonly abused drugs in the world, and its use is associated with pathological and behavioral toxicity. Thus, it is important to understand cannabinoid pharmacokinetics and the disposition of cannabinoids into biological fluids and tissues. Understanding the pharmacokinetics of a drug is essential to understanding the onset, magnitude, and duration of its pharmacodynamic effects, maximizing therapeutic and minimizing negative side effects.</p><p id="P4">Cannabinoid pharmacokinetics encompasses absorption after diverse routes of administration and from different drug formulations, analyte distribution throughout the body, metabolism by the liver and extra-hepatic tissues, and elimination in the feces, urine, sweat, oral fluid, and hair. Pharmacokinetic processes are dynamic, may change over time, and may be affected by the frequency and magnitude of drug exposure. The many contributions to our understanding of cannabinoid pharmacokinetics from the 1970s and 1980s are reviewed, and the findings of recent research expanding upon this knowledge are detailed. Cannabinoid pharmacokinetics research is challenging due to low analyte concentrations, rapid and extensive metabolism, and physico-chemical characteristics hindering the separation of drugs of interest from biological matrices and from each other. Drug recovery is reduced due to adsorption of compounds of interest to multiple surfaces. Much of the early cannabinoid data are based on radiolabeled cannabinoids yielding highly sensitive, but less specific, measurement of individual cannabinoid analytes. New extraction techniques and mass-spectrometric (MS) developments now permit highly sensitive and specific measurement of cannabinoids in a wide variety of biological matrices, improving our ability to characterize cannabinoid pharmacokinetics.</p><p id="P5" class="p p-last"><em>Cannabis sativa</em> contains over 421 different chemical compounds, including over 60 cannabinoids [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066082" role="button" aria-expanded="false" aria-haspopup="true">1</a>-<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R3" rid="R3" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">3</a>]. Cannabinoid plant chemistry is far more complex than that of pure THC, and different effects may be expected due to the presence of additional cannabinoids and other chemicals. Eighteen different classes of chemicals, including nitrogenous compounds, amino acids, hydrocarbons, carbohydrates, terpenes, and simple and fatty acids, contribute to the known pharmacological and toxicological properties of cannabis. THC is usually present in <em>Cannabis</em> plant material as a mixture of monocarboxylic acids, which readily and efficiently decarboxylate upon heating. THC decomposes when exposed to air, heat, or light; exposure to acid can oxidize the compound to cannabinol (CBN), a much less-potent cannabinoid. In addition, cannabis plants dried in the sun release variable amounts of THC through decarboxylation. During smoking, more than 2,000 compounds may be produced by pyrolysis. The pharmacokinetics of THC, the primary psychoactive component of cannabis, its metabolites ‘11-hydroxytetrahydrocannabinol’ (11-OH-THC) and ‘11-nor-9-carboxy-tetrahydrocannabinol’ (THC-COOH)]<sup><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#FN2" rid="FN2" class=" fn">2</a></sup>), and another cannabinoid present in high concentration, cannabidiol (CBD), a non-psychoactive agent with an interesting array of potential therapeutic indications, are included. <em>Mechoulam et al</em>. elucidated the structure of THC in 1964, enabling studies of the drug's pharmacokinetics [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066098" role="button" aria-expanded="false" aria-haspopup="true">4</a>]. THC, containing no N-atom, but with two stereogenic centers in a <em>trans</em> configuration, has been described by two different atom-numbering systems, either the dibenzopyran (or Δ<sup>9</sup>) or the monoterpene (or Δ<sup>1</sup>) system. In this review, the dibenzopyran (Δ<sup>9</sup>) system is employed.</p></div><div id="S2" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S2title">2. Pharmacokinetics of Cannabinoids</h2><div id="S3" class="sec sec-first"><h3>2.1. Absorption</h3><div id="S4" class="sec sec-first"><p></p><h4 class="inline">2.1.1. Smoking </h4><p id="P6" class="p p-first">Route of drug administration and drug formulation determine the rate of drug absorption. Smoking, the principal route of cannabis administration, provides a rapid and efficient method of drug delivery from the lungs to the brain, contributing to its abuse potential. Intense pleasurable and strongly reinforcing effects may be produced due to almost immediate drug exposure to the central nervous system (CNS). Slightly lower peak THC concentrations are achieved after smoking as compared to intravenous administration [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066138" role="button" aria-expanded="false" aria-haspopup="true">5</a>]. Bioavailability following the smoking route was reported as 2−56%, due in part to intra- and inter-subject variability in smoking dynamics, which contributes to uncertainty in dose delivery [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320603281" role="button" aria-expanded="false" aria-haspopup="true">6</a>-<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320603293" role="button" aria-expanded="false" aria-haspopup="true">9</a>]. The number, duration, and spacing of puffs, hold time, and inhalation volume, or smoking topography, greatly influences the degree of drug exposure [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066144" role="button" aria-expanded="false" aria-haspopup="true">10</a>-<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320603292" role="button" aria-expanded="false" aria-haspopup="true">12</a>]. Expectation of drug reward also may affect smoking dynamics. <em>Cami et al</em>. noted that subjects were able to change their method of smoking hashish cigarettes to obtain higher plasma concentrations of THC, when they expected to receive active drug in comparison to placebo cigarettes [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065984" role="button" aria-expanded="false" aria-haspopup="true">13</a>].</p><p id="P7">A continuous blood-withdrawal pump, collecting blood at a rate of 5 ml/min, enabled capture of the rapid THC absorption phase during smoking for the first time. Formation of 11-OH-THC and THC-COOH was slower, and peak concentrations were much lower [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066111" role="button" aria-expanded="false" aria-haspopup="true">14</a>]. The disposition of THC and its metabolites were followed for a period of 7 d after smoking a single placebo, and cigarettes containing 1.75% or 3.55% of THC. The mean (±S.D.) THC concentrations were 7.0±8.1 ng/ml and 18.1±12.0 ng/ml upon single inhalation of the low-dose (1.75% THC, <em>ca</em>. 16 mg) or the high-dose (3.55% THC, <em>ca</em>. 34 mg) cigarette, respectively, as determined by gas-chromatography/mass spectrometry (GC/MS) [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066007" role="button" aria-expanded="false" aria-haspopup="true">14</a>]. THC, detected in plasma immediately after the first cigarette puff (<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/figure/F1/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a>), was accompanied by the onset of cannabinoid effects [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065962" role="button" aria-expanded="false" aria-haspopup="true">15</a>]. Concentrations increased rapidly, reaching mean peaks of 84.3 ng/ml (range 50−129) and 162.2 ng/ml (range 76−267) for the above two cigarettes, respectively. Peak concentrations occurred at 9.0 min, prior to initiation of the last puff sequence at 9.8 min.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock ten_col whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a class="icnblk_img figpopup" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><img src="./Human Cannabinoid Pharmacokinetics_files/nihms-118643-f0002.gif" class="small-thumb" alt="Fig. 1" title="Fig. 1" src-large="/pmc/articles/PMC2689518/bin/nihms-118643-f0002.jpg"></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Fig. 1</a></div><!--caption a4--><div><span><em>Mean</em> (<em>N</em>=6) <em>plasma concentrations of THC, 11-OH-THC</em>, and THC-COOH during smoking of a single cannabis cigarette containing 3.55% of THC. Arrows (↓) indicate one inhalation or puff on the cannabis cigarette. Reprinted and adapted with permission</span> <strong>...</strong></div></div></div><p id="P8">Despite a computer-paced smoking procedure that controlled the number of puffs, length of inhalation, hold time, and time between puffs, there were large inter-subject differences in plasma THC concentrations due to differences in the depth of inhalation, as participants titrated their THC dose (<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/figure/F2/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2</span></a>). The mean THC concentrations were <em>ca</em>. 60 and 20% of the peak concentrations 15 and 30 min post smoking, respectively. Within 2 h, plasma THC concentrations were ≤ 5 ng/ml. THC Detection windows (GC/MS detection limit 0.5 ng/ml) varied from 3 to 12 h after smoking the low-dose (1.75% THC) cannabis cigarette, and from 6 to 27 h in the case of the high-dose (3.55% THC) cigarette.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock ten_col whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a class="icnblk_img figpopup" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><img src="./Human Cannabinoid Pharmacokinetics_files/nihms-118643-f0003.gif" class="small-thumb" alt="Fig. 2" title="Fig. 2" src-large="/pmc/articles/PMC2689518/bin/nihms-118643-f0003.jpg"></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Fig. 2</a></div><!--caption a4--><div><span>Time-dependent THC concentrations for six individuals (subjects B, C, and E–H) following smoking of a single cannabis cigarette containing 3.55% of THC. Reprinted and adapted with permission by Journal of Analytical Toxicology, p. 280 in [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065986" role="button" aria-expanded="false" aria-haspopup="true">14</a>],</span> <strong>...</strong></div></div></div><p id="P9">Similar mean maximum THC concentrations were reported in specimens collected immediately after cannabis smoking was completed. The mean peak THC concentrations were 94.3, 107.4, and 155.1 ng/ml after smoking single cigarettes of 1.32, 1.97, or 2.54% THC, respectively [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066122" role="button" aria-expanded="false" aria-haspopup="true">16</a>]. Other reported peak THC concentrations ranged between 45.6 and 187.8 ng/ml following smoking of a cigarette containing 1% of THC [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066103" role="button" aria-expanded="false" aria-haspopup="true">17</a>], and 33−118 ng/ml 3 min after <em>ad libitum</em> smoking of a cigarette containing <em>ca</em>. 2% of THC [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066099" role="button" aria-expanded="false" aria-haspopup="true">5</a>]. The smoking route is preferred by many cannabis users because of its rapid drug delivery and resultant fast onset of effects, but also for the ability to titrate dose to the desired degree of effect. In our controlled smoked-cannabis experiments described above, the individual with the lowest peak plasma concentration had the greatest cardiovascular response [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065973" role="button" aria-expanded="false" aria-haspopup="true">15</a>].</p><p id="P10" class="p p-last">The average concentrations in more than 30,000 cannabis preparations confiscated in the U.S. between 1980 and 1997 were 3.1% THC and only 0.3% CBD [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066030" role="button" aria-expanded="false" aria-haspopup="true">18</a>]. However, cannabis-based medicine extracts and clinical-grade cannabis contain high quantities of CBD, which frequently equal the percentage of THC [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066058" role="button" aria-expanded="false" aria-haspopup="true">19</a>]. CBD may modify the effects of THC and reportedly may inhibit cytochrome P450 (CYP 450)-mediated conversion of THC to 11-OH-THC [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066137" role="button" aria-expanded="false" aria-haspopup="true">20</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R21" rid="R21" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">21</a>], although results are not always consistent across studies. The formation of THC from CBD neither occurs by heat during smoking [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066037" role="button" aria-expanded="false" aria-haspopup="true">22</a>] nor by human metabolism.</p></div><div id="S5" class="sec"><p></p><h4 class="inline">2.1.2. Oral </h4><p id="P11" class="p p-first">There are fewer studies on the disposition of THC and its metabolites after oral administration of cannabis as compared to the smoked route. THC is readily absorbed due to its high octanol/water partition coefficient (<em>P</em>), estimated to be between 6,000 and over 9 × 10<sup>6</sup>, depending on the method of determination [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066026" role="button" aria-expanded="false" aria-haspopup="true">23</a>]. The advantages of cannabinoid smoking are offset by the harmful effects of cannabinoid smoke; hence smoking is generally not recommended for therapeutic applications. Synthetic THC, <em>i.e</em>., dronabinol (<em>Marinol</em>®) preparations, are usually taken orally, but may also be administered rectally. In addition, abuse of cannabis by the oral route also is common. Absorption is slower when cannabinoids are ingested, with lower, more-delayed peak THC concentrations [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066090" role="button" aria-expanded="false" aria-haspopup="true">24</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320603287" role="button" aria-expanded="false" aria-haspopup="true">25</a>]. Dose, route of administration, vehicle, and physiological factors such as absorption and rates of metabolism and excretion can influence drug concentrations in circulation. <em>Perez-Reyes et al</em>. described the efficacy of five different vehicles for oral administration of THC in gelatin capsules [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066153" role="button" aria-expanded="false" aria-haspopup="true">26</a>]. Glycocholate and sesame oil improved the bioavailability of oral THC; however, there was considerable variability in peak concentrations and rates of absorption, even when the drug was administered in the same vehicle. Oral THC bioavailability was reported to be 10−20% by <em>Wall et al</em>. [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066031" role="button" aria-expanded="false" aria-haspopup="true">27</a>]. Participants were dosed with either 15 mg (women) or 20 mg (men) of THC dissolved in sesame oil and contained in gelatin capsules. THC Plasma concentrations peaked <em>ca</em>. 4−6 h after ingestion of 15−20 mg of THC in sesame oil. A percentage of the THC was radiolabeled; however, investigators were unable to differentiate labeled THC from its labeled metabolites. Thus, THC concentrations were overestimated.</p><p id="P12">Possibly a more accurate assessment of oral bioavailability of THC in plasma samples was reported by <em>Ohlsson et al</em>., based on GC/MS experiments [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066002" role="button" aria-expanded="false" aria-haspopup="true">5</a>]. The peak THC concentrations ranged from 4.4 to 11 ng/ml, occurring 1−5 h following ingestion of 20 mg of THC in a chocolate cookie; the oral bioavailability was estimated to be 6%. Slow rates of absorption and low THC concentrations occur after oral administration of THC or cannabis. Several factors may account for the low oral bioavailability of 4−20% (as compared to intravenous drug administration), including variable absorption, degradation of drug in the stomach, and significant first-pass metabolism to active 11-OH-THC and inactive metabolites in the liver.</p><p id="P13">Currently, synthetic THC (<em>Marinol</em>®) is approved in the U.S.A. for reduction of nausea and vomiting in cancer chemotherapy, and to increase appetite in HIV-wasting disease. Potential new indications include the reduction of spasticity, analgesia, and as an agonist-replacement pharmacotherapy for cannabis dependence. Thus, the pharmacokinetics of oral THC is of great importance to the successful application of new therapeutic approaches. In a study of the plasma concentrations of THC, 11-OH-THC, and THC-COOH in 17 volunteers upon intake of a single <em>Marinol</em>® capsule (10 mg of THC), mean peak concentrations of 3.8 ng/ml of THC (range 1.1−12.7 ng/ml), 3.4 ng/ml of 11-OH-THC (range 1.2−5.6 ng/ml), and 26 ng/ml of THC-COOH (range 14−46 ng/ml) were found 1−2 h after ingestion [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320603296" role="button" aria-expanded="false" aria-haspopup="true">28</a>]. Similar THC and 11-OH-THC concentrations were observed with consistently higher THC-COOH concentrations. Interestingly, two THC peaks frequently were observed due to enterohepatic circulation. Onset is delayed, peak concentrations are lower, and duration of pharmacodynamic effects generally are extended with a delayed return to baseline, when THC is administered by the oral as compared to the smoked route [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066104" role="button" aria-expanded="false" aria-haspopup="true">29</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065987" role="button" aria-expanded="false" aria-haspopup="true">30</a>].</p><p id="P14">In addition, THC-containing foods, <em>i.e.</em>, hemp oil, beer, and other products, are commercially available for oral consumption. Hemp oil is produced from cannabis seed, and is an excellent source of essential amino acids and <em>ω</em>-linoleic and linolenic fatty acids. The THC content depends upon the effectiveness of cannabis-seed-cleaning and oil-filtration processes. Hemp oil with THC contents ≥ 300 and 1,500 mg/g were available in the U.S.A. and in Europe, respectively. Currently, the THC concentrations of hemp oil in the U.S.A. are low, reflecting the efforts of manufacturers to reduce the amount of THC in hemp-oil products.</p><p id="P15">In a recent, controlled cannabinoid-administration study of THC-containing hemp oils and dronabinol, the pharmacokinetics and pharmacodynamics of oral THC were evaluated. Up to 14.8 mg of THC was ingested by six volunteers each day in three divided doses with meals for five consecutive days [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066127" role="button" aria-expanded="false" aria-haspopup="true">31</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320603298" role="button" aria-expanded="false" aria-haspopup="true">32</a>]. There was a 10-d washout phase between each of the five dosing sessions. THC was quantified in plasma by solid-phase extraction, followed by GC/MS (positive-mode, chemical-ionization) analysis. THC and 11-OH-THC were rarely detected in plasma following the two lowest doses (0.39 and 0.47 mg/d of THC), while, as shown in <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/figure/F3/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3</span></a>, peak plasma concentrations of less than 6.5 ng/ml of THC, &lt;5.6 ng/ml of 11-OH-THC, and &lt;43.0 ng/ml of THC-COOH were found after the two highest THC doses (7.5 and 14.8 mg/d). Interestingly, THC-COOH concentrations after THC administration at a dose of 7.5 mg/d were greater than or equal to those after intake of the high-potency hemp-oil dose (14.8 mg/d). This could be due to the formulation of dronabinol, which afforded greater protection from degradation in the stomach due to encapsulation and perhaps, improved bioavailability of THC in sesame oil, the formulation of synthetic THC or dronabinol. Plasma THC and 11-OH-THC concentrations fell below the method's limits of quantification of 0.5 ng/ml by 25 h, while THC-COOH was still measurable for more than 50 h after the last dose of the higher-concentration hemp oils.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock ten_col whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a class="icnblk_img figpopup" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><img src="./Human Cannabinoid Pharmacokinetics_files/nihms-118643-f0004.gif" class="small-thumb" alt="Fig. 3" title="Fig. 3" src-large="/pmc/articles/PMC2689518/bin/nihms-118643-f0004.jpg"></a><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Fig. 3</a></div><!--caption a4--><div><span><em>Plasma concentrations</em> (<em>N</em>=1) <em>over 24 h for THC</em>, <em>11-OH-THC</em>, <em>and THC-COOH following administration of two doses</em> (2.5 mg each) <em>of synthetic THC</em> (dronabinol) <em>at 4.5 and 10.5 h</em>. Reprinted and adapted with permission by Elsevier, p. 152 in [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320603295" role="button" aria-expanded="false" aria-haspopup="true">32</a>], <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/figure/F2/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2</span></a>.</span></div></div></div><p id="P16">After oral THC dosing, <em>Nadulski et al</em>. reported generally higher THC-COOH concentrations than those of THC almost immediately after dosing, in contrast to what is found after smoking [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065991" role="button" aria-expanded="false" aria-haspopup="true">33</a>]. Concentrations of 11-OH-THC also were higher than those of THC, with an extended detection window. These investigators suggest that ratios of [11-OH-THC]/[THC] &gt;1 and &gt;1.5 within and after 2 h after consumption, respectively, are strong indications for oral intake of THC.</p><p id="P17" class="p p-last">Due to low bioavailability of oral THC formulations, alternative routes of drug administration, including oromucosal or sublingual dosing, vaporization of product and inhalation, and rectal administration, have been developed to improve the amount of delivered cannabinoids.</p></div><div id="S6" class="sec"><p></p><h4 class="inline">2.1.3. Oromucosal </h4><p id="P18" class="p p-first-last">Due to the chemical complexity of cannabis plant material compared to synthetic THC, extracts of cannabis that capture the full range of cannabinoids are being explored as therapeutic medications. Cannabis has been used as medicine for thousands of years [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066038" role="button" aria-expanded="false" aria-haspopup="true">34</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R35" rid="R35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066095" role="button" aria-expanded="false" aria-haspopup="true">35</a>]. Cultivation methods have been developed to reproducibly produce plants with defined THC or CBD concentrations. <em>GW Pharmaceuticals</em> has produced two standardized extract preparations, <em>Tetranabinex</em>®, which is high in THC, and <em>Nabidiolex</em>®, which is high in CBD. <em>Sativex</em>® contains equal proportions of <em>Tetranabinex</em>® and <em>Nabidiolex</em>®, and, hence, almost equal amounts of THC and CBD. THC and CBD represent approximately 70% of the product, with 5% of other cannabinoids, the remainder being terpenoids, flavonoids, sterols, alkanes, and other chemicals [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R36" rid="R36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066147" role="button" aria-expanded="false" aria-haspopup="true">36</a>]. Clinical trials of the efficacy of these extracts are ongoing for analgesia [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R37" rid="R37" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">37</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R38" rid="R38" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">38</a>] and spasticity, and other indications in affected patients [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R39" rid="R39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066106" role="button" aria-expanded="false" aria-haspopup="true">39</a>]. <em>Sativex</em>® is administered sublingually to avoid first-pass metabolism by the liver. <em>Sativex</em>® is approved in Canada for the treatment of neuropathic pain associated with multiple sclerosis, and in three European countries for a number of indications.</p></div><div id="S7" class="sec"><p></p><h4 class="inline">2.1.4. Rectal </h4><p id="P19" class="p p-first-last">Several different suppository formulations were evaluated in monkeys to determine the matrix that maximizes bioavailability and reduces first-pass metabolism [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R40" rid="R40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065956" role="button" aria-expanded="false" aria-haspopup="true">40</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R41" rid="R41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066100" role="button" aria-expanded="false" aria-haspopup="true">41</a>]; THC-hemisuccinate provided the highest bioavailability of 13.5%. <em>Brenneisen et al</em>. evaluated plasma THC concentrations in two patients who were prescribed THC-hemisuccinate suppositories or <em>Marinol</em>® for spasticity [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R42" rid="R42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066155" role="button" aria-expanded="false" aria-haspopup="true">42</a>]. THC did not accumulate in the blood following 10−15 mg daily doses. THC concentrations peaked within 1−8 h after oral administration, and ranged between 2.1 to 16.9 ng/ml. Rectal administration of 2.5−5 mg of THC produced maximum plasma concentrations of 1.1−4.1 ng/ml within 2−8 h. The bioavailability of the rectal route was approximately twice that of the oral route due to higher absorption and lower first-pass metabolism.</p></div><div id="S8" class="sec"><p></p><h4 class="inline">2.1.5. Transcutaneous </h4><p id="P20" class="p p-first">Another route of cannabinoid exposure that avoids first-pass metabolism and improves THC bioavailability is topical administration [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R43" rid="R43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066070" role="button" aria-expanded="false" aria-haspopup="true">43</a>]. Cannabinoids are highly hydrophobic, making transport across the aqueous layer of the skin the rate-limiting step in the diffusion process [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R44" rid="R44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066133" role="button" aria-expanded="false" aria-haspopup="true">44</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R45" rid="R45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065996" role="button" aria-expanded="false" aria-haspopup="true">45</a>]. <em>In vitro</em> diffusion studies may underestimate <em>in vivo</em> transdermal flux [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R43" rid="R43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066087" role="button" aria-expanded="false" aria-haspopup="true">43</a>]. After application of a dermal patch, mean steady-state plasma concentration of Δ<sup>8</sup>-THC was 4.4 ng/ml within 1.4 h, and was maintained for at least 48 h. Permeabilities of CBD and CBN were found to be 10-fold higher than for Δ<sup>8</sup>-THC. <em>In vivo</em> studies of transdermal drug delivery in guinea pigs noted the presence of significant amounts of plasma metabolites after topical application of THC [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R46" rid="R46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066116" role="button" aria-expanded="false" aria-haspopup="true">46</a>]. Additional research is planned with combinations of cannabinoids in EtOH to increase drug absorption.</p><p id="P21">Transdermal delivery of cannabinoids is hoped to reduce negative side effects seen with inhalation dosing [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R47" rid="R47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066028" role="button" aria-expanded="false" aria-haspopup="true">47</a>]. Transdermal delivery also bypasses first-pass metabolism of cannabinoids. These properties could improve the utility of transdermal cannabinoid medications. Applying a transdermal patch several hours before chemotherapy, and wearing it for several days, would be a convenient means for treating associated nausea and vomiting. Also, wearing a patch for a week to stimulate appetite could be a good alternative to twice a day oral dosing of dronabinol.</p><p id="P22" class="p p-last">The drug-abuse potential of cannabinoid transdermal patches is expected to be low because of slow delivery of THC to the brain. However, extraction of cannabinoids from the patch for administration by a more-rapid method has not been evaluated. Diversion of fentanyl patches by drug abusers for use in such a manner has been a significant problem.</p></div><div id="S9" class="sec"><p></p><h4 class="inline">2.1.6. Intravenous </h4><p id="P23" class="p p-first-last">Although THC is not abused by the intravenous route, pharmacodynamic and pharmacokinetic cannabinoid research has employed this technique. Recently, <em>D'Souza et al</em>. administered THC intravenously to evaluate the association between cannabinoids and psychosis [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R48" rid="R48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066158" role="button" aria-expanded="false" aria-haspopup="true">48</a>]. The double-blind, randomized, and placebo-controlled study investigated the behavioral, cognitive, and endocrine effects of 0, 2.5, and 5 mg of THC in healthy individuals with a history of cannabis exposure, but never diagnosed with a cannabis-abuse disorder. After 10 min, the plasma THC concentrations were 82±87.4 and 119.2±166.5 for intravenous doses of 2.5 and 5.0 mg, ng/ml respectively; the respective THC-COOH concentrations were 43.8±26.1 and 81.9±47 ng/ml. Some subjects withdrew from the study due to acute paranoia (1), panic (1), hypotension (2), withdrawal of consent due to dislike of THC effects (3), and other issues (2). One subject experienced a significant, acute paranoid reaction and was treated with 2 mg lorazepam. THC produced schizophrenia-like positive and negative symptoms and euphoria, and altered aspects of cognitive function. Plasma cortisol concentrations were not affected. THC produced a broad range of transient symptoms, behaviors, and cognitive deficits in healthy individuals that resembled endogenous psychoses. The investigators suggested that brain-cannabinoid-receptor function could be an important factor in the pathophysiology of psychotic disorders.</p></div><div id="S10" class="sec sec-last"><p></p><h4 class="inline">2.1.7. Cannabidiol Absorption </h4><p id="P24" class="p p-first">Cannabidiol (CBD) is a natural, non-psychoactive [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R49" rid="R49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065985" role="button" aria-expanded="false" aria-haspopup="true">49</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R50" rid="R50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320603285" role="button" aria-expanded="false" aria-haspopup="true">50</a>] constituent of <em>Cannabis sativa</em>, but possesses pharmacological activity, which is explored for therapeutic applications. CBD has been reported to be neuroprotective [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R51" rid="R51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066057" role="button" aria-expanded="false" aria-haspopup="true">51</a>], analgesic [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R37" rid="R37" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">37</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R38" rid="R38" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">38</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R52" rid="R52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320603294" role="button" aria-expanded="false" aria-haspopup="true">52</a>], sedating [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R37" rid="R37" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">37</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R38" rid="R38" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">38</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R53" rid="R53" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">53</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R54" rid="R54" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">54</a>], anti-emetic [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R54" rid="R54" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">54</a>], anti-spasmodic [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R55" rid="R55" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065955" role="button" aria-expanded="false" aria-haspopup="true">55</a>], and anti-inflammatory [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R56" rid="R56" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065959" role="button" aria-expanded="false" aria-haspopup="true">56</a>]. In addition, it has been reported that CBD blocks anxiety produced by THC [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R57" rid="R57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066052" role="button" aria-expanded="false" aria-haspopup="true">57</a>], and may be useful in the treatment of autoimmune diseases [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R53" rid="R53" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">53</a>]. CBD also has been reported to decrease some of the side effects of THC [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R36" rid="R36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066069" role="button" aria-expanded="false" aria-haspopup="true">36</a>]. These potential therapeutic applications alone warrant investigation of CBD pharmacokinetics. Further, the controversy over whether CBD alters the pharmacokinetics of THC in a clinically significant manner needs to be resolved [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R58" rid="R58" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">58</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R59" rid="R59" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">59</a>].</p><p id="P25"><em>Ohlsson et al</em>. reported CBD levels of 37−61 ng/ml (<em>n</em>=3, mean 48.4 ng/ml) 1 h after intravenous injection of 20 mg of deuterium-labeled CBD, and of 3.0−17.8 ng/ml (<em>n</em>=3, mean 10.2 ng/ml) 1 h after smoking a cigarette containing 19.2 mg of deuterium-labeled CBD [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R60" rid="R60" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066078" role="button" aria-expanded="false" aria-haspopup="true">60</a>]. Average bioavailability by the smoked route was 31 13% in five subjects, with a fourfold difference in availability noted. Based on the area under the curve (AUC) for 72 h and the dose after intravenous administration, a plasma clearance of 960−1560 ml/min was calculated. <em>Agurell et al</em>. found 1.1−11 ng/ml of CBD 1 h after oral application of 40 mg of CBD (<em>n</em>=12, mean 5.5 ng/ml) in chocolate cookies [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R61" rid="R61" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065971" role="button" aria-expanded="false" aria-haspopup="true">61</a>]. Recently, <em>Nadulski et al</em>. reported CBD concentrations of 0.30−2.57 ng/ml (mean: 0.95 ng/ml) 1 h after oral intake of 5.4 mg of CBD [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065992" role="button" aria-expanded="false" aria-haspopup="true">33</a>]. CBD remained detectable for 3−4 h after administration. The authors suggest that identification and quantification of CBD could be an additional proof of cannabis exposure and could improve interpretation of THC effects considering the potential ability of CBD to modify THC effects.</p><p id="P26" class="p p-last">When comparing sublingual administration of THC (25 mg) alone <em>vs</em>. THC/CBD (25 mg each) in cannabis-based medicinal extracts, no statistically significant differences in mean THC maximum concentration, half-life, or AUC for THC and 11-OHTHC were observed [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R62" rid="R62" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">62</a>]. The only statistically significant difference was in the time of maximum THC concentration. Despite administration of equivalent amounts of THC and CBD, lower plasma concentrations of CBD were always observed. The pharmacokinetics of THC, 11-OH-THC, and CBD also were evaluated after administration of 10 mg each of THC and CBD, either <em>via</em> the sublingual, buccal, oromucosal, or oral routes [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R63" rid="R63" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">63</a>]. All three analytes were detectable <em>ca</em>. 30 min after dosing, with higher THC than CBD concentrations. 11-OH-THC generally exceeded THC concentrations within 45 min of dosing. Mean maximum concentrations for THC, CBD, and 11-OH-THC were &lt;5, &lt;2, and &lt;7 ng/ml, respectively, across all administration routes. High intra- and inter-subject variability was noted.</p></div></div><div id="S11" class="sec"><h3>2.2. Distribution</h3><p id="P27" class="p p-first">THC Plasma concentrations decrease rapidly after the end of smoking due to rapid distribution into tissues and metabolism in the liver. THC is highly lipophilic and initially taken up by tissues that are highly perfused, such as the lung, heart, brain, and liver. Tracer doses of radioactive THC documented the large volume of distribution of THC and its slow elimination from body stores. In animals, after intravenous administration of labeled THC, higher levels of radioactivity were present in lung than in other tissues [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R64" rid="R64" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066027" role="button" aria-expanded="false" aria-haspopup="true">64</a>]. Studies of the distribution of THC into brain are especially important for understanding the relationships between THC dose and behavioral effects. After single intra-muscular administration of <sup>14</sup>C-labeled Δ<sup>8</sup>-THC to rats, maximal radioactivity was reached in brain after 2−4 h, representing 0.06% of the administered dose [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R65" rid="R65" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320603283" role="button" aria-expanded="false" aria-haspopup="true">65</a>]. Plasma concentrations were of similar magnitude to those measured in men exposed to marihuana smoke. <em>Kreuz</em> and <em>Axelrod</em> were the first to describe the persistent and preferential retention of radiolabeled THC in neutral fat after multiple doses, in contrast to limited retention in brain [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R66" rid="R66" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065995" role="button" aria-expanded="false" aria-haspopup="true">66</a>]. The ratio of fat to brain THC concentration was approximately 21 : 1 after 7 d of consecutive exposure, and 64 : 1 after 27 d. Other investigators also found that the amount of THC retained in the brain after administration of radiolabeled THC was less than 1% of the administered dose [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R67" rid="R67" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320603284" role="button" aria-expanded="false" aria-haspopup="true">67</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R68" rid="R68" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">68</a>]. With prolonged drug exposure, THC concentrates in human fat, being retained for extended periods of time [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R69" rid="R69" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066124" role="button" aria-expanded="false" aria-haspopup="true">69</a>]. It is suggested that fatty acid conjugates of THC and 11-OH-THC may be formed, increasing the stability of these compounds in fat [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R70" rid="R70" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066000" role="button" aria-expanded="false" aria-haspopup="true">70</a>].</p><p id="P28">Distribution of THC into peripheral organs and the brain was found to be similar in THC-tolerant <em>vs</em>. non-tolerant dogs [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R71" rid="R71" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066064" role="button" aria-expanded="false" aria-haspopup="true">71</a>]. In addition, these investigators found that tolerance to the behavioral effects of THC in pigeons was not due to decreased uptake of cannabinoids into the brain. Tolerance also was evaluated in humans. <em>Hunt</em> and <em>Jones</em> found that tolerance in humans developed during oral administration of 30 mg of THC every 4 h, for 10−12 d [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R72" rid="R72" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066086" role="button" aria-expanded="false" aria-haspopup="true">72</a>]. Few pharmacokinetic changes were noted during chronic administration, although average total metabolic clearance and initial apparent volume of distribution increased from 605 to 977 ml/min, and from 2.6 to 6.4 l/kg, respectively. Pharmacokinetic changes after chronic oral THC administration could not account for observed behavioral and physiologic tolerance, suggesting rather that tolerance was due to pharmacodynamic adaptation.</p><p id="P29"><em>Adams</em> and <em>Martin</em> studied the THC dose required to induce pharmacological effects in humans [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R73" rid="R73" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066049" role="button" aria-expanded="false" aria-haspopup="true">73</a>]. They determined that 2−22 mg of THC must be present in a cannabis cigarette to deliver 0.2−4.4 mg of THC, based on 10−25% bioavailability for smoked THC. Only 1% of this dose at peak concentration was found in the brain, indicating that only 2−44 μg of THC penetrates to the brain.</p><p id="P30">In a recent, highly interesting study, <em>Mura et al</em>. analyzed paired blood and brain specimens in 12 postmortem cases for THC and THC-COOH, and also for 11-OH-THC, in two regular cannabis smokers by GC/MS [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R74" rid="R74" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066039" role="button" aria-expanded="false" aria-haspopup="true">74</a>]. The THC concentrations in blood and brain ranged from &lt;0.2 to 11.5 ng/ml, and from 0.9 to 29.9 ng/g, respectively. There was no correlation between blood and brain concentrations; brain levels were always higher than blood levels, and in three cases measurable drug concentrations remained in the brain, when no longer detectable in the blood. In two additional cases, sufficient brain tissue was available to monitor THC, 11-OH-THC, and THC-COOH concentrations in both blood and seven brain areas known to have high concentrations of cannabinoid CB-1 receptors. THC, 11-OH-THC, and THC-COOH were found in substantial concentrations in all brain areas, including locus niger, hippocampus, occipital lobe, striatum-putamen-palladium, frontal lobe, spinal cord, and corpus callosum, the order generally being THC≥THC-COOH&gt;11-OH-THC. Blood concentrations were lower than in the two-paired brains. The authors postulate that long-lasting effects of cannabis during abstinence in heavy users may be due to residual THC and 11-OH-THC concentrations in the brain. The consequences of THC-COOH in the brain remain unknown.</p><p id="P31">Storage of THC after chronic exposure could also contribute to observed toxicities in other tissues. After single intramuscular administration of radioactive THC in rats, only 0.023% of the original THC dose was found in testis, although total radioactivity in epididymal fat was five- and eight times higher than that in the brain after 4 and 24 h, respectively [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R65" rid="R65" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320603297" role="button" aria-expanded="false" aria-haspopup="true">65</a>]. After multiple injections, concentrations of THC remained low in plasma, brain, and testis, not exceeding 2−7 ng/g, but the epididymal-fat tracer concentration was 40 to 80 times higher. The authors suggest that the blood–brain and blood–testicular barriers limit storage of THC in brain and testis during acute exposure; however, during THC chronic exposure, pharmacokinetic mechanisms are insufficient to prevent accumulation of THC in tissues, with subsequent deregulation of cellular processes, including apoptosis of spermatogenic cells.</p><p id="P32">In one of the latest investigations on THC distribution in tissues, the large-white-pig model was selected due to similarities with humans in drug biotransformation, including enzymes and isoenzymes of drug biotransformation, size, feeding patterns, digestive physiology, dietary habits, kidney structure and function, pulmonary vascular bed structure, coronary-artery distribution, propensity to obesity, respiratory rates, and tidal volume [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R75" rid="R75" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066010" role="button" aria-expanded="false" aria-haspopup="true">75</a>]. THC Plasma pharmacokinetics was found to be similar to those in humans. Eight pigs received 200 mg/kg intra-jugular THC injections, and two pigs were sacrificed 30 min, 2, 6, and 24 h later. At 30 min, high THC concentrations were noted in lung, kidney, liver, and heart, with comparable elimination kinetics in kidney, heart, spleen, muscle, and lung as observed in blood. The fastest THC elimination was noted in liver, where concentrations fell below measurable levels by 6 h. Mean brain concentration was approximately twice the blood concentration at 30 min, with highest levels in the cerebellum, and occipital and frontal cortex, and lowest concentrations in the medulla oblongata. THC Concentrations decreased in brain tissue slower than in blood. The slowest THC elimination was observed for fat tissue, where THC was still present at substantial concentrations 24 h later. 11-OH-THC was only found at high concentrations in the liver. The THC-COOH level was &lt;5 ng/g in most tissues, except in bile, where it increased for 24 h following THC injection. The authors suggest that the prolonged retention of THC in brain and fat in heavy cannabis users is responsible for the prolonged detection of THC-COOH in urine and cannabis-related flashbacks. The author of this review hypothesizes that this residual THC may also contribute to cognitive deficits noted early during abstinence in chronic cannabis users.</p><p id="P33">THC accumulation in the lung occurs because of high exposure from cannabis smoke, extensive perfusion of the lung, and high uptake of basic compounds in lung tissue. Lung tissue is readily available during postmortem analysis, and would be a good matrix for investigation of cannabis exposure.</p><p id="P34">Metabolism of THC to 11-OH-THC, THC-COOH, and other analytes also contributes to the reduction of THC in blood. <em>Perez-Reyes et al</em>. compared the pharmacokinetics and pharmacodynamics of tritiated THC and 11-OH-THC in 20 male volunteers [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R76" rid="R76" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065999" role="button" aria-expanded="false" aria-haspopup="true">76</a>]. Although equal doses produced equal psychoactive effects, drug effects were perceived more rapidly after exposure to 11-OH-THC than to THC. In addition, 11-OH-THC left the intravascular compartment faster than THC. These data suggest that 11-OH-THC diffuses into the brain more readily than THC does. Other possible explanations include lower plasma-protein binding of 11-OH-THC or enhanced crossing of the blood–brain barrier by the hydroxylated metabolite.</p><p id="P35">The distribution volume (<em>V</em><sub>d</sub>) of THC is large, <em>ca</em>. 10 l/kg, despite the fact that it is 95−99% protein-bound in plasma, primarily to lipoproteins [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R72" rid="R72" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066102" role="button" aria-expanded="false" aria-haspopup="true">72</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R77" rid="R77" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065976" role="button" aria-expanded="false" aria-haspopup="true">77</a>]. Protein-binding values for THC-COOH and THC-COOH glucuronide were similar to those of THC proper (<em>ca</em>. 97%) [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R78" rid="R78" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066035" role="button" aria-expanded="false" aria-haspopup="true">78</a>]. More recently, with the benefit of advanced analytical techniques, the steady state <em>V</em><sub>d</sub> value of THC was estimated to be 3.4 l/kg [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R70" rid="R70" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066083" role="button" aria-expanded="false" aria-haspopup="true">70</a>]. THC-COOH was found to be far less lipophilic than the parent drug, whose partition coefficient <em>P</em> value at neutral pH has been measured at 6,000 (or higher), and more lipophilic than the glucuronide [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R78" rid="R78" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065979" role="button" aria-expanded="false" aria-haspopup="true">78</a>]. The fraction of THC glucuronide present in blood after different routes of administration has not been adequately resolved, but, recently, the partition coefficient of this compound indicated an unexpectedly high lipophilicity, <em>ca</em>. 18 at pH 7.4.</p><p id="P36" class="p p-last">THC rapidly crosses the placenta, although concentrations were lower in canine and ovine fetal blood and tissues than in maternal plasma and tissues [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R79" rid="R79" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320603282" role="button" aria-expanded="false" aria-haspopup="true">79</a>]. The metabolites 11-OH-THC and THC-COOH crossed the placenta much less efficiently [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R80" rid="R80" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065968" role="button" aria-expanded="false" aria-haspopup="true">80</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R81" rid="R81" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066136" role="button" aria-expanded="false" aria-haspopup="true">81</a>]. No THC-COOH was detected in fetal plasma and tissues, indicating a lack of transfer across the placenta, and a lack of metabolism of THC in fetal monkey [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R80" rid="R80" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066101" role="button" aria-expanded="false" aria-haspopup="true">80</a>]. <em>Blackard</em> and <em>Tennes</em> reported that THC in cord blood was three to six times less than in maternal blood [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R82" rid="R82" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066076" role="button" aria-expanded="false" aria-haspopup="true">82</a>]. Transfer of THC to the fetus was greater in early pregnancy. THC also concentrates into breast milk from maternal plasma due to its high lipophilicity [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R83" rid="R83" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066020" role="button" aria-expanded="false" aria-haspopup="true">83</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R84" rid="R84" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066017" role="button" aria-expanded="false" aria-haspopup="true">84</a>]. THC Concentration in breast milk was 8.4 times higher than in plasma in one woman, yielding a daily THC exposure to the infant of 0.01 to 0.1 mg/d, assuming that the mother smokes one to two cannabis cigarettes each day [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R84" rid="R84" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066021" role="button" aria-expanded="false" aria-haspopup="true">84</a>].</p></div><div id="S12" class="sec"><h3>2.3. Metabolism</h3><div id="S13" class="sec sec-first"><p></p><h4 class="inline">2.3.1. Hepatic Metabolism </h4><p id="P37" class="p p-first">Burstein and co-workers were the first to show that 11-OH-THC and THC-COOH are primary metabolites of THC in rabbits and rhesus monkeys [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R85" rid="R85" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066041" role="button" aria-expanded="false" aria-haspopup="true">85</a>-<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R87" rid="R87" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066016" role="button" aria-expanded="false" aria-haspopup="true">87</a>]. They also documented that THC can be metabolized in the brain. <em>Harvey et al</em>. monitored the metabolism of THC, CBD, and CBN in mice, rats, and guinea pigs, and found extensive metabolism, but with inter-species variation [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R88" rid="R88" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">88</a>]. Phase-I oxidation reactions of THC include allylic and aliphatic hydroxylations, oxidation of alcohols to ketones and acids, <em>β</em>-oxidation, and degradation of the pentyl side chain. Conjugation with glucuronic acid is a common Phase-II reaction. 11-OH-THC was the primary metabolite in all three species, followed by 8<em>α</em>-OH-THC in the mouse and rat, and 8<em>β</em>-OH-THC in guinea pig. Side-chain hydroxylation was common in all three species. THC-COOH concentrations were higher in the mouse and rat, while THC-COOH glucuronide concentrations predominated in the guinea pig. THC Concentrations accumulated in the liver, lung, heart, and spleen.</p><p id="P38">Hydroxylation of THC at C(9) by the hepatic CYP 450 enzyme system leads to production of the equipotent metabolite 11-OH-THC [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R89" rid="R89" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066142" role="button" aria-expanded="false" aria-haspopup="true">89</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R90" rid="R90" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066092" role="button" aria-expanded="false" aria-haspopup="true">90</a>], originally thought by early investigators to be the true psychoactive analyte [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R64" rid="R64" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066130" role="button" aria-expanded="false" aria-haspopup="true">64</a>]. CYP 450 2C9, 2C19, and 3A4 are involved in the oxidation of THC [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R90" rid="R90" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065998" role="button" aria-expanded="false" aria-haspopup="true">90</a>]. More than 100 THC metabolites, including di- and trihydroxy compounds, ketones, aldehydes, and carboxylic acids, have been identified [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R21" rid="R21" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">21</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R70" rid="R70" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066149" role="button" aria-expanded="false" aria-haspopup="true">70</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R91" rid="R91" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">91</a>]. Although 11-OH-THC predominates as the first oxidation product, significant amounts of 8<em>β</em>-OH-THC and lower amounts of the 8<em>α</em>-OH-THC are formed. Much lower plasma 11-OH-THC concentrations (<em>ca</em>. 10% of THC concentrations) are found after cannabis smoking than after oral administration [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066043" role="button" aria-expanded="false" aria-haspopup="true">27</a>]. Peak 11-OH-THC concentrations occurred <em>ca</em>. 13 min after the start of smoking [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066118" role="button" aria-expanded="false" aria-haspopup="true">14</a>]. <em>Bornheim et al</em>. reported that 11-OH-THC and 8<em>β</em>-OH-THC were formed at the same rate in human-liver microsomes, with smaller amounts of ‘epoxyhexahydrocannabinol’, 8<em>α</em>-OH-THC, and 8-keto-THC [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R92" rid="R92" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066072" role="button" aria-expanded="false" aria-haspopup="true">92</a>]. CYP 450 2C9 is thought to be primarily responsible for the formation of 11-OH-THC, whereas CYP 450 3A catalyzes the formation of 8<em>β</em>-OH-THC, ‘epoxyhexahydrocannabinol’, and other minor metabolites. Less than fivefold variability in 2C9 rates of activity was observed, while much higher variability was noted for the 3A enzyme. Dihydroxylation of THC yields 8<em>β</em>,11-di-OH-THC. Excretion of 8<em>β</em>,11-di-OH-THC in urine was reported to be a good biomarker for recent cannabis use [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R93" rid="R93" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066073" role="button" aria-expanded="false" aria-haspopup="true">93</a>].</p><p id="P39">Oxidation of the psychoactive 11-OH-THC produces the inactive metabolite THC-COOH [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R64" rid="R64" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066047" role="button" aria-expanded="false" aria-haspopup="true">64</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R94" rid="R94" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066126" role="button" aria-expanded="false" aria-haspopup="true">94</a>]. THC-COOH and its glucuronide conjugate are the major end products of biotransformation in most species, including man [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R91" rid="R91" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">91</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R95" rid="R95" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066146" role="button" aria-expanded="false" aria-haspopup="true">95</a>]. THC-COOH concentrations gradually increase, and are greater than THC concentrations 30−45 min after the end of smoking [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R96" rid="R96" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066036" role="button" aria-expanded="false" aria-haspopup="true">96</a>]. After ingestion of a single oral dose of <em>Marinol</em>® (10 mg THC), plasma THC-COOH concentrations were higher than those of THC and 11-OH-THC as early as 1 h after dosing [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R97" rid="R97" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">97</a>]. Unlike after smoking, THC and 11-OH-THC concentrations are similar after oral THC administration.</p><p id="P40">Phase-II metabolism of THC-COOH involves addition of glucuronic acid, and, less commonly, of sulfate, glutathione, amino acids, and fatty acids <em>via</em> the 11-COOH group. The phenolic OH group may be a target as well. It is also possible to have two glucuronic acid moieties attached to THC-COOH, although steric hindrance at the phenolic OH group could be a factor. Addition of the glucuronide group improves water solubility, facilitating excretion, but renal clearance of these polar metabolites is low due to extensive protein binding [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R72" rid="R72" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066091" role="button" aria-expanded="false" aria-haspopup="true">72</a>]. No significant differences in metabolism between men and women have been reported [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066048" role="button" aria-expanded="false" aria-haspopup="true">27</a>].</p><p id="P41">After the initial distribution phase, the rate-limiting step in the metabolism of THC is its redistribution from lipid depots into blood [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R98" rid="R98" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065958" role="button" aria-expanded="false" aria-haspopup="true">98</a>]. <em>Lemberger et al</em>. suggested that frequent cannabis smoking could induce THC metabolism [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R99" rid="R99" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065982" role="button" aria-expanded="false" aria-haspopup="true">99</a>]. However, later studies did not corroborate this finding [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066110" role="button" aria-expanded="false" aria-haspopup="true">8</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R91" rid="R91" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">91</a>].</p><p id="P42" class="p p-last">More than 30 metabolites of CBD were identified in urine, with hydroxylation of the 7-Me group and subsequent oxidation to the corresponding carboxylic acid as the main metabolic route, in analogy to THC [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R100" rid="R100" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065967" role="button" aria-expanded="false" aria-haspopup="true">100</a>].</p></div><div id="S14" class="sec"><p></p><h4 class="inline">2.3.2. Extrahepatic Metabolism </h4><p id="P43" class="p p-first">Other tissues, including brain, intestine, and lung, may contribute to the metabolism of THC, although alternate hydroxylation pathways may be more prominent [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R86" rid="R86" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">86</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R101" rid="R101" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066018" role="button" aria-expanded="false" aria-haspopup="true">101</a>-<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R104" rid="R104" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066022" role="button" aria-expanded="false" aria-haspopup="true">104</a>]. An extrahepatic metabolic site should be suspected whenever total body clearance exceeds blood flow to the liver, or when severe liver dysfunction does not affect metabolic clearance [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R102" rid="R102" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066077" role="button" aria-expanded="false" aria-haspopup="true">102</a>]. Of the ten mammalian classes of CYP 450 systems, the cytochrome families 1−4 primarily metabolize xenobiotics, which are found in the liver, small intestine, peripheral blood, bone marrow, and mast cells in decreasing concentrations, with the lowest concentrations in the brain, pancreas, gall bladder, kidney, skin, salivary glands, and testes. Within the brain, higher concentrations of CYP 450 enzymes are found in the brain stem and cerebellum [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R102" rid="R102" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065970" role="button" aria-expanded="false" aria-haspopup="true">102</a>]. The hydrolyzing enzymes – non-specific esterases, <em>β</em>-glucuronidases, and sulphatases–are primarily found in the gastrointestinal tract. Side-chain hydroxylation of THC is prominent in THC metabolism by the lung. Metabolism of THC by fresh biopsies of human intestinal mucosa yielded polar hydroxylated metabolites that directly correlated with time and amount of intestinal tissue [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R101" rid="R101" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066062" role="button" aria-expanded="false" aria-haspopup="true">101</a>].</p><p id="P44" class="p p-last">In a study of the metabolism of THC in the brains of mice, rats, guinea pigs, and rabbits, <em>Watanabe et al</em>. found that brain microsomes oxidized THC to monohydroxylated metabolites [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R103" rid="R103" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065966" role="button" aria-expanded="false" aria-haspopup="true">103</a>]. Hydroxylation of C(4) of the pentyl side chain produced the most common THC metabolite in the brains of these animals, similar to THC metabolites produced in the lung. These metabolites are pharmacologically active, but their relative activity is unknown.</p></div><div id="S15" class="sec sec-last"><p></p><h4 class="inline">2.3.3. Metabolism of Cannabidiol </h4><p id="P45" class="p p-first-last">CBD Metabolism is similar to that of THC, with primary oxidation of C(9) to the alcohol and carboxylic acid [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066080" role="button" aria-expanded="false" aria-haspopup="true">8</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R100" rid="R100" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066084" role="button" aria-expanded="false" aria-haspopup="true">100</a>], as well as side-chain oxidation [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R88" rid="R88" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">88</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R100" rid="R100" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065964" role="button" aria-expanded="false" aria-haspopup="true">100</a>]. Like THC, CBD is subjected to a significant first-pass effect; however, unlike THC, a large proportion of the dose is excreted unchanged in the feces [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R105" rid="R105" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">105</a>]. <em>Benowitz et al</em>. reported that CBD is an <em>in vitro</em> inhibitor of liver microsomal drug-metabolizing enzymes, inhibiting hexobarbital metabolism in humans [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R50" rid="R50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320603288" role="button" aria-expanded="false" aria-haspopup="true">50</a>]. Others have reported that CBD selectively inhibits THC-metabolite formation <em>in vitro</em> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R58" rid="R58" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">58</a>]. <em>Hunt et al</em>. reported that the pharmacokinetics of THC were not affected by CBD, except for a slight slowing of the metabolism of 11-OH-THC to THC-COOH [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R106" rid="R106" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066006" role="button" aria-expanded="false" aria-haspopup="true">106</a>]. Co-administration of CBD did not significantly affect the total clearance, volume of distribution, and terminal elimination half-lives of THC metabolites. Concentration <em>vs</em>. time curves, and ratios of the maximum average concentration and AUC values for 11-OH-THC/THC, THC-COOH/THC, and THC-COOH/11-OH-THC showed that CBD only partially inhibited the hydroxylation of THC to 11-OH-THC catalyzed by CYP 2C, when data were compared after oral administration of THC alone, as compared to a THC and CBD preparation [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R107" rid="R107" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066012" role="button" aria-expanded="false" aria-haspopup="true">107</a>]. THC and CBD concentrations are high in the liver after oral administration, and there is high first-pass metabolism of THC. However, the effect of CBD on hydroxylation of THC was small in comparison to overall variability.</p></div></div><div id="S16" class="sec sec-last"><h3>2.4. Elimination</h3><p id="P46" class="p p-first">Within 5 d, a total of 80−90% of THC is excreted, mostly as hydroxylated and carboxylated metabolites [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R21" rid="R21" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">21</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R95" rid="R95" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066159" role="button" aria-expanded="false" aria-haspopup="true">95</a>]. More than 65% is excreted in the feces, <em>ca</em>. 20% being eliminated in the urine [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065975" role="button" aria-expanded="false" aria-haspopup="true">27</a>]. Numerous acidic metabolites are found in the urine, many of which are conjugated with glucuronic acid to increase their water solubility. The primary urinary metabolite is the acid-linked THC-COOH glucuronide conjugate [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R108" rid="R108" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066004" role="button" aria-expanded="false" aria-haspopup="true">108</a>], while 11-OH-THC predominates in the feces [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R21" rid="R21" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">21</a>]. The concentration of free THC-COOH, and the cross-reactivity of glucuronide-bound THC-COOH enable cannabinoid immunoassays to be performed directly on non-hydrolyzed urine, but confirmation and quantification of THC-COOH is usually performed after alkaline hydrolysis or <em>β</em>-glucuronidase hydrolysis to free THC-COOH for measurement by GC/MS. It was initially thought that little or no THC and 11-OH-THC were excreted in the urine.</p><div id="S17" class="sec"><p></p><h4 class="inline">2.4.1. Terminal Elimination Half-Lives of THC-COOH </h4><p id="P47" class="p p-first-last">Another common problem with studying the pharmacokinetics of cannabinoids in humans is the need for highly sensitive procedures to measure low cannabinoid concentrations in the terminal phase of excretion, and the requirement for monitoring plasma concentrations over an extended period to adequately determine cannabinoid half-lives. Many studies utilized short sampling intervals of 24−72 h that underestimate terminal THC and THC-COOH half-lives. The slow release of THC from lipid-storage compartments and significant enterohepatic circulation contribute to a long terminal half-life of THC in plasma, reported to be greater than 4.1 d in chronic cannabis users [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R109" rid="R109" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065983" role="button" aria-expanded="false" aria-haspopup="true">109</a>]. Isotopically labeled THC and sensitive analytical procedures were used to obtain this drug half-life. <em>Garrett</em> and <em>Hunt</em> reported that 10−15% of the THC dose is enterohepatically circulated in dogs [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R98" rid="R98" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066029" role="button" aria-expanded="false" aria-haspopup="true">98</a>]. <em>Johansson et al</em>. reported a THC-COOH plasma-elimination half-life of up to 12.6 d in a chronic cannabis user, when monitoring THC-COOH concentrations over four weeks [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R110" rid="R110" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066055" role="button" aria-expanded="false" aria-haspopup="true">110</a>]. Mean plasma THC-COOH elimination half-lives were 5.2±0.8 and 6.2±6.7 d for frequent and infrequent cannabis users, respectively. Similarly, when sensitive analytical procedures and sufficient sampling periods were employed for determining the terminal urinary excretion half-life of THC-COOH, it was estimated to 3−4 d [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R111" rid="R111" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066152" role="button" aria-expanded="false" aria-haspopup="true">111</a>]. Urinary THC-COOH concentrations drop rapidly until reaching a value of <em>ca</em>. 20−50 ng/ml, and then decrease at a much slower rate. No significant pharmacokinetic differences between chronic and occasional users have been substantiated [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R112" rid="R112" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320603291" role="button" aria-expanded="false" aria-haspopup="true">112</a>].</p></div><div id="S18" class="sec"><p></p><h4 class="inline">2.4.2. Percentage of THC Excreted as Urinary THC-COOH </h4><p id="P48" class="p p-first">An average of 93.9±24.5 mg of THC-COOH (range 34.6−171.6 μg) was measured in urine over a period of 7 d, following smoking of a single cannabis cigarette containing <em>ca</em>. 18 mg (1.75%) of THC [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R113" rid="R113" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065994" role="button" aria-expanded="false" aria-haspopup="true">113</a>]. The average amount of THC-COOH excreted in the same time period following the high dose (3.55% THC cigarette, <em>ca</em>. 34 mg THC) was 197.4±33.6 μg (range 107.5−305.0 μg). This represents an average of only 0.54±0.14 and 0.53±0.09% of the original amount of THC in the low- and high-dose cigarettes, respectively. These small percentages of the total THC dose found in the urine as THC-COOH are not surprising, considering the many factors that influence THC-COOH excretion after smoking. Prior to harvesting, cannabis plant material contains little active THC. When smoked, THC carboxylic acids spontaneously decarboxylate to produce THC, with nearly complete conversion upon heating. Pyrolysis of THC during smoking destroys additional drug. Drug availability is further reduced by loss of drug in the side-stream smoke and drug remaining in the unsmoked cigarette butt. These factors contribute to high variability in drug delivery by the smoked route. It is estimated that the systemic availability of smoked THC is <em>ca</em>. 8−24%, and that bioavailability depends strongly upon the experience of the cannabis users [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066151" role="button" aria-expanded="false" aria-haspopup="true">5</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066068" role="button" aria-expanded="false" aria-haspopup="true">17</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R114" rid="R114" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066061" role="button" aria-expanded="false" aria-haspopup="true">114</a>]. THC Bioavailability is reduced due to the combined effect of these factors; the actual available dose is much lower than the amount of THC and THC precursor present in the cigarette. Most of the THC dose is excreted in the feces (30−65%), rather than in the urine (20%) [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066157" role="button" aria-expanded="false" aria-haspopup="true">27</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R115" rid="R115" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066032" role="button" aria-expanded="false" aria-haspopup="true">115</a>]. Another factor affecting the low amount of recovered dose is measurement of a single metabolite. However, numerous cannabinoid metabolites are produced in humans as a result of THC metabolism, most of which are not detected or included in the calculations based on GC/MS analysis.</p><p id="P49">Following controlled oral administration of THC in dronabinol or hemp oil, urinary cannabinoid excretion was characterized in 4,381 urine specimens [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R116" rid="R116" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066156" role="button" aria-expanded="false" aria-haspopup="true">116</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R117" rid="R117" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066025" role="button" aria-expanded="false" aria-haspopup="true">117</a>]. THC Doses of 0.39−14.8 mg/d (from hemp oils or <em>Marinol</em>®) were administered for 5 d. All urine voids, collected over ten weeks, were tested by immunoassay and GC/MS analysis. With the U.S. federally mandated 50 μg/l immunoassay cutoff, and during ingestion of the two low doses typical of current hemp-oil THC concentrations (&lt;0.5 mg/d), mean detection rates were below 0.2% [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R116" rid="R116" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066040" role="button" aria-expanded="false" aria-haspopup="true">116</a>]. The two high doses (7.5 and 14.8 mg/d) produced mean detection rates of 23−46%, with intermittent positive tests up to 118 h. Maximum THC-COOH concentrations were 5.4−38.2 ng/ml for the low, and 19.0−436 μg/l for the high doses. The availability of cannabinoid-containing foodstuffs, cannabinoid-based therapeutics, and continued abuse of oral cannabis require scientific data for the accurate interpretation of cannabinoid tests. These data demonstrate that it is possible, but unlikely, for a urine specimen to test positive at the federally mandated cannabinoid cutoffs, following manufacturer's dosing recommendations for the ingestion of hemp oils of low THC concentration. Urine tests have a high likelihood of being positive following <em>Marinol</em>® therapy.</p><p id="P50" class="p p-last">These investigators also reported no significant differences (<em>P</em>≤0.05) in mean time of maximum excretion rate, mean maximum excretion rate, and mean terminal elimination half-life between the four THC doses (0.39−14.8 mg/d), with ranges of 67.4−94.9 h, 0.9−16.3 μg/h, and 44.2−64.0 h, respectively [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R117" rid="R117" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066141" role="button" aria-expanded="false" aria-haspopup="true">117</a>]. Mean apparent elimination half-lives (<em>t</em><sub>1/2</sub>) of 24.1±7.8 and 21.1±4.3 h for the low (7.5 mg/d) and high (14.8 mg/d) doses, respectively, were calculated from the excretion-rate curve prior to the last urine sample, with a THC-COOH concentration ≥15 ng/ml. An average of only 2.9±1.6%, 2.5±2.7%, 1.5±1.4%, and 0.6±0.5% of the THC in the dose of 0.39, 0.47, 7.5, and 14.8 mg/d, respectively, was excreted in the form of THC-COOH in the urine over each dosing session (14 d). This study demonstrated that the terminal urinary elimination half-life of THC-COOH following oral administration is <em>ca</em>. 2−3 d for doses ranging from 0.39−14.8 mg/d. These data also demonstrate that the apparent THC-COOH urinary elimination half-life, prior to reaching a concentration of 15 ng/ml, is significantly shorter than the terminal urinary elimination half-life.</p></div><div id="S19" class="sec"><p></p><h4 class="inline">2.4.3. Cannabinoid–Glucuronide Conjugates </h4><p id="P51" class="p p-first-last">Specimen preparation for cannabinoid testing frequently includes a hydrolysis step to free cannabinoids from their glucuronide conjugates. Most GC/MS procedures of urine samples measure total THC-COOH, following either an enzymatic hydrolysis with <em>β</em>-glucuronidase or, more commonly, an alkaline hydrolysis with NaOH. Alkaline hydrolysis appears to efficiently hydrolyze the ester glucuronide linkage.</p></div><div id="S20" class="sec sec-last"><p></p><h4 class="inline">2.4.4. Urinary Biomarkers of Recent Cannabis Use </h4><p id="P52" class="p p-first-last">Significantly higher concentrations of THC and 11-OH-THC in urine are observed, when <em>Escherichia coli </em><em>β</em>-glucuronidase is used in the hydrolysis method, compared to either <em>β</em>-glucuronidase from <em>Helix pomatia</em> or base treatment [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R118" rid="R118" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065981" role="button" aria-expanded="false" aria-haspopup="true">118</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R119" rid="R119" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066005" role="button" aria-expanded="false" aria-haspopup="true">119</a>]. THC and 11-OH-THC primarily are excreted in urine as glucuronide conjugates that are resistant to cleavage by alkaline hydrolysis or by enzymatic hydrolysis employing some types of <em>β</em>-glucuronidase. <em>Kemp et al</em>. demonstrated that <em>β</em>-glucuronidase from <em>E. coli</em> was needed to hydrolyze the ether glucuronide linkages of the active cannabinoid analytes. Mean THC concentrations in urine specimens from seven subjects, collected after each had smoked a single marijuana cigarette (3.58% of THC), was 22 ng/ml, when the <em>E. coli </em><em>β</em>-glucuronidase hydrolysis method was used; in contrast, the observed THC concentrations were nearly zero when using either <em>H. pomatia </em><em>β</em>-glucuronidase or base hydrolysis [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R118" rid="R118" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065977" role="button" aria-expanded="false" aria-haspopup="true">118</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R119" rid="R119" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065978" role="button" aria-expanded="false" aria-haspopup="true">119</a>]. Similar differences were found for 11-OH-THC, with a mean concentration of 72 ng/ml for the <em>E. coli</em> method, but concentrations &lt;10 ng/ml for the other methods. The authors suggested that finding THC and/or 11-OH-THC in the urine might provide a reliable marker of recent cannabis use, but adequate data from controlled drug-administration studies were not yet available to support or refute this observation. Using a modified analytical method with <em>E. coli </em><em>β</em>-glucuronidase, we have analyzed hundreds of urine specimens collected after controlled THC administration. We found that 11-OH-THC may be excreted in the urine of chronic cannabis users for a much longer period of time, beyond the period of pharmacodynamic effects and performance impairment. Additional research is necessary to determine the validity of estimating time of cannabis use from THC and 11-OH-THC concentrations in urine.</p></div></div></div><div id="S21" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S21title">3. Interpretation of Cannabinoid Concentrations in Biological Fluids</h2><div id="S22" class="sec sec-first"><h3>3.1. Plasma Concentrations</h3><p id="P53" class="p p-first">Compared to other drugs of abuse, analysis of cannabinoids presents some difficult challenges. THC and 11-OH-THC are highly lipophilic, and present in low concentrations in body fluids. Complex specimen matrices, <em>i.e.</em>, blood, sweat, or hair, may require multi-step extractions to separate cannabinoids from endogenous lipids and proteins. Care must be taken to avoid low recoveries of cannabinoids due to their high affinity to glass and plastic containers, and to alternate matrix-collection devices [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R120" rid="R120" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066065" role="button" aria-expanded="false" aria-haspopup="true">120</a>-<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R123" rid="R123" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066145" role="button" aria-expanded="false" aria-haspopup="true">123</a>]. THC and THC-COOH are predominantly found in the plasma fraction of blood, where 95−99% are bound to lipoproteins. Only <em>ca</em>. 10% of either compound is found in the erythrocytes [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R124" rid="R124" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066042" role="button" aria-expanded="false" aria-haspopup="true">124</a>]. Whole-blood cannabinoid concentrations are approximately one-half the concentrations found in plasma specimens, due to the low partition coefficient of drug into erythrocytes [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R96" rid="R96" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066096" role="button" aria-expanded="false" aria-haspopup="true">96</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R125" rid="R125" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066148" role="button" aria-expanded="false" aria-haspopup="true">125</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R126" rid="R126" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065969" role="button" aria-expanded="false" aria-haspopup="true">126</a>].</p><div id="S23" class="sec"><p></p><h4 class="inline">3.1.1. Intravenous THC Administration </h4><p id="P54" class="p p-first-last"><em>Kelly et al</em>. intravenously administered 5 mg of THC to eight males, and then periodically monitored THC, THC-COOH, and THC-COOH–glucuronide conjugates by GC/MS (1 ng/ml detection limit for THC and THC-COOH) in plasma with and without alkaline hydrolysis for up to 10 h, and then once daily for up to 12 d [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R77" rid="R77" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065957" role="button" aria-expanded="false" aria-haspopup="true">77</a>]. The elimination half-lives of THC, THC-COOH, and THC-COOH–glucuronide conjugate in the plasma of frequent cannabis users were 116.8 min, 5.2 d, and 6.8 d, respectively, and 93.3 min, 6.2 d, and 3.7 d in infrequent users. Conjugated THC-COOH was detected in the plasma of 75% of the frequent and 25% of the infrequent users after 12 d.</p></div><div id="S24" class="sec"><p></p><h4 class="inline">3.1.2. Smoked Cannabis </h4><p id="P55" class="p p-first">THC Detection times in plasma of 3.5−5.5 h were reported in individuals who smoked two cannabis cigarettes containing a total of <em>ca</em>. 10 mg of THC (GC/MS detection limit 0.8 ng/ml) [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R93" rid="R93" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066067" role="button" aria-expanded="false" aria-haspopup="true">93</a>], and up to 13 d for deuterated THC in the blood of chronic cannabis users, who smoked four cigarettes containing deuterium-labeled THC (GC/MS detection limit 0.02 ng/ml) [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R109" rid="R109" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066113" role="button" aria-expanded="false" aria-haspopup="true">109</a>]. In the latter study, the terminal half-life of THC in plasma was determined to be <em>ca</em>. 4.1 d, as compared to frequent estimates of 24−36 h in several other studies [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066014" role="button" aria-expanded="false" aria-haspopup="true">27</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R59" rid="R59" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">59</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R127" rid="R127" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065974" role="button" aria-expanded="false" aria-haspopup="true">127</a>] that lacked the sensitivity and the lengthy monitoring window of the radiolabeled protocol.</p><p id="P56">Few controlled drug-administration studies have monitored active 11-OH-THC plasma concentrations. <em>Huestis et al</em>. found plasma 11-OH-THC concentrations to be <em>ca</em>. 6−10% of the concurrent THC concentrations for up to 45 min after the start of smoking [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066088" role="button" aria-expanded="false" aria-haspopup="true">14</a>]. Mean peak 11-OH-THC concentrations occurred 13.5 min (range 9.0−22.8 min) after the start of smoking, and were 6.7 ng/ml (range 3.3−10.4 ng/ml) and 7.5 ng/ml (range 3.8−16 ng/ml) after smoking one cannabis cigarette containing 1.75 or 3.55% of THC, respectively. The concentrations of 11-OH-THC decreased gradually, with mean detection times of 4.5 and 11.2 h after the two doses.</p><p id="P57">The concentrations of THC-COOH were monitored in human plasma for 7 d after controlled cannabis smoking [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066024" role="button" aria-expanded="false" aria-haspopup="true">14</a>]. This inactive metabolite was detected in the plasma of all subjects by 8 min after the start of smoking. THC-COOH concentrations in plasma increased slowly, and reached a plateau for up to 4 h. Peak concentrations were consistently lower than peak THC concentrations, but were higher than 11-OH-THC peak concentrations. Mean peak THC-COOH concentrations were 24.5 ng/ml (range 15−54 ng/ml) and 54.0 ng/ml (range 22−101 ng/ml) after smoking the low- (1.75% of THC) or high-dose (3.55% of THC) cigarette, respectively. Following smoking of the lower dose, THC-COOH was detected from 48−168 h, with a mean of 84 h. Detection times ranged from 72−168 h, with a mean of 152 h, following smoking of the higher dose. The time course of detection of THC-COOH is much longer than either that of THC or 11-OH-THC. The AUC for the mean data from 0−168 h was 36.5 and 72.2 ng × h/ml, respectively, for the low- and high-dose conditions, demonstrating a dose-response relationship for the mean data [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066135" role="button" aria-expanded="false" aria-haspopup="true">14</a>]. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/figure/F2/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2</span></a> (see above) shows individual THC-concentration time profiles for six subjects, demonstrating the large inter-subject variability of the smoked route of drug administration. <em>Moeller et al</em>. measured serum THC and THC-COOH concentrations in 24 experienced users from 40−220 min after smoking cannabis cigarettes with a THC content of 300 μg/kg [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R128" rid="R128" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066003" role="button" aria-expanded="false" aria-haspopup="true">128</a>]. Mean serum THC and THC-COOH concentrations were <em>ca</em>. 13 and 22 ng/ml at 40 min, and 1 and 13 ng/ml at 220 min after smoking, respectively. The half-life of the rapid-distribution phase of THC was estimated to be 55 min over this short sampling interval.</p><p id="P58" class="p p-last">Most plasma or whole-blood analytical methods for the determination of cannabinoids have not included measurement of the glucuronide conjugates of THC, 11-OH-THC, or THC-COOH. The relative percentages of free and conjugated cannabinoids in plasma after different routes of drug administration are unclear. Even the efficacy of alkaline- and enzymatic-hydrolysis procedures to release analytes from their conjugates is not fully understood [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066001" role="button" aria-expanded="false" aria-haspopup="true">24</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R77" rid="R77" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066034" role="button" aria-expanded="false" aria-haspopup="true">77</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R93" rid="R93" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066054" role="button" aria-expanded="false" aria-haspopup="true">93</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R115" rid="R115" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065961" role="button" aria-expanded="false" aria-haspopup="true">115</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R118" rid="R118" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065980" role="button" aria-expanded="false" aria-haspopup="true">118</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R119" rid="R119" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065990" role="button" aria-expanded="false" aria-haspopup="true">119</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R129" rid="R129" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066114" role="button" aria-expanded="false" aria-haspopup="true">129</a>-<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R133" rid="R133" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">133</a>]. In general, the concentrations of conjugate are believed to be lower in plasma, following intravenous or smoked administration, but may be of much greater magnitude after oral intake. There is no indication that the glucuronide conjugates are active, although supporting data are lacking.</p></div><div id="S25" class="sec"><p></p><h4 class="inline">3.1.3. Oral Administration </h4><p id="P59" class="p p-first-last">After oral and sublingual administration of THC, THC-containing food products, or cannabis-based extracts, the concentrations of THC and 11-OH-THC are much lower than those found upon smoked administration. Plasma concentrations of THC in patients receiving 10−15 mg of <em>Marinol</em>® as an anti-emetic were low or even non-measurable in 57 patients [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R134" rid="R134" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066134" role="button" aria-expanded="false" aria-haspopup="true">134</a>]. After daily administration of 10−15 mg of <em>Marinol</em>®, <em>Brenneisen et al</em>. found peak plasma concentrations of THC and THC-COOH of 2.1−16.9 ng/ml within 1−8 h, and of 74.5−244 ng/ml within 2−8 h, respectively [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R42" rid="R42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066131" role="button" aria-expanded="false" aria-haspopup="true">42</a>]. In our oral, controlled THC-administration studies, peak plasma THC, 11-OH-THC, and THC-COOH concentrations were less than 6.5, 5.6, and 24.4 ng/ml, respectively, following up to 14.8 mg/d of THC in the form of THC-containing food products or <em>Marinol</em>® [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R135" rid="R135" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">135</a>]. Peak concentrations and time-to-peak concentrations varied sometimes considerably between subjects. Plasma THC and 11-OH-THC were negative for all participants and for all doses by 16 h after administration of the last THC dose. Plasma THC-COOH persisted for a longer period of time, following the two highest doses of 7.5 mg/d of dronabinol, and 14.8 mg/d of THC in hemp oil. <em>Ohlsson et al</em>. reported that orally administered THC (20 mg) in a cookie yielded low and irregular plasma concentrations, compared to intravenous and inhaled THC [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066019" role="button" aria-expanded="false" aria-haspopup="true">5</a>].</p></div><div id="S26" class="sec"><p></p><h4 class="inline">3.1.4. Cannabinoid Concentrations after Frequent Use </h4><p id="P60" class="p p-first-last">Most THC plasma data have been collected following acute exposure; less is known of plasma THC concentrations in frequent users. <em>Peat</em> reported THC, 11-OH-THC, and THC-COOH plasma concentrations in frequent cannabis users of 0.86±0.22, 0.46±0.17, and 45.8±13.1 ng/ml, respectively, a minimum of 12 h after the last smoked dose [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R136" rid="R136" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">136</a>]. No difference in terminal half-life in frequent or infrequent users was observed. <em>Johansson et al</em>. administered radiolabeled THC to frequent cannabis users, and found a terminal elimination half-life of 4.1 d for THC in plasma, due to extensive storage and release from body fat [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R109" rid="R109" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066132" role="button" aria-expanded="false" aria-haspopup="true">109</a>].</p></div><div id="S27" class="sec sec-last"><p></p><h4 class="inline">3.1.5. Prediction Models for Estimation of Cannabis Exposure </h4><p id="P61" class="p p-first">There continues to be controversy in the interpretation of cannabinoid results from blood analysis, some general concepts having wide support. A dose-response relationship has been demonstrated for smoked THC and THC plasma concentrations [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066160" role="button" aria-expanded="false" aria-haspopup="true">16</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066105" role="button" aria-expanded="false" aria-haspopup="true">17</a>]. It is well-established that plasma THC concentrations begin to decline prior to the time of peak effects, although it has been shown that THC effects appear rapidly after initiation of smoking [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066120" role="button" aria-expanded="false" aria-haspopup="true">15</a>]. Individual drug concentrations and ratios of cannabinoid metabolite to parent drug concentration have been suggested as potentially useful indicators of recent drug use [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065989" role="button" aria-expanded="false" aria-haspopup="true">24</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R137" rid="R137" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066115" role="button" aria-expanded="false" aria-haspopup="true">137</a>]. Some 45 min after cannabis smoking, the ratio [THC-COOH]/[THC] in the plasma was reported to be &gt;1 [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R77" rid="R77" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066074" role="button" aria-expanded="false" aria-haspopup="true">77</a>]. This is in agreement with results reported by <em>Mason</em> and <em>McBay</em> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R96" rid="R96" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066013" role="button" aria-expanded="false" aria-haspopup="true">96</a>], and those by <em>Huestis et al</em>. [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065963" role="button" aria-expanded="false" aria-haspopup="true">15</a>], who found that peak effects occurred when THC and THC-COOH concentrations reached equivalency, within 30−45 min after initiation of smoking. Measurement of cannabinoid analytes with short time courses of detection (<em>e.g.</em>, 8<em>β</em>,11-dihydroxytetrahydrocannabinol) as markers of recent THC exposure has not found widespread use [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R96" rid="R96" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066046" role="button" aria-expanded="false" aria-haspopup="true">96</a>]. Recent exposure (6−8 h) and possible impairment have been linked to plasma THC concentrations in excess of 2−3 ng/ml [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066033" role="button" aria-expanded="false" aria-haspopup="true">14</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R96" rid="R96" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066117" role="button" aria-expanded="false" aria-haspopup="true">96</a>]. <em>Gjerde et al</em>. [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R138" rid="R138" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066045" role="button" aria-expanded="false" aria-haspopup="true">138</a>] suggested that 1.6 ng/ml of THC in whole blood may indicate possible impairment. This correlates well with the suggested concentration of plasma THC, due to the fact that THC in hemolyzed blood is approximately one-half the concentration of plasma THC [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R139" rid="R139" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066094" role="button" aria-expanded="false" aria-haspopup="true">139</a>]. Interpretation is further complicated by residual THC and THC-COOH concentrations found in blood of frequent cannabis users. In general, it is suggested that chronic cannabis smokers may have residual plasma THC concentrations of &lt;2 ng/ml some 12 h after smoking cannabis [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R136" rid="R136" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">136</a>]. Significantly higher residual concentrations of THC-COOH may be found.</p><p id="P62">Accurate prediction of the time of cannabis exposure would provide valuable information in establishing the role of cannabis as a contributing factor to events under investigation. Two mathematical models for the prediction of time of cannabis use from the analysis of a single plasma specimen for cannabinoids were developed [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R140" rid="R140" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066023" role="button" aria-expanded="false" aria-haspopup="true">140</a>]. Model I is based on THC concentrations, and model II is based on the ratio [THC-COOH]/[THC] in the plasma (<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/figure/F4/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4</span></a>). Both models correctly predicted the times of exposure within the 95%-confidence interval for more than 90% of the specimens evaluated. Furthermore, plasma THC and THC-COOH concentrations reported in the literature, following oral and smoked cannabis exposure, in frequent and infrequent cannabis smokers, and with measurements obtained by a wide variety of methods (including radioimmunoassay and GC/MS analysis), were evaluated with these models. Plasma THC concentrations &lt;2.0 ng/ml were excluded from use in both models, due to the possibility of residual THC concentrations in frequent smokers. <em>Manno et al</em>. evaluated the usefulness of these models in predicting the time of cannabis use in a controlled cannabis-smoking study [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R132" rid="R132" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066112" role="button" aria-expanded="false" aria-haspopup="true">132</a>]. The models were found to accurately predict the time of last use within the 95%-confidence intervals. Due to the limited distribution of THC and THC-COOH into red blood cells, it is important to remember, when comparing whole-blood THC and/or THC-COOH concentrations to plasma concentrations, to double the whole-blood concentration prior to comparison.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock ten_col whole_rhythm clearfix" id="F4" co-legend-rid="lgnd_F4"><a class="icnblk_img figpopup" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><img src="./Human Cannabinoid Pharmacokinetics_files/nihms-118643-f0005.gif" class="small-thumb" alt="Fig. 4" title="Fig. 4" src-large="/pmc/articles/PMC2689518/bin/nihms-118643-f0005.jpg"></a><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Fig. 4</a></div><!--caption a4--><div><span>Predictive mathematical models for estimating the elapsed time of last cannabis use based on plasma THC and THC-COOH concentrations. Reprinted and adapted with permission by Journal of Analytical Toxicology, p. 285 in [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R140" rid="R140" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066143" role="button" aria-expanded="false" aria-haspopup="true">140</a>], <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/figure/F1/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a>.</span></div></div></div><p id="P63">More recently, the validation of these predictive models was extended to include estimation of time of use after multiple doses of THC and at low THC concentrations (0.5−2 ng/ml), situations that were not included in the original models [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R141" rid="R141" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066121" role="button" aria-expanded="false" aria-haspopup="true">141</a>]. Some 38 cannabis users each smoked a cigarette containing 2.64% of THC in the morning, and 30 also smoked a second cigarette in the afternoon. Blood specimens (<em>n</em>=717) were collected at intervals after smoking, and plasma THC and THC-COOH concentrations were measured by GC/MS analysis. The predicted times of cannabis smoking, based on each model, were then compared to the actual smoking times. The most accurate approach applied a combination of models I and II. For all 717 plasma specimens, 99% of the predicted times of last use were within the 95%-confidence interval, 0.9% were overestimated, and none was underestimated. For 289 plasma specimens collected after multiple doses, 97% were correct, with no underestimates. All time estimates were correct for 77 plasma specimens, with THC concentrations of 0.5−2.0 ng/ml, a concentration range not previously examined. The models provide an objective, validated method for assessing the contribution of cannabis to accidents or clinical symptoms.</p><p id="P64" class="p p-last">These models also appeared to be valuable when applied to the small amount of data from published studies of oral ingestion available at the time. Additional studies were performed to determine if the predictive models could estimate last usage after multiple oral doses, a route of administration more popular with the advent of cannabis therapies. A total of 18 subjects received oral THC, as <em>Marinol</em>® or hemp oil [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R142" rid="R142" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">142</a>]. Each of twelve subjects in one group received a single oral dose of dronabinol (10 mg of synthetic THC). In another protocol, six subjects received four different oral daily doses, divided into thirds, and administered with meals for five consecutive days. There was a 10-d washout period between each dosing regimen. The daily doses were 0.39, 0.47, and 14.8 mg of THC in hemp oil, and 7.5 mg in the form of dronabinol. Blood specimens were collected throughout the study, and analyzed for plasma THC and THC-COOH levels by GC/MS analysis, with quantification limits of 0.5 and 1.0 ng/ml, respectively. The actual times between ingestion of THC and blood collection spanned 0.5−16 h. All plasma specimens with analyte concentrations that were equal to or larger than the quantification limit (<em>n</em>=90) were evaluated. Models I and II correctly predicted the time of last THC ingestion in the case of 74.4 and 90.0% of the plasma specimens, respectively. Some 96.7% of the predicted times were correct, with one overestimate and two underestimates, using the time interval defined by the lowest and highest 95%-confidence limit of both models. These results provide further evidence of the usefulness of the predictive models in estimating the time of last oral THC ingestion following single or multiple doses.</p></div></div><div id="S28" class="sec"><h3>3.2. Urine Concentrations</h3><p id="P65" class="p p-first">Detection of cannabinoids in urine is indicative of prior cannabis exposure, but the long excretion half-life of THC-COOH in the body, especially in chronic cannabis users, makes it difficult to predict the timing of past drug use. In a single extreme case, one individual's urine was positive at a concentration &gt;20 ng/ml (by immunoassay) up to 67 d after last drug exposure [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R143" rid="R143" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065965" role="button" aria-expanded="false" aria-haspopup="true">143</a>]. This individual had used cannabis heavily for more than ten years. However, a naive user's urine may be found negative by immunoassay after only a few hours following smoking of a single cannabis cigarette [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R144" rid="R144" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065997" role="button" aria-expanded="false" aria-haspopup="true">144</a>]. Assay cutoff concentrations and the sensitivity and specificity of the immunoassay affect drug-detection times. A positive urine test for cannabinoids indicates only that drug exposure has occurred. The result does not provide information on the route of administration, the amount of drug exposure, when drug exposure occurred, or the degree of impairment.</p><p id="P66" class="p">To date, there are too few urinary data on THC and 11-OH-THC levels to guide interpretation of positive urine cannabinoid tests; however, data are available for guiding interpretation of total urinary THC-COOH concentrations. Total THC-COOH concentrations include both the free THC-COOH and THC-COOH–glucuronide conjugate concentrations determined after alkaline or enzymatic hydrolysis. Substantial intra- and inter-subject variability occurs in patterns of THC-COOH excretion. THC-COOH concentration in the first specimen after smoking is indicative of how rapidly the metabolite can appear in urine. Mean first urine THC-COOH concentrations were 47±22.3 and 75.3±48.9 ng/ml after smoking one cigarette containing 1.75 or 3.55% of THC, respectively [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R113" rid="R113" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065972" role="button" aria-expanded="false" aria-haspopup="true">113</a>]. Some 50% of the subjects’ first urine specimen after the low dose, and some 83% of the first urine specimens after the high dose were positive by GC/MS at a THC-COOH cutoff concentration of 15 ng/ml. Thus, THC-COOH concentrations in the first urine specimen are dependent upon the relative potency of the cigarette, the elapsed time following drug administration, smoking efficiency, and individual differences in drug metabolism and excretion. Mean peak urine THC-COOH concentrations averaged at 89.8±31.9 ng/ml (range 20.6−234.2 ng/ml) and 153.4±49.2 ng/ml (range 29.9−355.2 ng/ml) following smoking of <em>ca</em>. 15.8 and 33.8 mg of THC, respectively. The mean times of peak urine concentration were 7.7±0.8 h and 13.9±3.5 h for the low and high dose, respectively. Although peak concentrations appeared to be dose-related, there was a twelvefold variation between individuals.</p><div id="S29" class="sec"><p></p><h4 class="inline">3.2.1. THC-COOH Detection Windows in Urine </h4><p id="P67" class="p p-first-last">Drug detection time, or the duration of time after drug administration in which the urine of an individual tests positive for cannabinoids, is an important factor in the interpretation of urine drug results. Detection time is dependent on pharmacological factors (<em>e.g.</em>, drug dose, type of administration, rates of metabolism and excretion) and analytical factors (<em>e.g.</em>, assay sensitivity, specificity, accuracy). Mean detection times in urine following smoking vary considerably between subjects, even in controlled smoking studies, where cannabis dosing is standardized and smoking is computer-paced. During the terminal elimination phase, consecutive urine specimens may fluctuate between positive and negative, as THC-COOH concentrations approach the cutoff concentration. It may be important in drug-treatment settings or in clinical trials to differentiate between new drug use and residual excretion of previously used cannabinoids. After smoking a cigarette containing 1.75% of THC, three out of six subjects had additional positive urine samples interspersed between negative urine samples [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R144" rid="R144" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065960" role="button" aria-expanded="false" aria-haspopup="true">144</a>]. This had the effect of producing much longer detection times for the last positive specimen. With a currently accepted confirmation cutoff of 15 ng/ml for THC-COOH, which is most often used in urine-drug testing, the mean GC/MS THC-COOH detection times for the last positive urine sample, following the smoking of a single cigarette with 1.75 or 3.55% of THC, were 33.7±9.2 h (range 8−68.5 h) and 88.6±23.2 h (range 57−122.3 h), respectively. <em>Wingert et al</em>. reported that lowering the urine immunoassay cutoff from 50 to 20 ng/ml, and employing a confirmation cutoff of 10 ng/ml, increased the THC positive rate from 2.8 to 4.1% [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R145" rid="R145" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066089" role="button" aria-expanded="false" aria-haspopup="true">145</a>].</p></div><div id="S30" class="sec sec-last"><p></p><h4 class="inline">3.2.2. Normalization of Cannabinoid Urine Concentrations to Urine Creatinine Concentrations </h4><p id="P68" class="p p-first">Normalization of cannabinoid concentration to urine creatinine concentration aids in the differentiation of new from prior cannabis use, and reduces the variability of drug measurement due to urine dilution. Due to the long half-life of drug in the body, especially in chronic cannabis users, toxicologists and practitioners are frequently asked to determine if a positive urine test represents a new episode of drug use or represents continued excretion of residual drug. Random urine specimens contain varying amounts of creatinine, depending on the degree of concentration of the urine. <em>Hawks</em> first suggested creatinine normalization of urine test results to account for variations in urine volume in the bladder [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R146" rid="R146" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">146</a>]. Whereas urine volume is highly variable due to changes in liquid, salt, and protein intake, exercise, and age, creatinine excretion is much more stable.</p><p id="P69"><em>Manno et al</em>. recommended that an increase of 150% in the creatinine-normalized cannabinoid concentration above the previous specimen can be considered indicative of a <em>new</em> episode of drug exposure [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R147" rid="R147" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">147</a>]. If the increase is greater than or equal to the threshold selected, then new use is predicted. This approach has received wide attention for potential use in treatment and employee-assistance programs, but there was limited evaluation of the usefulness of this ratio under controlled dosing conditions.</p><p id="P70"><em>Huestis</em> and <em>Cone</em> conducted a controlled clinical study of the excretion profile of creatinine and cannabinoid metabolites in a group of six cannabis users, who smoked two different doses of cannabis, separated by weekly intervals [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R148" rid="R148" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065988" role="button" aria-expanded="false" aria-haspopup="true">148</a>]. As seen in <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/figure/F5/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5</span></a>, normalization of urinary THC-COOH concentration to the urinary creatinine concentration produces a smoother excretion pattern and facilitates interpretation of consecutive urine drug-test results.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock ten_col whole_rhythm clearfix" id="F5" co-legend-rid="lgnd_F5"><a class="icnblk_img figpopup" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"><img src="./Human Cannabinoid Pharmacokinetics_files/nihms-118643-f0006.gif" class="small-thumb" alt="Fig. 5" title="Fig. 5" src-large="/pmc/articles/PMC2689518/bin/nihms-118643-f0006.jpg"></a><div class="icnblk_cntnt" id="lgnd_F5"><div><a class="figpopup" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5">Fig. 5</a></div><!--caption a4--><div><span>Urine concentrations of THC-COOH and THC-COOH/creatinine for one subject following smoking of a single cannabis cigarette containing 3.55% of THC. Reprinted and adapted with permission by Journal of Analytical Toxicology, p. 450 in [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R148" rid="R148" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066075" role="button" aria-expanded="false" aria-haspopup="true">148</a>], <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/figure/F3/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3</span></a>.</span></div></div></div><p id="P71">Being able to differentiate new cannabis use from residual THC-COOH excretion in urine would be highly useful for drug treatment, criminal justice, and employee assistance drug testing programs. We evaluated the ratios of creatinine normalized THC-COOH concentrations from more than 1800 pairs of urine specimens collected during a controlled smoked THC administration study. The ratio times 100 of the creatinine normalized later specimen divided by the creatinine normalized earlier specimen were evaluated for determining the best ratio to predict new cannabis use. A relative operating characteristic (ROC) curve was constructed from sensitivity and specificity data for 26 different cutoffs, ranging from 10 to 200%. The most accurate ratio (85.4%) was 50%, with a sensitivity of 80.1%, a specificity of 90.2%, and false positive and false negative predictions of 5.6 and 7.4%, respectively. When the previously recommended increase of 150% was used as a threshold for new use, sensitivity of detecting new use was only 33.4%, and specificity was high (99.8%), for an overall accuracy prediction of 74.2%. To further substantiate the validity of the derived ROC curve, urine-cannabinoid-metabolite and creatinine data from another controlled clinical trial that specifically addressed water dilution as a means of specimen adulteration were evaluated [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R149" rid="R149" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066150" role="button" aria-expanded="false" aria-haspopup="true">149</a>]. Sensitivity, specificity, accuracy, and false positives and negatives were 71.9, 91.6, 83.9, 5.4, and 10.7%, respectively, when the 50% criteria was applied. These data indicate that selection of a threshold to evaluate sequential creatinine-normalized urine drug concentrations can improve the ability to distinguish residual excretion from new drug usage.</p><p id="P72"><em>Lafolie et al</em>. reported the results of urinary excretion of cannabinoids by a heavy cannabis smoker [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R150" rid="R150" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172065993" role="button" aria-expanded="false" aria-haspopup="true">150</a>]. Cannabinoids were detectable for 93 d after cessation of smoking, with a decreasing ratio of cannabinoids to creatinine over time. An excretion half-life of 32 d was determined. When cannabinoid concentrations had not been normalized to creatinine concentrations, a number of false positive indications of new drug use would have occurred.</p><p id="P73" class="p p-last"><em>Fraser et al</em>. conducted a series of studies evaluating the application of [THC-COOH]/[creatinine] ratios for urine specimens collected at least 96 h apart from heavy, chronic cannabis users in an outpatient setting [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R151" rid="R151" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066109" role="button" aria-expanded="false" aria-haspopup="true">151</a>-<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R153" rid="R153" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066097" role="button" aria-expanded="false" aria-haspopup="true">153</a>]. Mean urinary THC-COOH concentrations, mean [THC-COOH]/[creatinine] ratios, and mean [THC-COOH]/[creatinine] ratios from consecutively collected specimens were considerably above the proposed 50% ratio to differentiate new use. The proposed 50% ratio was developed from more than 1,800 urine specimens collected after occasional cannabis use on a secure research unit [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R148" rid="R148" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066129" role="button" aria-expanded="false" aria-haspopup="true">148</a>]. As suggested, the 50% ratio may not be appropriate for differentiating new drug use from residual drug excretion in heavy users. [THC-COOH]/[Creatinine] ratios decrease reliably until THC-COOH concentrations are between 20−50 ng/ml. Within this range, cannabinoid excretion is more variable, most likely based on the slow and variable release of stored THC from fat tissue. The factors governing release of THC stores are not known. Additional research is being performed to attempt to determine appropriate ratio cutoffs for reliably predicting new drug use in heavy, chronic users.</p></div></div><div id="S31" class="sec"><h3>3.3. Oral-Fluid Testing</h3><p id="P74" class="p p-first">Oral fluid also is a suitable specimen for monitoring cannabinoid exposure, and is being evaluated for driving under the influence of drugs, drug treatment, workplace drug testing, and for clinical trials [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R154" rid="R154" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066044" role="button" aria-expanded="false" aria-haspopup="true">154</a>-<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R159" rid="R159" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320603286" role="button" aria-expanded="false" aria-haspopup="true">159</a>]. Adequate sensitivity is best achieved with an assay directed toward detection of THC, rather than of 11-OH-THC or THC-COOH. The oral mucosa is exposed to high concentrations of THC during smoking, and serves as the source of THC found in oral fluid. Only minor amounts of drug and metabolites diffuse from the plasma into oral fluid [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R146" rid="R146" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">146</a>]. Following intravenous administration of radiolabeled THC, no radioactivity could be demonstrated in oral fluid [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R160" rid="R160" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320603280" role="button" aria-expanded="false" aria-haspopup="true">160</a>]. No measurable 11-OH-THC or THC-COOH were found by GC/MS (detection limit 0.5 ng/ml) in oral fluid for 7 d, following cannabis smoking [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R161" rid="R161" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">161</a>], or in oral fluid from 22 subjects positive for THC-COOH in the urine [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R162" rid="R162" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066056" role="button" aria-expanded="false" aria-haspopup="true">162</a>]. Oral fluid collected with the <em>Salivette</em> collection device was positive for THC in 14 of these 22 participants. Although no 11-OH-THC or THC-COOH was identified by GC/MS, CBN and CBD were found in addition to THC. Several hours after smoking, the oral mucosa serves as a depot for release of THC into the oral fluid. In addition, as detection limits continue to decrease with the development of new analytical instrumentation, it may be possible to measure low concentrations of THC-COOH in oral fluid.</p><p id="P75">Detection times of cannabinoids in oral fluid are shorter than in urine, and more indicative of recent cannabis use [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R154" rid="R154" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066108" role="button" aria-expanded="false" aria-haspopup="true">154</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R156" rid="R156" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066085" role="button" aria-expanded="false" aria-haspopup="true">156</a>]. Oral-fluid THC concentrations temporally correlate with plasma cannabinoid concentrations and behavioral and physiological effects, but wide intra- and inter-individual variation precludes the use of oral-fluid concentrations as indicators of drug impairment [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R161" rid="R161" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">161</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R163" rid="R163" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">163</a>]. THC may be detected at low concentrations by radioimmunoassay for up to 24 h after use.</p><p id="P76"><em>Fig. 6</em> depicts excretion of THC in oral fluid and plasma, as well as creatinine-normalized THC-COOH excretion in urine in one subject after smoking a single cannabis cigarette containing 3.55% of THC [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R164" rid="R164" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066154" role="button" aria-expanded="false" aria-haspopup="true">164</a>]. After smoking cannabis, oral-fluid cannabinoid tests were positive for THC by GC/MS/MS, with a cutoff of 0.5 ng/ml for 13±3 h (range 1−24 h) [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R165" rid="R165" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066123" role="button" aria-expanded="false" aria-haspopup="true">165</a>]. After these times, occasional positive oral-fluid results were interspersed with negative tests for up to 34 h.</p><p id="P77"><em>Peel et al</em>. tested oral-fluid samples from 56 drivers, suspected of being under the influence of cannabis, with the <em>EMIT</em>® screening test and by GC/MS analysis [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R166" rid="R166" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066051" role="button" aria-expanded="false" aria-haspopup="true">166</a>]. They suggested that the ease and non-invasiveness of sample collection made oral fluid a useful alternative matrix for detection of recent cannabis use. Oral-fluid samples also are being evaluated in the European Union's Roadside Testing Assessment (ROSITA) project to reduce the number of individuals driving under the influence of drugs and to improve road safety. The ease and non-invasiveness of oral-fluid collection, reduced hazards in specimen handling and testing, and shorter detection window are attractive attributes to the use of this specimen for identifying the presence of potentially performance-impairing drugs.</p><p id="P78"><em>Laloup et al</em>. compared THC levels in oral fluid (collected with the <em>Intercept</em>® device) and plasma from 139 individuals suspected of driving under the influence of drugs, using LC/MS/MS [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R167" rid="R167" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066015" role="button" aria-expanded="false" aria-haspopup="true">167</a>]. They determined that, with a limit of quantification of 0.5 ng/ml in the plasma, the optimal cut-off in oral fluid was 1.2 ng/ml, yielding a sensitivity of 94.7% and a specificity of 92.0%. When a higher plasma cutoff was the target (2 ng/ml), oral fluid THC concentrations of 5.2 ng/ml reliably predicted a positive blood THC result, with a sensitivity of 91.6% and a specificity of 88.6%.</p><p id="P79">In a recent study of smoked and oral cannabis, the <em>Intercept DOA Oral-Specimen-Collection Device</em> and GC/MS/MS (cutoff 0.5 ng/ml) were paired to monitor oral-fluid cannabinoids in ten participants [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R165" rid="R165" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066060" role="button" aria-expanded="false" aria-haspopup="true">165</a>]. As mentioned above, oral-fluid specimens tested positive for up to 34 h. A different oral-fluid collection device, the <em>Cozart RapiScan</em> device, was used with a cannabinoid cutoff of 10 ng/ml to screen for cannabis use [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R168" rid="R168" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066139" role="button" aria-expanded="false" aria-haspopup="true">168</a>]. Positive oral-fluid cannabinoid tests were not obtained more than 2 h after last use, suggesting that much lower cutoff concentrations were needed to improve sensitivity. A procedure for direct analysis of cannabinoids in oral fluid with solid-phase micro-extraction and ion-trap GC/MS has been developed, with a limit of detection of 1.0 ng/ml [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R169" rid="R169" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066079" role="button" aria-expanded="false" aria-haspopup="true">169</a>]. Detection of cannabinoids in oral fluid is a rapidly developing field; however, there are many scientific issues to resolve. One of the most important is the degree of absorption of the drug to oral-fluid collection devices.</p><p id="P80">Recently, there has been renewed interest in oral-fluid drug testing for programs associated with drug treatment, workplace, and driving under the influence of drugs. Small and inconsistent specimen volume collection, poor extraction of cannabinoids from the collection device, low analyte concentrations for cannabinoids, and the potential for external contamination from environmental smoke are limitations to this monitoring method. Recently, independent evaluations of the extraction of cannabinoids from the collection device [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R170" rid="R170" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066071" role="button" aria-expanded="false" aria-haspopup="true">170</a>-<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R173" rid="R173" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066008" role="button" aria-expanded="false" aria-haspopup="true">173</a>] and measurement of oral-fluid THC-COOH in concentrations as low as picograms per milliliter appear to adequately address these potential problems. <em>Day et al</em>. reached a detection limit of 10 pg/ml for THC-COOH in oral fluid by GC/MS/MS [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R174" rid="R174" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066107" role="button" aria-expanded="false" aria-haspopup="true">174</a>]. <em>Moore et al</em>. developed a GC/MS method using a micro-fluidic <em>Dean</em>'s switch for two-dimensional (2D) chromatography to sufficiently improve signal to noise, allowing the monitoring of THC-COOH concentrations of ≥ 2 pg/ml in oral fluid [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R175" rid="R175" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066125" role="button" aria-expanded="false" aria-haspopup="true">175</a>]. Extraction efficiency for THC-COOH from the <em>Quantisal</em>™ (<em>Immunalysis</em>, Pomona, CA) oral-fluid collection device was 80% at a concentration of 10 pg/ml, with a coefficient of variation of 8.23%. The extraction efficiency of the buffer was reported to be between 79.6 and 91.4% for various concentrations of THC [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R173" rid="R173" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066081" role="button" aria-expanded="false" aria-haspopup="true">173</a>]. Specimens collected almost immediately after smoking cannabis, <em>i.e.</em>, after 15 and 45 min, and later, after 1, 2, and 8 h, all contained THC-COOH. This new method was used for the analysis of 143 oral-fluid specimens, screening positive for cannabinoids by Enzyme-Linked Immunosorbent Assay (ELISA). Some 95 specimens (66.4%) tested positive for THC and THC-COOH; 14 (9.7%) were positive for THC-COOH only, and 27 (18.8%) were positive for THC only [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R176" rid="R176" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066066" role="button" aria-expanded="false" aria-haspopup="true">176</a>]. The observation that THC-COOH was found in 76.2% of the tested oral-fluid specimens, screening positive for cannabinoids, suggests that there is a definitive means of differentiating passive cannabis exposure from actual cannabis usage. This limitation has curtailed the use of oral-fluid testing to monitor cannabis use.</p><p id="P81" class="p p-last"><em>Niedbala et al</em>. evaluated passive contamination of oral fluid in individuals exposed to cannabis smoke in an enclosed car [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R177" rid="R177" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066009" role="button" aria-expanded="false" aria-haspopup="true">177</a>]. First, oral-fluid collection devices were contaminated when opened within the smoke-filled car. When the specimens were collected outside of the car, immediately following smoking, specimens from passive smokers were negative. Environmental cannabis smoke can contaminate collection devices, unless specimens are collected outside the area of smoke contamination.</p></div><div id="S32" class="sec"><h3>3.4. Cannabinoids in Sweat</h3><p id="P82" class="p p-first">To date, there are no published data on the excretion of cannabinoids in sweat following controlled THC administration, although our laboratory at <em>NIH</em> is conducting such research. Sweat testing is being applied to monitor cannabis use in drug treatment, criminal justice, workplace drug testing, and clinical studies [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R161" rid="R161" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">161</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R178" rid="R178" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320603290" role="button" aria-expanded="false" aria-haspopup="true">178</a>]. In 1989, <em>Balabanova</em> and <em>Schneider</em> used radioimmunoassay to detect cannabinoids in apocrine sweat [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R179" rid="R179" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066128" role="button" aria-expanded="false" aria-haspopup="true">179</a>]. Currently, there is a single commercially available sweat-collection device, the <em>PharmChek</em> patch (<em>PharmChem Laboratories</em>, Texas, USA). Generally, the patch is worn for 7 d, and then exchanged for a new patch once each week during visits to the treatment clinic or parole officer. Theoretically, this permits constant monitoring of drug use throughout the week, extending the window of drug detection and improving test sensitivity. As with oral-fluid testing, this is a developing analytical technique, with much to be learned about the pharmacokinetics of cannabinoid excretion in sweat, potential re-absorption of THC by the skin, possible degradation of THC on the patch, and adsorption of THC onto the patch-collection device. It is known that THC is the primary analyte detected in sweat, with little 11-OH-THC and THC-COOH. Understanding the pharmacokinetics of THC excretion also is important for the interpretation of hair cannabinoid tests, as sweat has been shown to contribute to the amount of drug found in hair (see below).</p><p id="P83" class="p p-last">Several investigators have evaluated the sensitivity and specificity of different screening assays for detecting cannabinoids in sweat [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R157" rid="R157" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320603289" role="button" aria-expanded="false" aria-haspopup="true">157</a>][<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R180" rid="R180" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066140" role="button" aria-expanded="false" aria-haspopup="true">180</a>]. <em>Kintz et al</em>. identified THC (4−38 ng/patch) in 20 known heroin abusers who wore the <em>PharmChek</em> patch for 5 d, while attending a detoxification center [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R181" rid="R181" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066119" role="button" aria-expanded="false" aria-haspopup="true">181</a>]. Sweat was extracted with MeOH, and analyzed by GC/MS. The same investigators also evaluated forehead swipes with cosmetic pads for monitoring cannabinoids in sweat from individuals suspected of driving under the influence of drugs [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R162" rid="R162" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066093" role="button" aria-expanded="false" aria-haspopup="true">162</a>]. THC, but not 11-OH-THC or THC-COOH, was detected (4−152 ng/pad) by GC/EI-MS in the sweat of 16 out of 22 individuals who tested positive for cannabinoids in urine. Ion-trap tandem mass spectrometry also has been used to measure cannabinoids in sweat collected with the <em>PharmChek</em> sweat patch, with a detection limit of 1 ng/patch [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R182" rid="R182" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">182</a>].</p></div><div id="S33" class="sec sec-last"><h3>3.5. Cannabinoids in Hair</h3><p id="P84" class="p p-first">There are multiple mechanisms for the incorporation of cannabinoids in hair. THC and its metabolites may be incorporated into the hair bulb that is surrounded by capillaries. Drug may also diffuse into hair from sebum secreted onto the hair shaft, and from sweat excreted onto the skin surface. Drug may also be incorporated into hair from the environment. Cannabis is primarily smoked, providing an opportunity for environmental contamination of hair with THC in cannabis smoke. Basic drugs such as cocaine and methamphetamine concentrate in hair due to ionic bonding to melanin, the pigment in hair that determines hair color. The more neutral and lipophilic THC is not strongly bound to melanin, resulting in much lower concentrations of THC in hair as compared to other drugs of abuse. Usually, THC is present in hair at a higher concentration than its THC-COOH metabolite [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R183" rid="R183" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">183</a>-<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R186" rid="R186" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066059" role="button" aria-expanded="false" aria-haspopup="true">186</a>].</p><p id="P85">An advantage of measuring THC-COOH in hair is that this compound is not present in cannabis smoke, avoiding the issue of passive exposure from the environment. Analysis of cannabinoids in hair is challenging due to the high analytical sensitivity required. THC-COOH is present in the femto- to picogram range per milligram of hair. GC/MS/MS Analysis has been required in most analytical investigations, but a new procedure based on GC/MS equipped with a <em>Dean</em>'s switch and cryofocusing was recently published [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R187" rid="R187" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066050" role="button" aria-expanded="false" aria-haspopup="true">187</a>]. <em>Cirimele et al</em>. [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R188" rid="R188" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066011" role="button" aria-expanded="false" aria-haspopup="true">188</a>] proposed a novel approach to the screening of hair specimens for the presence of cannabinoids in hair. They developed a rapid, simple GC/MS screening method for THC, CBN, and CBD in hair, which did not require derivatization prior to analysis. The method was found to be a sensitive screen for cannabis detection by GC/MS analysis; identification of THC-COOH was recommended as a confirmatory procedure.</p><p id="P86">It is difficult to conduct controlled cannabinoid-administration studies on the disposition of cannabinoids in hair because of the inability to differentiate administered drug from previously self-administered cannabis. If isotopically labeled drug were administered, it would be possible to identify newly administered drug in hair. There are advantages to monitoring drug use with hair testing, including a wide window of drug detection, a less invasive specimen-collection procedure, and the ability to collect a second specimen at a later time. However, one of the weakest aspects of testing for cannabinoids in hair is the low sensitivity of drug detection in this alternate matrix.</p><p id="P87" class="p p-last">In the only controlled cannabinoid dosing study published to date, <em>Huestis et al</em>. collected 53 head-hair specimens from 38 males with a history of cannabis use documented by questionnaire, urinalysis, and controlled, double-blind administration of THC [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R189" rid="R189" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_172066053" role="button" aria-expanded="false" aria-haspopup="true">189</a>]. Subjects completed a questionnaire indicating daily cannabis use (<em>N</em>=18) or non-daily use, <em>i.e.</em>, smoking one to five cannabis cigarettes per week (<em>N</em>=20). Hair specimens were collected from each subject at the time of admittance to a closed research unit, following smoking of two cigarettes containing 2.7% of THC (<em>N</em>=13), or following multiple oral doses with a total of 116 mg THC (<em>N</em>=2). Pre- and post-dose detection rates did not differ statistically. Therefore, all 53 specimens were considered as one group. Some 19 specimens (36%) had no detectable THC or THC-COOH at the GC/MS/MS limits of quantification of 1.0 and 0.1 pg/mg hair, respectively. Two specimens (3.8%) had measurable THC only, 14 (26%) showed THC-COOH only, and 18 (34%) had both cannabinoids. Detection rates were significantly different (<em>p</em>&lt;0.05, <em>Fisher</em>'s exact test) between daily cannabis users (85%) and non-daily users (52%). There was no difference in detection rates between African, American, and Caucasian subjects (<em>p</em>&gt;0.3, <em>Fisher</em>'s exact test). For specimens with detectable cannabinoids, concentrations ranged from 3.4 to &gt;100 pg THC/mg, and from 0.10 to 7.3 pg THC-COOH/mg hair. THC and THC-COOH concentrations were positively correlated (<em>r</em>=0.38, <em>p</em>&lt;0.01, <em>Pearson</em>'s product moment correlation). Only about one-third of non-daily users and two-thirds of daily cannabis users gave rise to positive cannabinoid hair tests by GC/MS/MS, with detection limits of 1 and 0.1 ng/mg for THC and THC-COOH, respectively. All participants showed positive urine cannabinoid tests at the time of hair collection.</p></div></div><div id="S34" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S34title">4. Conclusions</h2><p id="P88" class="p p-first-last">An understanding of human cannabinoid pharmacokinetics is important for the development and monitoring of new therapeutic medications and to the interpretation of cannabinoid test results in a wide variety of biological matrices, including blood, plasma, urine, oral fluid, sweat, and hair. With the advent of new preparations containing THC, CBD, and other cannabinoids, and new administration routes, additional research is needed. Also, controlled drug-administration studies that provide the scientific database for interpreting cannabinoid concentrations in biological fluids and tissues are increasingly difficult to conduct due to safety and ethical concerns, and because of the high costs of performing human research. However, these data are essential for appropriate application of pharmacotherapies, and for drug testing in treatment, workplace, and forensic cases.</p></div><div id="unreferenced-ft" class="tsec sec headless whole_rhythm"><div class="unreferenced">​
                    <!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock ten_col whole_rhythm clearfix" id="F6" co-legend-rid="lgnd_F6"><a class="icnblk_img figpopup" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6"><img src="./Human Cannabinoid Pharmacokinetics_files/nihms-118643-f0007.gif" class="small-thumb" alt="Fig. 6" title="Fig. 6" src-large="/pmc/articles/PMC2689518/bin/nihms-118643-f0007.jpg"></a><div class="icnblk_cntnt" id="lgnd_F6"><div><a class="figpopup" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6">Fig. 6</a></div><!--caption a4--><div><span>Excretion patterns of THC in oral fluid and plasma, and urinary THC-COOH/creatinine levels in a human subject following smoking of a single cannabis cigarette containing 3.55% of THC. The THC-COOH/creatinine ratio is illustrated for all urine specimens</span> <strong>...</strong></div></div></div></div></div><div id="__fn-groupidm140594133112944" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__fn-groupidm140594133112944title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN1"><sup>1</sup>Unless noted otherwise, THC always refers to the Δ<sup>9</sup>-variant.</p><p class="fn sec" id="FN2"><sup>2</sup>Non-systematic compound names cited in the literature are used for the sake of clarity.</p></div></div><div id="__ref-listidm140594133109840" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__ref-listidm140594133109840title">REFERENCES</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="citation">Turner CE, ElSohly MA, Boeren EG. <span><span class="ref-journal">J. Nat. Prod. </span>1980;<span class="ref-vol">43</span>:169.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6991645" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="citation">Claussen U, Korte F. <span><span class="ref-journal">Justus Liebigs Ann. Chem. </span>1968;<span class="ref-vol">713</span>:162.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/5684054" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="citation">ElSohly HN, Boeren EG, Turner CE, ElSohly MA.  In: <span class="ref-journal">The Cannabinoids: Chemical, Pharmacologic and Therapeutic Aspects.</span> Agurell S, Dewey WL, Willette RE, editors. Academic Press; Orlando: 1984. p. 89.</span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="citation">Mechoulam R. <span><span class="ref-journal">Science. </span>1970;<span class="ref-vol">168</span>:1159.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/4910003" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="citation">Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK. <span><span class="ref-journal">Clin. Pharmacol. Ther. </span>1980;<span class="ref-vol">28</span>:409.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6250760" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="citation">Agurell S, Leander K. <span><span class="ref-journal">Acta Pharm. Suecica. </span>1971;<span class="ref-vol">8</span>:391.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/5135173" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="citation">Ohlsson A, Agurell S, Londgren JE, Gillespie HK, Hollister LE.  In: <span class="ref-journal">Pharmacokinetics and Pharmacodynamics of Psychoactive Drugs.</span> Barnett G, Chiang CN, editors. Mosby Yearbook; St. Louis: 1985. p. 75.</span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="citation">Agurell S, Halldin M, Lindgren JE, Ohlsson A, Widman M, Gillespie H, Hollister L. <span><span class="ref-journal">Pharmacol. Rev. </span>1986;<span class="ref-vol">38</span>:21.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/3012605" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="citation">Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK. <span><span class="ref-journal">Biomed. Environ. Mass Spectrom. </span>1982;<span class="ref-vol">9</span>:6.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6277407" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="citation">Azorlosa JL, Heishman SJ, Stitzer ML, Mahaffey JM. <span><span class="ref-journal">J. Pharmacol. Exper. Ther. </span>1992;<span class="ref-vol">261</span>:114.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1313866" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="citation">Heishman SJ, Stitzer ML, Yingling JE. <span><span class="ref-journal">Pharmacol. Biochem. Behav. </span>1989;<span class="ref-vol">34</span>:173.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2560548" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="citation">Perez-Reyes M. <span><span class="ref-journal">NIDA Res. Monograph. </span>1990;<span class="ref-vol">99</span>:42.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2176276" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="citation">Cami J, Guerra D, Ugena B, Segura J, de La Torre R. <span><span class="ref-journal">Pharmacol. Biochem. Behav. </span>1991;<span class="ref-vol">40</span>:115.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1664106" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="citation">Huestis MA, Henningfield JE, Cone EJ. <span><span class="ref-journal">J. Anal. Toxicol. </span>1992;<span class="ref-vol">16</span>:276.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1338215" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="citation">Huestis MA, Sampson AH, Holicky BJ, Henningfield JE, Cone EJ. <span><span class="ref-journal">Clin. Pharmacol. Ther. </span>1992;<span class="ref-vol">52</span>:31.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1320536" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="citation">Perez-Reyes M, Di Guiseppi S, Davis KH, Schindler VH, Cook CE. <span><span class="ref-journal">Clin. Pharmacol. Ther. </span>1982;<span class="ref-vol">31</span>:617.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6280918" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="citation">Perez-Reyes M, Owens SM, Di Guiseppi S. <span><span class="ref-journal">J. Clin. Pharmacol. </span>1981;<span class="ref-vol">21</span>:201S.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6271825" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="citation">ElSohly MA, Ross SA, Mehmedic Z, Arafat R, Banahan BFI. <span><span class="ref-journal">J. Forensic Sci. </span>2000;<span class="ref-vol">45</span>:24.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/10641915" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="citation">Russo EB, McPartland JM. <span><span class="ref-journal">Psychopharmacology. </span>2003;<span class="ref-vol">165</span>:431.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/12491031" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="citation">Bornheim LM, Grillo MP. <span><span class="ref-journal">Chem. Res. Toxicol. </span>1998;<span class="ref-vol">11</span>:1209.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9778318" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="citation">Harvey DJ.  In: <span class="ref-journal">Marijuana and Medicine.</span> Nahas GG, Sutin KM, Harvey DJ, Agurell S, editors. Humana Press; Totowa: 2001. p. 91.</span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="citation">Mechoulam R, Hanus L. <span><span class="ref-journal">Chem. Phys. Lipids. </span>2002;<span class="ref-vol">121</span>:35.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/12505688" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="citation">Harder S, Rietbrock S. <span><span class="ref-journal">Int. J. Clin. Pharmacol. Ther. </span>1997;<span class="ref-vol">35</span>:155.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9112136" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="citation">Law B, Mason PA, Moffat AC, Gleadle RI, King LJ. <span><span class="ref-journal">J. Pharm. Pharmacol. </span>1984;<span class="ref-vol">36</span>:289.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6145762" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="citation">Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK. <span><span class="ref-journal">NIDA Res. Monograph. </span>1981;<span class="ref-vol">34</span>:250.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6261133" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="citation">Perez-Reyes M, Lipton MA, Timmons MC, Wall ME, Brine DR, Davis KH. <span><span class="ref-journal">Clin. Pharmacol. Ther. </span>1973;<span class="ref-vol">14</span>:48.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/4683071" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="citation">Wall ME, Sadler BM, Brine D, Taylor H, Perez-Reyes M. <span><span class="ref-journal">Clin. Pharmacol. Ther. </span>1983;<span class="ref-vol">34</span>:352.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6309462" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="citation">Kim KR, Yoon HR. <span><span class="ref-journal">J. Chromatogr., Sect. B. </span>1996;<span class="ref-vol">682</span>:55.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8832425" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="citation">Binitie A. <span><span class="ref-journal">Psychopharmacologia. </span>1975;<span class="ref-vol">44</span>:301.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1208765" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="citation">Meier HJ, Vonesch HJ. <span><span class="ref-journal">Schweiz. Med. Wochenschr. </span>1997;<span class="ref-vol">127</span>:214.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9157527" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="citation">Goodwin RS, Gustafson RA, Barnes A, Nebro W, Moolchan ET, Huestis MA. <span><span class="ref-journal">Ther. Drug Monit. </span>2006;<span class="ref-vol">28</span>:545.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16885723" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32. <span class="citation">Gustafson RA, Moolchan ET, Barnes A, Levine B, Huestis MA. <span><span class="ref-journal">J. Chromatogr., B. </span>2003;<span class="ref-vol">798</span>:145.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/14630369" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33. <span class="citation">Nadulski T, Sporkert F, Schnelle M, Stadelmann AM, Roser P, Schefter T, Pragst F. <span><span class="ref-journal">J. Anal. Toxicol. </span>2005;<span class="ref-vol">29</span>:782.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16356335" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R34">34. <span class="citation">Mechoulam R. <span><span class="ref-journal">Br. J. Pharmacol. </span>2005;<span class="ref-vol">146</span>:913.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751232/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16205721" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R35">35. <span class="citation">Zias J, Stark H, Seligman J, Levy R, Werker E, Breuer A, Mechoulam R. <span><span class="ref-journal">Nature. </span>1993;<span class="ref-vol">363</span>:215.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8387642" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R36">36. <span class="citation">Russo E, Guy GW. <span><span class="ref-journal">Med. Hypotheses. </span>2006;<span class="ref-vol">66</span>:234.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16209908" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R37">37. <span class="citation">Vaughan CW, Christie MJ.  In: <span class="ref-journal">Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential.</span> Grotenhermen F, Russo E, editors. The Haworth Integrative Healing Press; New York: 1984. p. 89.</span></div><div class="ref-cit-blk half_rhythm" id="R38">38. <span class="citation">Holdcroft A.  In: <span class="ref-journal">Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential.</span> Grotenhermen F, Russo E, editors. The Haworth Integrative Healing Press; New York: 1984. p. 181.</span></div><div class="ref-cit-blk half_rhythm" id="R39">39. <span class="citation">Zajicek J, Fox P, Sanders H, Wright D, Vickery J, Nunn A, Thompson A. <span><span class="ref-journal">Lancet. </span>2003;<span class="ref-vol">362</span>:1517.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/14615106" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R40">40. <span class="citation">Mattes RD, Shaw LM, Edling-Owens J, Engelman K, ElSohly MA. <span><span class="ref-journal">Pharmacol. Biochem. Behav. </span>1993;<span class="ref-vol">44</span>:745.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8383856" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R41">41. <span class="citation">Mattes RD, Engelman K, Shaw LM, ElSohly MA. <span><span class="ref-journal">Pharmacol. Biochem. Behav. </span>1994;<span class="ref-vol">49</span>:187.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/7816872" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R42">42. <span class="citation">Brenneisen R, Egli A, ElSohly MA, Henn V, Spiess Y. <span><span class="ref-journal">Int. J. Clin. Pharmacol. Ther. </span>1996;<span class="ref-vol">34</span>:446.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8897084" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R43">43. <span class="citation">Stinchcomb AL, Valiveti S, Hammell DC, Ramsey DR. <span><span class="ref-journal">J. Pharm. Pharmacol. </span>2004;<span class="ref-vol">56</span>:291.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15025853" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R44">44. <span class="citation">Scheuplein RJ. <span><span class="ref-journal">J. Invest. Dermatol. </span>1967;<span class="ref-vol">48</span>:79.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6018244" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R45">45. <span class="citation">Challapalli PV, Stinchcomb AL. <span><span class="ref-journal">Int J. Pharm. </span>2002;<span class="ref-vol">241</span>:329.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/12100860" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R46">46. <span class="citation">Valiveti S, Hammell DC, Earles DC, Stinchcomb AL. <span><span class="ref-journal">J. Pharm. Sci. </span>2004;<span class="ref-vol">93</span>:1154.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15067692" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R47">47. <span class="citation">Vinciguerra V, Moore T, Brennan E. <span><span class="ref-journal">N. Y. State J. Med. </span>1988;<span class="ref-vol">88</span>:525.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/3231372" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R48">48. <span class="citation">D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieva R, Krystal JH. <span><span class="ref-journal">Neuropsychopharmacology. </span>2004;<span class="ref-vol">29</span>:1558.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15173844" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R49">49. <span class="citation">Perez-Reyes M, Timmons MC, Davis KH, Wall EM. <span><span class="ref-journal">Experientia. </span>1973;<span class="ref-vol">29</span>:1368.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/4761242" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R50">50. <span class="citation">Benowitz NL, Nguyen TL, Jones RT, Herning RI, Bachman J. <span><span class="ref-journal">Clin. Pharm. Ther. </span>1980;<span class="ref-vol">28</span>:115.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/7389248" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R51">51. <span class="citation">Hampson AJ, Grimaldi M, Axelrod J, Wink D. <span><span class="ref-journal">Proc. Natl. Acad. Sci. U.S.A. </span>1998;<span class="ref-vol">95</span>:8268.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20965/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9653176" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R52">52. <span class="citation">Karst M, Salim K, Burstein S, Conrad I, Hoy L, Schneider U. <span><span class="ref-journal">J. Am. Med. Assoc. </span>2003;<span class="ref-vol">290</span>:1757.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/14519710" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R53">53. <span class="citation">Melamede R.  In: <span class="ref-journal">Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential.</span> Grotenhermen F, Russo E, editors. The Haworth Integrative Healing Press; New York: 1984. p. 111.</span></div><div class="ref-cit-blk half_rhythm" id="R54">54. <span class="citation">Plasse T.  In: <span class="ref-journal">Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential.</span> Grotenhermen F, Russo E, editors. The Haworth Integrative Healing Press; New York: 1984. p. 165.</span></div><div class="ref-cit-blk half_rhythm" id="R55">55. <span class="citation">Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Huffman JW, Layward L. <span><span class="ref-journal">Nature. </span>2000;<span class="ref-vol">404</span>:84.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/10716447" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R56">56. <span class="citation">Malfait AM, Galllily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R, Feldmann M. <span><span class="ref-journal">Proc. Natl. Acad. Sci. U.S.A. </span>2000;<span class="ref-vol">97</span>:9561.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC16904/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/10920191" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R57">57. <span class="citation">Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG. <span><span class="ref-journal">Psychopharmacology. </span>1982;<span class="ref-vol">76</span>:245.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6285406" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R58">58. <span class="citation">McArdle K, Mackie P, Pertwee R, Guy G, Whittle B, Hawksworth G. <span><span class="ref-journal">Toxicology. </span>2001;<span class="ref-vol">168</span>:133.</span></span></div><div class="ref-cit-blk half_rhythm" id="R59">59. <span class="citation">Agurell S, Gillespie H, Halldin M, Hollister LE, Johansson E, Lindgren JE, Ohlsson A, Szirmai M, Widman M.  In: <span class="ref-journal">Marihuana '84: Proceedings of the Oxford Symposium on Cannabis.</span> Harvey DJ, Paton WDM, Nahas GG, editors. IRL Press; Oxford: 1984. p. 49.</span></div><div class="ref-cit-blk half_rhythm" id="R60">60. <span class="citation">Ohlsson A, Lindgren JE, Andersson S, Agurell S, Gillespie H, Hollister LE. <span><span class="ref-journal">Biomed. Environ. Mass Spectrom. </span>1986;<span class="ref-vol">13</span>:77.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2937482" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R61">61. <span class="citation">Agurell S, Carlsson S, Lindgren JE, Ohlsson A, Gillespie H, Hollister L. <span><span class="ref-journal">Experientia. </span>1981;<span class="ref-vol">37</span>:1090.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6273208" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R62">62. <span class="citation">Guy GW, Robson PJ. <span><span class="ref-journal">J. Cannabis Ther. </span>2004;<span class="ref-vol">3</span>:121.</span></span></div><div class="ref-cit-blk half_rhythm" id="R63">63. <span class="citation">Guy GW, Robson PJ. <span><span class="ref-journal">J. Cannabis Ther. </span>2004;<span class="ref-vol">3</span>:79.</span></span></div><div class="ref-cit-blk half_rhythm" id="R64">64. <span class="citation">Lemberger L, Silberstein SD, Axelrod J, Kopin IJ. <span><span class="ref-journal">Science. </span>1970;<span class="ref-vol">170</span>:1320.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/5479011" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R65">65. <span class="citation">Nahas GG, Frick HC, Lattimer JK, Latour C, Harvey D. <span><span class="ref-journal">Human Psychopharmacol. </span>2002;<span class="ref-vol">17</span>:103.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/12404700" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R66">66. <span class="citation">Kreuz DS, Axelrod J. <span><span class="ref-journal">Science. </span>1973;<span class="ref-vol">179</span>:391.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/4682965" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R67">67. <span class="citation">Garrett ER. <span><span class="ref-journal">Adv. Biosci. </span>1978;<span class="ref-vol">22−23</span>:105.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/756823" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R68">68. <span class="citation">Harvey DJ, Leuschner JTA, Paton WDM.  In: <span class="ref-journal">Marihuana '84: Proceedings of the Oxford Symposium on Cannabis.</span> Harvey DJ, Paton WDM, Nahas GG, editors. IRL Press; Oxford: 1984. p. 77.</span></div><div class="ref-cit-blk half_rhythm" id="R69">69. <span class="citation">Johansson E, Norén K, Sjövall J, Halldin MM. <span><span class="ref-journal">Biomed. Chromatogr. </span>1989;<span class="ref-vol">3</span>:35.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2539872" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R70">70. <span class="citation">Grotenhermen F. <span><span class="ref-journal">Clin. Pharmacokinet. </span>2003;<span class="ref-vol">42</span>:327.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/12648025" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R71">71. <span class="citation">Dewey WL, McMillan DE, Harris LS, Turk RF. <span><span class="ref-journal">Biochem. Pharmacol. </span>1972;<span class="ref-vol">22</span>:399.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/4687135" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R72">72. <span class="citation">Hunt CA, Jones RT. <span><span class="ref-journal">J. Pharmacol. Exper. Ther. </span>1980;<span class="ref-vol">215</span>:35.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6256518" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R73">73. <span class="citation">Adams IB, Martin BR. <span><span class="ref-journal">Addiction. </span>1996;<span class="ref-vol">91</span>:1585.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8972919" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R74">74. <span class="citation">Mura P, Kintz P, Dumestre V, Raul S, Hauet T. <span><span class="ref-journal">J. Anal. Toxicol. </span>2005;<span class="ref-vol">29</span>:842.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16356342" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R75">75. <span class="citation">Brunet B, Doucet C, Venisse N, Hauet T, Hebrard W, Papet Y, Mauco G, Mura P. <span><span class="ref-journal">Forensic Sci. Int. </span>2006;<span class="ref-vol">161</span>:169.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16859848" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R76">76. <span class="citation">Perez-Reyes M, Timmons MC, Lipton MA, Davis KH, Wall ME. <span><span class="ref-journal">Science. </span>1972;<span class="ref-vol">177</span>:633.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/4558903" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R77">77. <span class="citation">Kelly P, Jones RT. <span><span class="ref-journal">J. Anal. Toxicol. </span>1992;<span class="ref-vol">16</span>:228.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1323733" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R78">78. <span class="citation">Skopp G, Potsch L, Mauden M, Richter B. <span><span class="ref-journal">Forensic Sci. Int. </span>2002;<span class="ref-vol">126</span>:17.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/11955826" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R79">79. <span class="citation">Lee CC, Chiang CN. <span><span class="ref-journal">NIDA Res. Monograph. </span>1985;<span class="ref-vol">60</span>:110.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2997613" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R80">80. <span class="citation">Bailey JR, Cunny HC, Paule M, Slikker W., Jr. <span><span class="ref-journal">Toxicol. Appl. Pharmacol. </span>1987;<span class="ref-vol">90</span>:315.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2820086" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R81">81. <span class="citation">Martin BR, Dewey WL, Harris LS, Beckner JS. <span><span class="ref-journal">Res. Commun. Chem. Pathol. Pharmacol. </span>1977;<span class="ref-vol">17</span>:457.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/897339" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R82">82. <span class="citation">Blackard C, Tennes K. <span><span class="ref-journal">New Engl. J. Med. </span>1984;<span class="ref-vol">311</span>:797.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6088979" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R83">83. <span class="citation">Atkinson HC, Begg EJ, Darrlow BA. <span><span class="ref-journal">Clin. Pharmacokinet. </span>1988;<span class="ref-vol">14</span>:217.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/3292101" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R84">84. <span class="citation">Perez-Reyes M, Wall ME. <span><span class="ref-journal">N. Engl. J. Med. </span>1982;<span class="ref-vol">307</span>:819.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6287261" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R85">85. <span class="citation">Burstein S, Rosenfeld J, Wittstruck T. <span><span class="ref-journal">Science. </span>1972;<span class="ref-vol">176</span>:422.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/5026162" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R86">86. <span class="citation">Ben-Zvi Z, Bergen JR, Burstein S, Sehgal PK, Varanelli C.  In: <span class="ref-journal">The Pharmacology of Marijuana.</span> Braude MC, Szara S, editors. Raven Press; New York: 1976. p. 63.</span></div><div class="ref-cit-blk half_rhythm" id="R87">87. <span class="citation">Ben-Zvi Z, Burstein S. <span><span class="ref-journal">Res. Commun. Chem. Pathol. Pharmacol. </span>1974;<span class="ref-vol">8</span>:223.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/4855455" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R88">88. <span class="citation">Harvey DJ, Martin BR, Paton WDM.  In: <span class="ref-journal">Marijuana: Biological Effects.</span> Nahas GG, Paton WDM, editors. Pergamon Press; Oxford: 1979. p. 45.</span></div><div class="ref-cit-blk half_rhythm" id="R89">89. <span class="citation">Iribarne C, Berthou F, Baird S, Dreano Y, Picart D, Bail JP, Beaune P, Menez JF. <span><span class="ref-journal">Chem. Res. Toxicol. </span>1996;<span class="ref-vol">9</span>:365.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8839037" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R90">90. <span class="citation">Matsunaga T, Iwawaki Y, Watanabe K, Yamamoto I, Kageyama T, Yoshimura H. <span><span class="ref-journal">Life Sci. </span>1995;<span class="ref-vol">56</span>:2089.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/7776836" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R91">91. <span class="citation">Harvey DJ, Paton WDM. <span><span class="ref-journal">Rev. Biochem. Toxicol. </span>1986;<span class="ref-vol">6</span>:221.</span></span></div><div class="ref-cit-blk half_rhythm" id="R92">92. <span class="citation">Bornheim LM, Lasker JM, Raucy JL. <span><span class="ref-journal">Drug Metab. Dispos. </span>1992;<span class="ref-vol">20</span>:241.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1352216" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R93">93. <span class="citation">McBurney LJ, Bobbie BA, Sepp LA. <span><span class="ref-journal">J. Anal. Toxicol. </span>1986;<span class="ref-vol">10</span>:56.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/3009969" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R94">94. <span class="citation">Mechoulam R, Zvi ZB, Agurell S, Nilsson IM, Nilsson JLG, Edery H, Grunfeld Y. <span><span class="ref-journal">Experientia. </span>1973;<span class="ref-vol">29</span>:1193.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/4758913" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R95">95. <span class="citation">Halldin MM, Widman M, Bahr CV, Lindgren JE, Martin BR. <span><span class="ref-journal">Drug Metab. Dispos. </span>1982;<span class="ref-vol">10</span>:297.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6126323" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R96">96. <span class="citation">Mason AP, McBay AJ. <span><span class="ref-journal">J. Forensic Sci. </span>1985;<span class="ref-vol">30</span>:615.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2993473" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R97">97. <span class="citation">Sporkert F, Pragst F, Ploner CJ, Tschirch A, Stadelmann AM. Annual Meeting of the International Association of Forensic Toxicologists (TIAFT); Prague, Czech Republic. August 26−30, 2001.p. 62.</span></div><div class="ref-cit-blk half_rhythm" id="R98">98. <span class="citation">Garrett ER, Hunt CA. <span><span class="ref-journal">J. Pharm. Sci. </span>1977;<span class="ref-vol">66</span>:395.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/845807" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R99">99. <span class="citation">Lemberger L, Tamarkin NR, Axelrod J. <span><span class="ref-journal">Science. </span>1971;<span class="ref-vol">173</span>:72.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/5087483" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R100">100. <span class="citation">Harvey DJ, Mechoulam R. <span><span class="ref-journal">Xenobiotica. </span>1990;<span class="ref-vol">20</span>:303.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2336840" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R101">101. <span class="citation">Greene ML, Saunders DR. <span><span class="ref-journal">Gastroenterology. </span>1974;<span class="ref-vol">66</span>:365.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/4813501" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R102">102. <span class="citation">Krishna DR, Klotz U. <span><span class="ref-journal">Clin. Pharmacokinet. </span>1994;<span class="ref-vol">26</span>:144.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8162658" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R103">103. <span class="citation">Watanabe K, Tanaka T, Yamamoto I, Yoshimura H. <span><span class="ref-journal">Biochem. Biophys. Res. Commun. </span>1988;<span class="ref-vol">157</span>:75.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2848522" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R104">104. <span class="citation">Widman M, Nordqvist M, Dollery CT, Briant RH. <span><span class="ref-journal">J. Pharm. Pharmacol. </span>1975;<span class="ref-vol">27</span>:842.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1493" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R105">105. <span class="citation">Wall ME, Brine DR, Perez-Reyes M.  In: <span class="ref-journal">The Pharmacology of Marihuana.</span> Braude MC, Szara S, editors. Raven Press; New York: 1976. p. 93.</span></div><div class="ref-cit-blk half_rhythm" id="R106">106. <span class="citation">Hunt CA, Jones RT, Herning RI, Bachman J. <span><span class="ref-journal">J. Pharmacokinet. Biopharm. </span>1981;<span class="ref-vol">9</span>:245.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6270295" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R107">107. <span class="citation">Nadulski T, Pragst F, Weinberg G, Roser P, Schnelle M, Fronk EM, Stadelmann AM. <span><span class="ref-journal">Ther. Drug Monit. </span>2005;<span class="ref-vol">27</span>:799.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16306858" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R108">108. <span class="citation">Williams PL, Moffat AC. <span><span class="ref-journal">J. Pharm. Pharmacol. </span>1980;<span class="ref-vol">32</span>:445.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6105177" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R109">109. <span class="citation">Johansson E, Agurell S, Hollister LE, Halldin MM. <span><span class="ref-journal">J. Pharm. Pharmacol. </span>1988;<span class="ref-vol">40</span>:374.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2899638" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R110">110. <span class="citation">Johansson E, Halldin MM, Agurell S, Hollister LE, Gillespie HK. <span><span class="ref-journal">Eur. J. Clin. Pharmacol. </span>1989;<span class="ref-vol">37</span>:273.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2558889" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R111">111. <span class="citation">Johansson E, Halldin MM. <span><span class="ref-journal">J. Anal. Toxicol. </span>1989;<span class="ref-vol">13</span>:218.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2550702" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R112">112. <span class="citation">Chiang CN, Rapaka RS. <span><span class="ref-journal">NIDA Res. Monograph. </span>1987;<span class="ref-vol">79</span>:173.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2830536" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R113">113. <span class="citation">Huestis MA, Mitchell JM, Cone EJ. <span><span class="ref-journal">J. Anal. Toxicol. </span>1996;<span class="ref-vol">20</span>:441.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8889681" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R114">114. <span class="citation">Lindgren JE, Ohlsson A, Agurell S, Hollister L, Gillespie H. <span><span class="ref-journal">Psychopharmacology. </span>1981;<span class="ref-vol">74</span>:208.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6267648" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R115">115. <span class="citation">Wall ME, Perez-Reyes M. <span><span class="ref-journal">J. Clin. Pharmacol. </span>1981;<span class="ref-vol">21</span>:178S.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6271823" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R116">116. <span class="citation">Gustafson RA, Levine B, Stout PR, Klette KL, George MP, Moolchan ET, Huestis MA. <span><span class="ref-journal">Clin. Chem. </span>2003;<span class="ref-vol">49</span>:1114.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/12816908" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R117">117. <span class="citation">Gustafson RA, Kim I, Stout PR, Klette KL, George MP, Moolchan ET, Levine B, Huestis MA. <span><span class="ref-journal">J. Anal. Toxicol. </span>2004;<span class="ref-vol">28</span>:160.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15107145" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R118">118. <span class="citation">Kemp PM, Abukhalaf IK, Manno JE, Manno BR, Alford DD, McWilliams ME, Nixon FE, Fitzgerald MJ, Reeves RR, Wood MJ. <span><span class="ref-journal">J. Anal. Toxicol. </span>1995;<span class="ref-vol">19</span>:292.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/7500615" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R119">119. <span class="citation">Kemp PM, Abukhalaf IK, Manno JE, Manno BR, Alford DD, Abusada GA. <span><span class="ref-journal">J. Anal. Toxicol. </span>1995;<span class="ref-vol">19</span>:285.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/7500614" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R120">120. <span class="citation">Blanc JA, Manneh VA, Ernst R, Berger DE, de Keczer SA, Chase C, Centofanti JM, DeLizza AJ. <span><span class="ref-journal">Clin. Chem. </span>1993;<span class="ref-vol">39</span>:1705.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8394791" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R121">121. <span class="citation">Bloom AS. <span><span class="ref-journal">J. Pharmacol. Exper. Ther. </span>1982;<span class="ref-vol">221</span>:97.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6278139" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R122">122. <span class="citation">Christophersen AS. <span><span class="ref-journal">J. Anal. Toxicol. </span>1986;<span class="ref-vol">10</span>:129.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/3018361" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R123">123. <span class="citation">Joern WA. <span><span class="ref-journal">J. Anal. Toxicol. </span>1992;<span class="ref-vol">16</span>:401.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1338115" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R124">124. <span class="citation">Garrett ER, Hunt CA. <span><span class="ref-journal">J. Pharm. Sci. </span>1974;<span class="ref-vol">63</span>:1056.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/4853640" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R125">125. <span class="citation">Huang W, Moody DE, Andrenyak DM, Smith EK, Foltz RL, Huestis MA, Newton JF. <span><span class="ref-journal">J. Anal. Toxicol. </span>2001;<span class="ref-vol">25</span>:531.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/11599596" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R126">126. <span class="citation">Owens SM, McBay AJ, Reisner HM, Perez-Reyes M. <span><span class="ref-journal">Clin. Chem. </span>1981;<span class="ref-vol">27</span>:619.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6258825" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R127">127. <span class="citation">Lemberger L, Crabtree RE, Rowe HM. <span><span class="ref-journal">Science. </span>1972;<span class="ref-vol">177</span>:62.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/5041775" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R128">128. <span class="citation">Moeller MR, Doerr G, Warth S. <span><span class="ref-journal">J. Forensic Sci. </span>1992;<span class="ref-vol">37</span>:969.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1324293" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R129">129. <span class="citation">Feng S, ElSohly MA, Salamone S, Salem MY. <span><span class="ref-journal">J. Anal. Toxicol. </span>2000;<span class="ref-vol">24</span>:395.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/10999345" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R130">130. <span class="citation">Foltz RL.  In: <span class="ref-journal">Advances in Analytical Toxicology.</span> Baselt RC, editor. Biomedical Publications; Foster City: 1984. p. 125.</span></div><div class="ref-cit-blk half_rhythm" id="R131">131. <span class="citation">Green MD, Belanger G, Hum DW, Belanger A, Tephly TR. <span><span class="ref-journal">Drug Metab. Dispos. </span>1997;<span class="ref-vol">25</span>:1389.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9394029" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R132">132. <span class="citation">Manno JE, Manno BR, Kemp PM, Alford DD, Abukhalaf IK, McWilliams ME, Hagaman FN, Fitzgerald MJ. <span><span class="ref-journal">J. Anal. Toxicol. </span>2001;<span class="ref-vol">25</span>:538.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/11599597" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R133">133. <span class="citation">Wall ME, Taylor HL.  In: <span class="ref-journal">Marihuana '84: Proceedings of the Oxford Symposium on Cannabis.</span> Harvey DJ, Paton SW, Nahas GG, editors. IRL Press; Oxford: 1984. p. 69.</span></div><div class="ref-cit-blk half_rhythm" id="R134">134. <span class="citation">Shaw LM, Edling-Owens J, Mattes R. <span><span class="ref-journal">Clin. Chem. </span>1991;<span class="ref-vol">37</span>:2062.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1662560" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R135">135. <span class="citation">Nebro W, Barnes A, Gustafson R, Moolchan E, Huestis M. results presented at the FBI/SOFT/TIAFT Meeting; Washington DC. August 2004.</span></div><div class="ref-cit-blk half_rhythm" id="R136">136. <span class="citation">Peat MA.  In: <span class="ref-journal">Advances in Analytical Toxicology II.</span> Baselt RC, editor. Year Book Medical Publishers; Chicago: 1989. p. 186.</span></div><div class="ref-cit-blk half_rhythm" id="R137">137. <span class="citation">Hanson VW, Buonarati MH, Baselt RC, Wade NA, Yep C, Biasotti AA, Reeve VC, Wong AS, Orbanowsky MW. <span><span class="ref-journal">J. Anal. Toxicol. </span>1983;<span class="ref-vol">7</span>:96.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6304423" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R138">138. <span class="citation">Gjerde H, Beylich KM, Morland J. <span><span class="ref-journal">Accid. Anal. Prev. </span>1993;<span class="ref-vol">25</span>:479.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8357462" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R139">139. <span class="citation">Mason AP, McBay AJ. <span><span class="ref-journal">J. Forensic Sci. </span>1984;<span class="ref-vol">29</span>:987.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6502125" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R140">140. <span class="citation">Huestis MA, Henningfield JE, Cone EJ. <span><span class="ref-journal">J. Anal. Toxicol. </span>1992;<span class="ref-vol">16</span>:283.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1338216" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R141">141. <span class="citation">Huestis MA, Barnes A, Smith ML. <span><span class="ref-journal">Clin. Chem. </span>2005;<span class="ref-vol">51</span>:2289.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16223887" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R142">142. <span class="citation">Smith M, Nebro W, Gustafson R, Huestis M. Annual Meeting of the International Association of Forensic Toxicologists (TIAFT); Seoul, Korea. August 29 – September 2, 2005.p. 1.</span></div><div class="ref-cit-blk half_rhythm" id="R143">143. <span class="citation">Ellis GM, Mann MA, Judson BA, Schramm NT, Tashchian A. <span><span class="ref-journal">Clin. Pharmacol. Ther. </span>1985;<span class="ref-vol">38</span>:572.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/3902318" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R144">144. <span class="citation">Huestis MA, Mitchell JM, Cone EJ. <span><span class="ref-journal">J. Anal. Toxicol. </span>1995;<span class="ref-vol">19</span>:443.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8926739" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R145">145. <span class="citation">Wingert WE. <span><span class="ref-journal">Clin. Chem. </span>1997;<span class="ref-vol">43</span>:100.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8990229" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R146">146. <span class="citation">Hawks RL.  In: <span class="ref-journal">The Cannabinoids: Chemical, Pharmacologic, and Therapeutic Aspects.</span> Agurell S, Dewey W, Willette R, editors. Academic Press; Rockville: 1983. p. 1.</span></div><div class="ref-cit-blk half_rhythm" id="R147">147. <span class="citation">Manno JE, Ferslew KE, Manno BR.  In: <span class="ref-journal">The Cannabinoids: Chemical, Pharmacologic, and Therapeutic Aspects.</span> Agurell S, Dewey WL, Willette RE, editors. Harcourt Brace Jonanovich; Orlando: 1984. p. 281.</span></div><div class="ref-cit-blk half_rhythm" id="R148">148. <span class="citation">Huestis MA, Cone EJ. <span><span class="ref-journal">J. Anal. Toxicol. </span>1998;<span class="ref-vol">22</span>:445.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9788519" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R149">149. <span class="citation">Cone EJ, Lange R, Darwin WD. <span><span class="ref-journal">J. Anal. Toxicol. </span>1998;<span class="ref-vol">22</span>:460.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9788521" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R150">150. <span class="citation">Lafolie P, Beck O, Blennow G, Boreus L, Borg S, Elwin CE, Karlsson L, Odelius G, Hjemdahl P. <span><span class="ref-journal">Clin. Chem. </span>1991;<span class="ref-vol">37</span>:1927.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1934467" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R151">151. <span class="citation">Fraser AD, Worth D. <span><span class="ref-journal">Forensic Sci. Int. </span>2003;<span class="ref-vol">137</span>:196.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/14609657" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R152">152. <span class="citation">Fraser AD, Worth D. <span><span class="ref-journal">Ther. Drug Monit. </span>2002;<span class="ref-vol">24</span>:746.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/12451292" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R153">153. <span class="citation">Fraser AD, Worth D. <span><span class="ref-journal">Forensic Sci. Int. </span>2004;<span class="ref-vol">143</span>:147.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15240035" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R154">154. <span class="citation">Menkes DB, Howard RC, Spears GFS, Cairns ER. <span><span class="ref-journal">Psychopharmacology. </span>1991;<span class="ref-vol">103</span>:277.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1851311" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R155">155. <span class="citation">Gross SJ, Soares JR. <span><span class="ref-journal">J. Anal. Toxicol. </span>1978;<span class="ref-vol">2</span>:98.</span></span></div><div class="ref-cit-blk half_rhythm" id="R156">156. <span class="citation">Gross SJ, Worthy TE, Nerder L, Zimmermann EG, Soares JR, Lomax P. <span><span class="ref-journal">J. Anal. Toxicol. </span>1985;<span class="ref-vol">9</span>:1.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2984463" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R157">157. <span class="citation">Mura P, Kintz P, Papet Y, Ruesch G, Piriou A. <span><span class="ref-journal">Acta Clin. Belg. </span>1999;<span class="ref-vol">1</span>:35.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/10216980" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R158">158. <span class="citation">Soares JR, Gross SJ. <span><span class="ref-journal">Life Sci. </span>1976;<span class="ref-vol">19</span>:1711.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1004131" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R159">159. <span class="citation">Soares JR, Grant JD, Gross SJ. <span><span class="ref-journal">NIDA Res. Monograph. </span>1982;<span class="ref-vol">42</span>:44.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6294525" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R160">160. <span class="citation">Hawks RL. <span><span class="ref-journal">NIDA Res. Monograph. </span>1982;<span class="ref-vol">42</span>:125.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6294522" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R161">161. <span class="citation">Huestis MA, Cone EJ.  In: <span class="ref-journal">Drug Abuse Handbook.</span> Karch SB, editor. CRC Press; Boca Raton: 1998. p. 799.</span></div><div class="ref-cit-blk half_rhythm" id="R162">162. <span class="citation">Kintz P, Cirimele V, Ludes B. <span><span class="ref-journal">J. Anal. Toxicol. </span>2000;<span class="ref-vol">24</span>:557.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/11043659" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R163">163. <span class="citation">Huestis MA, Dickerson S, Cone EJ. <span><span class="ref-journal">Am. Acad. Forensic Sci. Annual Meeting. </span>1992:190.</span></span></div><div class="ref-cit-blk half_rhythm" id="R164">164. <span class="citation">Huestis MA, Cone EJ. <span><span class="ref-journal">J. Anal. Toxicol. </span>2004;<span class="ref-vol">28</span>:394.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15516285" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R165">165. <span class="citation">Niedbala RS, Kardos KW, Fritch DF, Kardos S, Fries T, Waga J. <span><span class="ref-journal">J. Anal. Toxicol. </span>2001;<span class="ref-vol">25</span>:289.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/11499881" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R166">166. <span class="citation">Peel HW, Perrigo BJ, Mikhael NZ. <span><span class="ref-journal">J. Forensic Sci. </span>1984;<span class="ref-vol">29</span>:185.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6366113" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R167">167. <span class="citation">Laloup M, Del Mar Ramirez Fernandez M, Wood M, De Boeck G, Maes V, Samyn N. <span><span class="ref-journal">Forensic Sci. Int. </span>2006;<span class="ref-vol">161</span>:175.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16842950" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R168">168. <span class="citation">Jehanli A, Brannan S, Moore L, Spiehler VR. <span><span class="ref-journal">J. Forensic Sci. </span>2001;<span class="ref-vol">46</span>:1214.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/11569567" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R169">169. <span class="citation">Hall BJ, Satterfield-Doerr M, Parikh AR, Brodbelt JS. <span><span class="ref-journal">Anal. Chem. </span>1998;<span class="ref-vol">70</span>:1788.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9599579" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R170">170. <span class="citation">Walsh JM, Flegel R, Crouch DJ, Cangianelli L, Baudys J. <span><span class="ref-journal">J. Anal. Toxicol. </span>2003;<span class="ref-vol">27</span>:429.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/14606995" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R171">171. <span class="citation">Crouch DJ. <span><span class="ref-journal">Forensic Sci. Int. </span>2005;<span class="ref-vol">150</span>:165.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15899565" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R172">172. <span class="citation">Crouch DJ, Walsh JM, Flegel R, Cangianelli L, Baudys J, Atkins R. <span><span class="ref-journal">J. Anal. Toxicol. </span>2005;<span class="ref-vol">29</span>:244.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15975256" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R173">173. <span class="citation">Quintela O, Crouch DJ, Andrenyak DM. <span><span class="ref-journal">J. Anal. Toxicol. </span>2006;<span class="ref-vol">30</span>:614.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/17132261" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R174">174. <span class="citation">Day D, Kuntz DJ, Feldman M, Presley L. <span><span class="ref-journal">J. Anal. Toxicol. </span>2006;<span class="ref-vol">30</span>:645.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/17137523" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R175">175. <span class="citation">Moore C, Coulter C, Rana S, Vincent M, Soares J. <span><span class="ref-journal">J. Anal. Toxicol. </span>2006;<span class="ref-vol">30</span>:409.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16959131" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R176">176. <span class="citation">Moore C, Ross W, Coulter C, Adams L, Rana S, Vincent M, Soares J. <span><span class="ref-journal">J. Anal. Toxicol. </span>2006;<span class="ref-vol">30</span>:413.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16959132" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R177">177. <span class="citation">Niedbala RS, Kardos KW, Fritch DF, Kunsman KP, Blum KA, Newland GA, Waga J, Kurtz L, Bronsgeest M, Cone EJ. <span><span class="ref-journal">J. Anal. Toxicol. </span>2005;<span class="ref-vol">29</span>:607.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16419389" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R178">178. <span class="citation">Kidwell DA, Holland JC, Athanaselis S. <span><span class="ref-journal">J. Chromatogr. </span>1998;<span class="ref-vol">713</span>:111.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9700555" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R179">179. <span class="citation">Balabanova S, Schneider E. <span><span class="ref-journal">Beitr. Gerichtl. Med. </span>1989;<span class="ref-vol">48</span>:45.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2241828" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R180">180. <span class="citation">Samyn N, van Haeren C. <span><span class="ref-journal">Int. J. Legal Med. </span>2000;<span class="ref-vol">113</span>:150.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/10876986" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R181">181. <span class="citation">Kintz P, Brenniesen R, Bundeli P, Mangin P. <span><span class="ref-journal">Clin. Chem. </span>1997;<span class="ref-vol">43</span>:736.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9166224" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R182">182. <span class="citation">Ehorn C, Fretthold D, Maharaj M. Annual Meeting of the International Association of Forensic Toxicologists (TIAFT); Tampa, U.S.A.. October 31 – November 4, 1994.p. 11.</span></div><div class="ref-cit-blk half_rhythm" id="R183">183. <span class="citation">Cairns T, Kippenberger DJ, Scholtz H, Baumgartner WA. In: de Zeeuw RA, Al Hosani I, Al Munthiri S, Maqbool A, editors. Hair Analysis in Forensic Toxicology: Proceedings of the 1995 International Conference and Workshop; Abu Dhabi. 1995; Organizing Committee; p. 185.</span></div><div class="ref-cit-blk half_rhythm" id="R184">184. <span class="citation">Cirimele V.  In: <span class="ref-journal">Drug Testing in Hair.</span> Kintz P, editor. CRC Press; Boca Raton: 1996. p. 181.</span></div><div class="ref-cit-blk half_rhythm" id="R185">185. <span class="citation">Kintz P, Cirimele V, Mangin P. <span><span class="ref-journal">J. Forensic Sci. </span>1995;<span class="ref-vol">40</span>:619.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/7595299" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R186">186. <span class="citation">Moore C, Guzaldo F, Donahue T. <span><span class="ref-journal">J. Anal. Toxicol. </span>2001;<span class="ref-vol">25</span>:555.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/11599599" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R187">187. <span class="citation">Moore C, Rana S, Coulter C, Feyerherm F, Prest H. <span><span class="ref-journal">J. Anal. Toxicol. </span>2006;<span class="ref-vol">30</span>:171.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16803651" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R188">188. <span class="citation">Cirimele V, Sachs H, Kintz P, Mangin P. <span><span class="ref-journal">J. Anal. Toxicol. </span>1996;<span class="ref-vol">20</span>:13.</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8837945" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R189">189. <span class="citation">Huestis MA, Gustafson RA, Moolchan ET, Barnes A, Bourland JA, Sweeney SA, Hayes EF, Carpenter PM, Smith ML. <span><span class="ref-journal">Forensic Sci. Int. </span>2007;<span class="ref-vol">169</span>:129.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2274831/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16963215" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#S1title">1. Introduction</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#S2title">2. Pharmacokinetics of Cannabinoids</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#S21title">3. Interpretation of Cannabinoid Concentrations in Biological Fluids</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#S34title">4. Conclusions</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#__fn-groupidm140594133112944title">Footnotes</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#__ref-listidm140594133109840title">REFERENCES</a></li></ul></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/epub/">ePub (beta)</a></li> | <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/pdf/nihms-118643.pdf">PDF (750K)</a></li> | <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#" data-citationid="PMC2689518" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2689518%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./Human Cannabinoid Pharmacokinetics_files/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2689518%2F&amp;text=Human%20Cannabinoid%20Pharmacokinetics" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./Human Cannabinoid Pharmacokinetics_files/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2689518%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./Human Cannabinoid Pharmacokinetics_files/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="17712819" data-aiid="2689518" data-aid="2689518" data-iid="179191" data-domainid="319" data-domain="nihpa" data-accid="PMC2689518" data-md5="fc78c7208ef73cd1ae482d0713f2c2d8">
<div class="portlet pubmed_favoritesad">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Save items</span></h3></div>
<a name="Shutter" sid="1" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="pmfavad" toggles="ui-portlet_content-4" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-4" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<input type="hidden" name="absid" id="absid" value="2689518"><div id="pubmed_favoritesad" class="empty" data-db="pmc">
<span role="menubar"><div class="ui-ncbisetswitch ltd-hover" role="menuitem" aria-expanded="false" aria-haspopup="true"><a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/" class="jig-ncbisetswitch blind collink ltd-hover ui-ncbisetswitch-hasStar" id="favList" data-jigconfig="destSelector:&#39;#favUL&#39;,starExists:true,createCollectionUrl:&#39;#&#39;,manageCollectionsUrl:&#39;/myncbi/collections/&#39;"><span class="star"></span>Add to Favorites</a><a class="ui-ncbisetswitch-button ltd-hover" title="View more options" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#"><span class="ui-icon ui-icon-triangle-1-s ui-ncbisetswitch-down">View more options</span></a></div></span><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu ui-ncbisetswitch-popper"><ul id="favUL" class="ui-ncbisetswitch-options"></ul><ul class="ui-ncbisetswitch-actions"><li class="ui-ncbisetswitch-actions-create" style="display: block;"><a class="ui-ncbisetswitch-create-collection" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#">Create collection...</a></li><li class="ui-ncbisetswitch-actions-manage" style="display: block;"><a class="ui-ncbisetswitch-manage-collections" href="https://www.ncbi.nlm.nih.gov/myncbi/collections/">Manage collections...</a></li></ul></div>
</div>
<div class="colloading">loading</div>
<span id="submenu_AddToCollections"><form method="post"><input type="submit" class="button_apply" name="addtocollection" value="1"></form></span>
</div></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div>
<a name="Shutter" sid="1" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" toggles="ui-portlet_content-5" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-5" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/19151803" ref="reftype=relart&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">[Passive inhalation of cannabis smoke--is it detectable?].</a><span class="source">[Tidsskr Nor Laegeforen. 2009]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-6" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Westin AA, Slørdal L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Tidsskr Nor Laegeforen. 2009 Jan 15; 129(2):109-13. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/17236827" ref="reftype=relart&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Development of a LC/MS/MS method for the analysis of cannabinoids in human EDTA-plasma and urine after small doses of Cannabis sativa extracts.</a><span class="source">[J Chromatogr B Analyt Technol ...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-7" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Grauwiler SB, Scholer A, Drewe J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Chromatogr B Analyt Technol Biomed Life Sci. 2007 May 1; 850(1-2):515-22. Epub 2007 Jan 11.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/6750029" ref="reftype=relart&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">An evaluation of a homogeneous enzyme immunoassay (EMIT) for cannabinoid detection in biological fluids.</a><span class="source">[J Forensic Sci Soc. 1982]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-8" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Law B, Pocock K, Moffat AC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Forensic Sci Soc. 1982 Jul; 22(3):275-81. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/26349566" ref="reftype=relart&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">High-resolution mass spectrometric determination of the synthetic cannabinoids MAM-2201, AM-2201, AM-2232, and their metabolites in postmortem plasma and urine by LC/Q-TOFMS.</a><span class="source">[Int J Legal Med. 2015]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-9" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Zaitsu K, Nakayama H, Yamanaka M, Hisatsune K, Taki K, Asano T, Kamata T, Katagai M, Hayashi Y, Kusano M, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Int J Legal Med. 2015 Nov; 129(6):1233-45. Epub 2015 Sep 8.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/10572977" ref="reftype=relart&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Chromatographic procedures for determination of cannabinoids in biological samples, with special attention to blood and alternative matrices like hair, saliva, sweat and meconium.</a><span class="source">[J Chromatogr B Biomed Sci Appl...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-10" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Staub C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Chromatogr B Biomed Sci Appl. 1999 Oct 15; 733(1-2):119-26. </em>
</div>
</li>
</ul>
<a class="seemore" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=17712819&amp;log%24=relatedreviews&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Reviews&amp;rendering-type=normal">See reviews...</a><a class="seemore" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=17712819&amp;log%24=relatedarticles&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Related%20Records&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Cited by other articles in PMC</span></h3></div>
<a name="Shutter" sid="1" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-11" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-11" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412026/" ref="reftype=relart&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Determination of ∆-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography–Tandem Mass Spectrometry</a><span class="source">[Journal of Analytical Toxicolo...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-12" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Andrenyak DM, Moody DE, Slawson MH, O'Leary DS, Haney M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Journal of Analytical Toxicology. 2017 Jan 9; 41(4): 277-288</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408584/" ref="reftype=relart&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Fatty acid binding protein-1 (FABP1) and the human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias</a><span class="source">[Lipids. 2016]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-13" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Schroeder F, McIntosh AL, Martin GG, Huang H, Landrock D, Chung S, Landrock KK, Dangott LJ, Li S, Kaczocha M, Murphy EJ, Atshaves BP, Kier AB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Lipids. 2016 Apr 27; 51(6): 655-676</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322802/" ref="reftype=relart&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">FABP1: A NOVEL HEPATIC ENDOCANNABINOID AND CANNABINOID BINDING PROTEIN</a><span class="source">[Biochemistry. 2016]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-14" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Huang H, McIntosh AL, Martin GG, Landrock D, Chung S, Landrock KK, Dangott LJ, Li S, Kier AB, Schroeder F. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Biochemistry. 2016 Sep 2; 55(37): 5243-5255</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314139/" ref="reftype=relart&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Endocannabinoids: A Promising Impact for Traumatic Brain Injury</a><span class="source">[Frontiers in Pharmacology. 2017]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-15" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Schurman LD, Lichtman AH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Frontiers in Pharmacology. 2017 Feb 17; 8: 69</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260817/" ref="reftype=relart&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Tasty THC: Promises and Challenges of Cannabis Edibles</a><span class="source">[Methods report (RTI Press). 2016]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-16" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Barrus DG, Capogrossi KL, Cates SC, Gourdet CK, Peiper NC, Novak SP, Lefever TW, Wiley JL. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Methods report (RTI Press). 2016 Nov; 2016: 10.3768/rtipress.2016.op.0035.1611</em>
</div>
</li>
</ul>
<a class="seemore" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/citedby/" ref="reftype=relart&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|CitedBy&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Links</span></h3></div>
<a name="Shutter" sid="1" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-17" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-17" aria-hidden="false"><ul>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/17712819/" ref="reftype=PubMed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|PubMed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">PubMed</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-18" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">PubMed<div class="brieflinkpopdesc">PubMed citations for these articles</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/?Db=pcsubstance&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_pcsubstance&amp;IdsFromResult=2689518" ref="reftype=Substance&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|PubChem%20Substance&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Substance</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-19" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Substance<div class="brieflinkpopdesc">PubChem Substance links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/?Db=taxonomy&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_taxonomy&amp;IdsFromResult=2689518" ref="reftype=Taxonomy&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Taxonomy&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Taxonomy</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-20" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Taxonomy<div class="brieflinkpopdesc">Related taxonomy entry</div>
</div>
</li>
</ul></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Recent Activity</span></h3></div>
<a name="Shutter" sid="1" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" toggles="ui-portlet_content-21" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-21" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class="">
<div class="action">
<a href="javascript:historyDisplayState(&#39;ClearHT&#39;)">Clear</a><a href="javascript:historyDisplayState(&#39;HTOff&#39;)" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState(&#39;HTOn&#39;)" class="HTOff">Turn On</a>
</div>
<ul id="activity"><li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="https://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=5938a576f22a26351adfb63a">Human Cannabinoid Pharmacokinetics</a><div class="ralinkpop offscreen_noflow">Human Cannabinoid Pharmacokinetics<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2007 Aug; 4(8)1770</div>
</div>
<div class="tertiary"></div>
</li></ul>
<p class="HTOn">Your browsing activity is empty.</p>
<p class="HTOff">Activity recording is turned off.</p>
<p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState(&#39;HTOn&#39;)">Turn recording back on</a></p>
<a class="seemore" href="https://www.ncbi.nlm.nih.gov/sites/myncbi/recentactivity">See more...</a>
</div></div></div>
</div>
<div>
<div class="portlet brieflink pmc_para_cit" id="crb--P5" name="crb--P5" rid="P5" style="position: absolute; visibility: visible; width: 370px; top: 1665px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-22"><ul>
<li class="two_line" reference_id="R1">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6991645/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Constituents of Cannabis sativa L. XVII. A review of the natural constituents.</a><span class="one_line_source">[J Nat Prod.  1980]</span><div class="alt-note">
<div class="authors">Turner CE, Elsohly MA, Boeren EG</div>
<div class="citation">J Nat Prod. 1980 Mar-Apr; 43(2):169-234.</div>
</div>
</li>
<li class="two_line" reference_id="R4">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/4910003/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Marihuana chemistry.</a><span class="one_line_source">[Science.  1970]</span><div class="alt-note">
<div class="authors">Mechoulam R</div>
<div class="citation">Science. 1970 Jun 5; 168(3936):1159-66.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P6" name="crb--P6" rid="P6" style="position: absolute; visibility: visible; width: 370px; top: 2114px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-23"><ul>
<li class="two_line" reference_id="R5">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6250760/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking.</a><span class="one_line_source">[Clin Pharmacol Ther.  1980]</span><div class="alt-note">
<div class="authors">Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK</div>
<div class="citation">Clin Pharmacol Ther. 1980 Sep; 28(3):409-16.</div>
</div>
</li>
<li class="two_line" reference_id="R6">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/5135173/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Stability, transfer and absorption of cannabinoid constituents of cannabis (hashish) during smoking.</a><span class="one_line_source">[Acta Pharm Suec.  1971]</span><div class="alt-note">
<div class="authors">Agurell S, Leander K</div>
<div class="citation">Acta Pharm Suec. 1971 Sep; 8(4):391-402.</div>
</div>
</li>
<li class="two_line" reference_id="R9">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6277407/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Single dose kinetics of deuterium labelled delta 1-tetrahydrocannabinol in heavy and light cannabis users.</a><span class="one_line_source">[Biomed Mass Spectrom.  1982]</span><div class="alt-note">
<div class="authors">Ohlsson A, Lindgren JE, Wahlén A, Agurell S, Hollister LE, Gillespie HK</div>
<div class="citation">Biomed Mass Spectrom. 1982 Jan; 9(1):6-10.</div>
</div>
</li>
<li class="two_line" reference_id="R10">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1313866/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Marijuana smoking: effect of varying delta 9-tetrahydrocannabinol content and number of puffs.</a><span class="one_line_source">[J Pharmacol Exp Ther.  1992]</span><div class="alt-note">
<div class="authors">Azorlosa JL, Heishman SJ, Stitzer ML, Mahaffey JM</div>
<div class="citation">J Pharmacol Exp Ther. 1992 Apr; 261(1):114-22.</div>
</div>
</li>
<li class="two_line" reference_id="R12">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/2176276/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Marijuana smoking: factors that influence the bioavailability of tetrahydrocannabinol.</a><span class="one_line_source">[NIDA Res Monogr.  1990]</span><div class="alt-note">
<div class="authors">Perez-Reyes M</div>
<div class="citation">NIDA Res Monogr. 1990; 99():42-62.</div>
</div>
</li>
<li class="two_line" reference_id="R13" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1664106/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effect of subject expectancy on the THC intoxication and disposition from smoked hashish cigarettes.</a><span class="one_line_source">[Pharmacol Biochem Behav.  1991]</span><div class="alt-note">
<div class="authors">Camí J, Guerra D, Ugena B, Segura J, de la Torre R</div>
<div class="citation">Pharmacol Biochem Behav. 1991 Sep; 40(1):115-9.</div>
</div>
</li>
</ul><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P7" name="crb--P7" rid="P7" style="position: absolute; visibility: visible; width: 370px; top: 2356px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-24"><ul>
<li class="two_line" reference_id="R14">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1338215/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.</a><span class="one_line_source">[J Anal Toxicol.  1992]</span><div class="alt-note">
<div class="authors">Huestis MA, Henningfield JE, Cone EJ</div>
<div class="citation">J Anal Toxicol. 1992 Sep-Oct; 16(5):276-82.</div>
</div>
</li>
<li class="two_line" reference_id="R15">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1320536/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Characterization of the absorption phase of marijuana smoking.</a><span class="one_line_source">[Clin Pharmacol Ther.  1992]</span><div class="alt-note">
<div class="authors">Huestis MA, Sampson AH, Holicky BJ, Henningfield JE, Cone EJ</div>
<div class="citation">Clin Pharmacol Ther. 1992 Jul; 52(1):31-41.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P9" name="crb--P9" rid="P9" style="position: absolute; visibility: visible; width: 370px; top: 3033px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-25"><ul>
<li class="two_line" reference_id="R16">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6280918/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Comparison of effects of marihuana cigarettes to three different potencies.</a><span class="one_line_source">[Clin Pharmacol Ther.  1982]</span><div class="alt-note">
<div class="authors">Perez-Reyes M, Di Guiseppi S, Davis KH, Schindler VH, Cook CE</div>
<div class="citation">Clin Pharmacol Ther. 1982 May; 31(5):617-24.</div>
</div>
</li>
<li class="two_line" reference_id="R17">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6271825/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The clinical pharmacology and dynamics of marihuana cigarette smoking.</a><span class="one_line_source">[J Clin Pharmacol.  1981]</span><div class="alt-note">
<div class="authors">Perez-Reyes M, Owens SM, Di Guiseppi S</div>
<div class="citation">J Clin Pharmacol. 1981 Aug-Sep; 21(8-9 Suppl):201S-207S.</div>
</div>
</li>
<li class="two_line" reference_id="R5">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6250760/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking.</a><span class="one_line_source">[Clin Pharmacol Ther.  1980]</span><div class="alt-note">
<div class="authors">Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK</div>
<div class="citation">Clin Pharmacol Ther. 1980 Sep; 28(3):409-16.</div>
</div>
</li>
<li class="two_line" reference_id="R15">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1320536/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Characterization of the absorption phase of marijuana smoking.</a><span class="one_line_source">[Clin Pharmacol Ther.  1992]</span><div class="alt-note">
<div class="authors">Huestis MA, Sampson AH, Holicky BJ, Henningfield JE, Cone EJ</div>
<div class="citation">Clin Pharmacol Ther. 1992 Jul; 52(1):31-41.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P10" name="crb--P10" rid="P10" style="position: absolute; visibility: visible; width: 370px; top: 3212px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-26"><ul>
<li class="two_line" reference_id="R18">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/10641915/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Potency trends of delta9-THC and other cannabinoids in confiscated marijuana from 1980-1997.</a><span class="one_line_source">[J Forensic Sci.  2000]</span><div class="alt-note">
<div class="authors">ElSohly MA, Ross SA, Mehmedic Z, Arafat R, Yi B, Banahan BF 3rd</div>
<div class="citation">J Forensic Sci. 2000 Jan; 45(1):24-30.</div>
</div>
</li>
<li class="two_line" reference_id="R19">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/12491031/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabis is more than simply delta(9)-tetrahydrocannabinol.</a><span class="one_line_source">[Psychopharmacology (Berl).  2003]</span><div class="alt-note">
<div class="authors">Russo EB, McPartland JM</div>
<div class="citation">Psychopharmacology (Berl). 2003 Feb; 165(4):431-2; author reply 433-4.</div>
</div>
</li>
<li class="two_line" reference_id="R20" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9778318/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Characterization of cytochrome P450 3A inactivation by cannabidiol: possible involvement of cannabidiol-hydroxyquinone as a P450 inactivator.</a><span class="one_line_source">[Chem Res Toxicol.  1998]</span><div class="alt-note">
<div class="authors">Bornheim LM, Grillo MP</div>
<div class="citation">Chem Res Toxicol. 1998 Oct; 11(10):1209-16.</div>
</div>
</li>
<li class="two_line" reference_id="R22" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/12505688/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects.</a><span class="one_line_source">[Chem Phys Lipids.  2002]</span><div class="alt-note">
<div class="authors">Mechoulam R, Hanus L</div>
<div class="citation">Chem Phys Lipids. 2002 Dec 31; 121(1-2):35-43.</div>
</div>
</li>
</ul><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P11" name="crb--P11" rid="P11" style="position: absolute; visibility: visible; width: 370px; top: 3349px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-27"><ul>
<li class="two_line" reference_id="R23">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9112136/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Concentration-effect relationship of delta-9-tetrahydrocannabiol and prediction of psychotropic effects after smoking marijuana.</a><span class="one_line_source">[Int J Clin Pharmacol Ther.  1997]</span><div class="alt-note">
<div class="authors">Harder S, Rietbrock S</div>
<div class="citation">Int J Clin Pharmacol Ther. 1997 Apr; 35(4):155-9.</div>
</div>
</li>
<li class="two_line" reference_id="R24">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6145762/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin.</a><span class="one_line_source">[J Pharm Pharmacol.  1984]</span><div class="alt-note">
<div class="authors">Law B, Mason PA, Moffat AC, Gleadle RI, King LJ</div>
<div class="citation">J Pharm Pharmacol. 1984 May; 36(5):289-94.</div>
</div>
</li>
<li class="two_line" reference_id="R25">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6261133/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Plasma levels of delta 9-tetrahydrocannabinol after intravenous, oral, and smoke administration.</a><span class="one_line_source">[NIDA Res Monogr.  1981]</span><div class="alt-note">
<div class="authors">Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK</div>
<div class="citation">NIDA Res Monogr. 1981 Feb; 34():250-6.</div>
</div>
</li>
<li class="two_line" reference_id="R26">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/4683071/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pharmacology of orally administered   9 -tetrahydrocannabinol.</a><span class="one_line_source">[Clin Pharmacol Ther.  1973]</span><div class="alt-note">
<div class="authors">Perez-Reyes M, Lipton MA, Timmons MC, Wall ME, Brine DR, Davis KH</div>
<div class="citation">Clin Pharmacol Ther. 1973 Jan-Feb; 14(1):48-55.</div>
</div>
</li>
<li class="two_line" reference_id="R27">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6309462/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women.</a><span class="one_line_source">[Clin Pharmacol Ther.  1983]</span><div class="alt-note">
<div class="authors">Wall ME, Sadler BM, Brine D, Taylor H, Perez-Reyes M</div>
<div class="citation">Clin Pharmacol Ther. 1983 Sep; 34(3):352-63.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P12" name="crb--P12" rid="P12" style="position: absolute; visibility: visible; width: 370px; top: 3718px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-28"><ul><li class="two_line" reference_id="R5">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6250760/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking.</a><span class="one_line_source">[Clin Pharmacol Ther.  1980]</span><div class="alt-note">
<div class="authors">Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK</div>
<div class="citation">Clin Pharmacol Ther. 1980 Sep; 28(3):409-16.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P13" name="crb--P13" rid="P13" style="position: absolute; visibility: visible; width: 370px; top: 3876px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-29"><ul>
<li class="two_line" reference_id="R28">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8832425/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Rapid screening for acidic non-steroidal anti-inflammatory drugs in urine by gas chromatography-mass spectrometry in the selected-ion monitoring mode.</a><span class="one_line_source">[J Chromatogr B Biomed Appl.  1996]</span><div class="alt-note">
<div class="authors">Kim KR, Yoon HR</div>
<div class="citation">J Chromatogr B Biomed Appl. 1996 Jun 28; 682(1):55-66.</div>
</div>
</li>
<li class="two_line" reference_id="R29">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1208765/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Psychosis following ingestion of hemp in children.</a><span class="one_line_source">[Psychopharmacologia.  1975]</span><div class="alt-note">
<div class="authors">Binitie A</div>
<div class="citation">Psychopharmacologia. 1975 Nov 21; 44(3):301-2.</div>
</div>
</li>
<li class="two_line" reference_id="R30">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9157527/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">[Cannabis poisoning after eating salad].</a><span class="one_line_source">[Schweiz Med Wochenschr.  1997]</span><div class="alt-note">
<div class="authors">Meier H, Vonesch HJ</div>
<div class="citation">Schweiz Med Wochenschr. 1997 Feb 8; 127(6):214-8.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P15" name="crb--P15" rid="P15" style="position: absolute; visibility: visible; width: 370px; top: 4276px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-30"><ul>
<li class="two_line" reference_id="R31">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16885723/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.</a><span class="one_line_source">[Ther Drug Monit.  2006]</span><div class="alt-note">
<div class="authors">Goodwin RS, Gustafson RA, Barnes A, Nebro W, Moolchan ET, Huestis MA</div>
<div class="citation">Ther Drug Monit. 2006 Aug; 28(4):545-51.</div>
</div>
</li>
<li class="two_line" reference_id="R32">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/14630369/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Validated method for the simultaneous determination of Delta 9-tetrahydrocannabinol (THC), 11-hydroxy-THC and 11-nor-9-carboxy-THC in human plasma using solid phase extraction and gas chromatography-mass spectrometry with positive chemical ionization.</a><span class="one_line_source">[J Chromatogr B Analyt Technol Biomed Life Sci.  2003]</span><div class="alt-note">
<div class="authors">Gustafson RA, Moolchan ET, Barnes A, Levine B, Huestis MA</div>
<div class="citation">J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Dec 5; 798(1):145-54.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P16" name="crb--P16" rid="P16" style="position: absolute; visibility: visible; width: 370px; top: 4720px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-31"><ul><li class="two_line" reference_id="R33">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16356335/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract.</a><span class="one_line_source">[J Anal Toxicol.  2005]</span><div class="alt-note">
<div class="authors">Nadulski T, Sporkert F, Schnelle M, Stadelmann AM, Roser P, Schefter T, Pragst F</div>
<div class="citation">J Anal Toxicol. 2005 Nov-Dec; 29(8):782-9.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P18" name="crb--P18" rid="P18" style="position: absolute; visibility: visible; width: 370px; top: 4910px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-32"><ul>
<li class="two_line" reference_id="R34">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16205721/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Plant cannabinoids: a neglected pharmacological treasure trove.</a><span class="one_line_source">[Br J Pharmacol.  2005]</span><div class="alt-note">
<div class="authors">Mechoulam R</div>
<div class="citation">Br J Pharmacol. 2005 Dec; 146(7):913-5.</div>
</div>
</li>
<li class="two_line" reference_id="R35">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8387642/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Early medical use of cannabis.</a><span class="one_line_source">[Nature.  1993]</span><div class="alt-note">
<div class="authors">Zias J, Stark H, Sellgman J, Levy R, Werker E, Breuer A, Mechoulam R</div>
<div class="citation">Nature. 1993 May 20; 363(6426):215.</div>
</div>
</li>
<li class="two_line" reference_id="R36">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16209908/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol.</a><span class="one_line_source">[Med Hypotheses.  2006]</span><div class="alt-note">
<div class="authors">Russo E, Guy GW</div>
<div class="citation">Med Hypotheses. 2006; 66(2):234-46.</div>
</div>
</li>
<li class="two_line" reference_id="R39">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/14615106/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.</a><span class="one_line_source">[Lancet.  2003]</span><div class="alt-note">
<div class="authors">Zajicek J, Fox P, Sanders H, Wright D, Vickery J, Nunn A, Thompson A, UK MS Research Group.</div>
<div class="citation">Lancet. 2003 Nov 8; 362(9395):1517-26.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P19" name="crb--P19" rid="P19" style="position: absolute; visibility: visible; width: 370px; top: 5173px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-33"><ul>
<li class="two_line" reference_id="R40">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8383856/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Bypassing the first-pass effect for the therapeutic use of cannabinoids.</a><span class="one_line_source">[Pharmacol Biochem Behav.  1993]</span><div class="alt-note">
<div class="authors">Mattes RD, Shaw LM, Edling-Owens J, Engelman K, Elsohly MA</div>
<div class="citation">Pharmacol Biochem Behav. 1993 Mar; 44(3):745-7.</div>
</div>
</li>
<li class="two_line" reference_id="R41">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/7816872/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabinoids and appetite stimulation.</a><span class="one_line_source">[Pharmacol Biochem Behav.  1994]</span><div class="alt-note">
<div class="authors">Mattes RD, Engelman K, Shaw LM, Elsohly MA</div>
<div class="citation">Pharmacol Biochem Behav. 1994 Sep; 49(1):187-95.</div>
</div>
</li>
<li class="two_line" reference_id="R42">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8897084/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The effect of orally and rectally administered delta 9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients.</a><span class="one_line_source">[Int J Clin Pharmacol Ther.  1996]</span><div class="alt-note">
<div class="authors">Brenneisen R, Egli A, Elsohly MA, Henn V, Spiess Y</div>
<div class="citation">Int J Clin Pharmacol Ther. 1996 Oct; 34(10):446-52.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P20" name="crb--P20" rid="P20" style="position: absolute; visibility: visible; width: 370px; top: 5352px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-34"><ul>
<li class="two_line" reference_id="R43">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/15025853/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Human skin permeation of Delta8-tetrahydrocannabinol, cannabidiol and cannabinol.</a><span class="one_line_source">[J Pharm Pharmacol.  2004]</span><div class="alt-note">
<div class="authors">Stinchcomb AL, Valiveti S, Hammell DC, Ramsey DR</div>
<div class="citation">J Pharm Pharmacol. 2004 Mar; 56(3):291-7.</div>
</div>
</li>
<li class="two_line" reference_id="R44">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6018244/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration.</a><span class="one_line_source">[J Invest Dermatol.  1967]</span><div class="alt-note">
<div class="authors">Scheuplein RJ</div>
<div class="citation">J Invest Dermatol. 1967 Jan; 48(1):79-88.</div>
</div>
</li>
<li class="two_line" reference_id="R45">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/12100860/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">In vitro experiment optimization for measuring tetrahydrocannabinol skin permeation.</a><span class="one_line_source">[Int J Pharm.  2002]</span><div class="alt-note">
<div class="authors">Challapalli PV, Stinchcomb AL</div>
<div class="citation">Int J Pharm. 2002 Jul 25; 241(2):329-39.</div>
</div>
</li>
<li class="two_line" reference_id="R46">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/15067692/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">In vitro/in vivo correlation studies for transdermal delta 8-THC development.</a><span class="one_line_source">[J Pharm Sci.  2004]</span><div class="alt-note">
<div class="authors">Valiveti S, Hammell DC, Earles DC, Stinchcomb AL</div>
<div class="citation">J Pharm Sci. 2004 May; 93(5):1154-64.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P21" name="crb--P21" rid="P21" style="position: absolute; visibility: visible; width: 370px; top: 5533px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-35"><ul><li class="two_line" reference_id="R47">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/3231372/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Inhalation marijuana as an antiemetic for cancer chemotherapy.</a><span class="one_line_source">[N Y State J Med.  1988]</span><div class="alt-note">
<div class="authors">Vinciguerra V, Moore T, Brennan E</div>
<div class="citation">N Y State J Med. 1988 Oct; 88(10):525-7.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P23" name="crb--P23" rid="P23" style="position: absolute; visibility: visible; width: 370px; top: 5765px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-36"><ul><li class="two_line" reference_id="R48">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/15173844/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis.</a><span class="one_line_source">[Neuropsychopharmacology.  2004]</span><div class="alt-note">
<div class="authors">D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieva R, Krystal JH</div>
<div class="citation">Neuropsychopharmacology. 2004 Aug; 29(8):1558-72.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P24" name="crb--P24" rid="P24" style="position: absolute; visibility: visible; width: 370px; top: 6070px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-37"><ul>
<li class="two_line" reference_id="R49">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/4761242/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol.</a><span class="one_line_source">[Experientia.  1973]</span><div class="alt-note">
<div class="authors">Perez-Reyes M, Timmons MC, Davis KH, Wall EM</div>
<div class="citation">Experientia. 1973 Nov 15; 29(11):1368-9.</div>
</div>
</li>
<li class="two_line" reference_id="R50">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/7389248/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Metabolic and psychophysiologic studies of cannabidiol-hexobarbital interaction.</a><span class="one_line_source">[Clin Pharmacol Ther.  1980]</span><div class="alt-note">
<div class="authors">Benowitz NL, Nguyen TL, Jones RT, Herning RI, Bachman J</div>
<div class="citation">Clin Pharmacol Ther. 1980 Jul; 28(1):115-20.</div>
</div>
</li>
<li class="two_line" reference_id="R51">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9653176/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.</a><span class="one_line_source">[Proc Natl Acad Sci U S A.  1998]</span><div class="alt-note">
<div class="authors">Hampson AJ, Grimaldi M, Axelrod J, Wink D</div>
<div class="citation">Proc Natl Acad Sci U S A. 1998 Jul 7; 95(14):8268-73.</div>
</div>
</li>
<li class="two_line" reference_id="R52" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/14519710/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial.</a><span class="one_line_source">[JAMA.  2003]</span><div class="alt-note">
<div class="authors">Karst M, Salim K, Burstein S, Conrad I, Hoy L, Schneider U</div>
<div class="citation">JAMA. 2003 Oct 1; 290(13):1757-62.</div>
</div>
</li>
<li class="two_line" reference_id="R55" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/10716447/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabinoids control spasticity and tremor in a multiple sclerosis model.</a><span class="one_line_source">[Nature.  2000]</span><div class="alt-note">
<div class="authors">Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Huffman JW, Layward L</div>
<div class="citation">Nature. 2000 Mar 2; 404(6773):84-7.</div>
</div>
</li>
<li class="two_line" reference_id="R56" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/10920191/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.</a><span class="one_line_source">[Proc Natl Acad Sci U S A.  2000]</span><div class="alt-note">
<div class="authors">Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R, Feldmann M</div>
<div class="citation">Proc Natl Acad Sci U S A. 2000 Aug 15; 97(17):9561-6.</div>
</div>
</li>
<li class="two_line" reference_id="R57" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6285406/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects.</a><span class="one_line_source">[Psychopharmacology (Berl).  1982]</span><div class="alt-note">
<div class="authors">Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG</div>
<div class="citation">Psychopharmacology (Berl). 1982; 76(3):245-50.</div>
</div>
</li>
<li class="two_line" reference_id="R36" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16209908/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol.</a><span class="one_line_source">[Med Hypotheses.  2006]</span><div class="alt-note">
<div class="authors">Russo E, Guy GW</div>
<div class="citation">Med Hypotheses. 2006; 66(2):234-46.</div>
</div>
</li>
</ul><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P25" name="crb--P25" rid="P25" style="position: absolute; visibility: visible; width: 370px; top: 6249px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-38"><ul>
<li class="two_line" reference_id="R60">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/2937482/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration.</a><span class="one_line_source">[Biomed Environ Mass Spectrom.  1986]</span><div class="alt-note">
<div class="authors">Ohlsson A, Lindgren JE, Andersson S, Agurell S, Gillespie H, Hollister LE</div>
<div class="citation">Biomed Environ Mass Spectrom. 1986 Feb; 13(2):77-83.</div>
</div>
</li>
<li class="two_line" reference_id="R61">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6273208/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography.</a><span class="one_line_source">[Experientia.  1981]</span><div class="alt-note">
<div class="authors">Agurell S, Carlsson S, Lindgren JE, Ohlsson A, Gillespie H, Hollister L</div>
<div class="citation">Experientia. 1981 Oct 15; 37(10):1090-2.</div>
</div>
</li>
<li class="two_line" reference_id="R33">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16356335/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract.</a><span class="one_line_source">[J Anal Toxicol.  2005]</span><div class="alt-note">
<div class="authors">Nadulski T, Sporkert F, Schnelle M, Stadelmann AM, Roser P, Schefter T, Pragst F</div>
<div class="citation">J Anal Toxicol. 2005 Nov-Dec; 29(8):782-9.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P27" name="crb--P27" rid="P27" style="position: absolute; visibility: visible; width: 370px; top: 6731px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-39"><ul>
<li class="two_line" reference_id="R64">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/5479011/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Marihuana: studies on the disposition and metabolism of delta-9-tetrahydrocannabinol in man.</a><span class="one_line_source">[Science.  1970]</span><div class="alt-note">
<div class="authors">Lemberger L, Silberstein SD, Axelrod J, Kopin IJ</div>
<div class="citation">Science. 1970 Dec 18; 170(3964):1320-2.</div>
</div>
</li>
<li class="two_line" reference_id="R65">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/12404700/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Pharmacokinetics of THC in brain and testis, male gametotoxicity and premature apoptosis of spermatozoa.</a><span class="one_line_source">[Hum Psychopharmacol.  2002]</span><div class="alt-note">
<div class="authors">Nahas GG, Frick HC, Lattimer JK, Latour C, Harvey D</div>
<div class="citation">Hum Psychopharmacol. 2002 Mar; 17(2):103-13.</div>
</div>
</li>
<li class="two_line" reference_id="R66">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/4682965/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Delta-9-tetrahydrocannabinol: localization in body fat.</a><span class="one_line_source">[Science.  1973]</span><div class="alt-note">
<div class="authors">Kreuz DS, Axelrod J</div>
<div class="citation">Science. 1973 Jan 26; 179(4071):391-3.</div>
</div>
</li>
<li class="two_line" reference_id="R67">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/756823/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pharmacokinetics and disposition of delta 9-tetrahydrocannabinol and its metabolites.</a><span class="one_line_source">[Adv Biosci.  1978]</span><div class="alt-note">
<div class="authors">Garrett ER</div>
<div class="citation">Adv Biosci. 1978 Jul 22-23; 22-23():105-21.</div>
</div>
</li>
<li class="two_line" reference_id="R69">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/2539872/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Determination of delta 1-tetrahydrocannabinol in human fat biopsies from marihuana users by gas chromatography-mass spectrometry.</a><span class="one_line_source">[Biomed Chromatogr.  1989]</span><div class="alt-note">
<div class="authors">Johansson E, Norén K, Sjövall J, Halldin MM</div>
<div class="citation">Biomed Chromatogr. 1989 Jan; 3(1):35-8.</div>
</div>
</li>
<li class="two_line" reference_id="R70">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/12648025/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Pharmacokinetics and pharmacodynamics of cannabinoids.</a><span class="one_line_source">[Clin Pharmacokinet.  2003]</span><div class="alt-note">
<div class="authors">Grotenhermen F</div>
<div class="citation">Clin Pharmacokinet. 2003; 42(4):327-60.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P28" name="crb--P28" rid="P28" style="position: absolute; visibility: visible; width: 370px; top: 7058px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-40"><ul>
<li class="two_line" reference_id="R71">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/4687135/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Distribution of radioactivity in brain of tolerant and nontolerant pigeons treated with  3 H-  9 -tetrahydrocannabinol.</a><span class="one_line_source">[Biochem Pharmacol.  1973]</span><div class="alt-note">
<div class="authors">Dewey WL, McMillan DE, Harris LS, Turk RF</div>
<div class="citation">Biochem Pharmacol. 1973 Feb 1; 22(3):399-405.</div>
</div>
</li>
<li class="two_line" reference_id="R72">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6256518/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Tolerance and disposition of tetrahydrocannabinol in man.</a><span class="one_line_source">[J Pharmacol Exp Ther.  1980]</span><div class="alt-note">
<div class="authors">Hunt CA, Jones RT</div>
<div class="citation">J Pharmacol Exp Ther. 1980 Oct; 215(1):35-44.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P29" name="crb--P29" rid="P29" style="position: absolute; visibility: visible; width: 370px; top: 7237px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-41"><ul><li class="two_line" reference_id="R73">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8972919/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Cannabis: pharmacology and toxicology in animals and humans.</a><span class="one_line_source">[Addiction.  1996]</span><div class="alt-note">
<div class="authors">Adams IB, Martin BR</div>
<div class="citation">Addiction. 1996 Nov; 91(11):1585-614.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P30" name="crb--P30" rid="P30" style="position: absolute; visibility: visible; width: 370px; top: 7332px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-42"><ul><li class="two_line" reference_id="R74">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16356342/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">THC can be detected in brain while absent in blood.</a><span class="one_line_source">[J Anal Toxicol.  2005]</span><div class="alt-note">
<div class="authors">Mura P, Kintz P, Dumestre V, Raul S, Hauet T</div>
<div class="citation">J Anal Toxicol. 2005 Nov-Dec; 29(8):842-3.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P31" name="crb--P31" rid="P31" style="position: absolute; visibility: visible; width: 370px; top: 7616px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-43"><ul><li class="two_line" reference_id="R65">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/12404700/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Pharmacokinetics of THC in brain and testis, male gametotoxicity and premature apoptosis of spermatozoa.</a><span class="one_line_source">[Hum Psychopharmacol.  2002]</span><div class="alt-note">
<div class="authors">Nahas GG, Frick HC, Lattimer JK, Latour C, Harvey D</div>
<div class="citation">Hum Psychopharmacol. 2002 Mar; 17(2):103-13.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P32" name="crb--P32" rid="P32" style="position: absolute; visibility: visible; width: 370px; top: 7795px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-44"><ul><li class="two_line" reference_id="R75">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16859848/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Validation of Large White Pig as an animal model for the study of cannabinoids metabolism: application to the study of THC distribution in tissues.</a><span class="one_line_source">[Forensic Sci Int.  2006]</span><div class="alt-note">
<div class="authors">Brunet B, Doucet C, Venisse N, Hauet T, Hébrard W, Papet Y, Mauco G, Mura P</div>
<div class="citation">Forensic Sci Int. 2006 Sep 12; 161(2-3):169-74.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P34" name="crb--P34" rid="P34" style="position: absolute; visibility: visible; width: 370px; top: 8237px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-45"><ul><li class="two_line" reference_id="R76">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/4558903/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Intravenous injection in man of   9 -tetrahydrocannabinol and 11-OH-  9 -tetrahydrocannabinol.</a><span class="one_line_source">[Science.  1972]</span><div class="alt-note">
<div class="authors">Perez-Reyes M, Timmons MC, Lipton MA, Davis KH, Wall ME</div>
<div class="citation">Science. 1972 Aug 18; 177(4049):633-5.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P35" name="crb--P35" rid="P35" style="position: absolute; visibility: visible; width: 370px; top: 8395px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-46"><ul>
<li class="two_line" reference_id="R72">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6256518/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Tolerance and disposition of tetrahydrocannabinol in man.</a><span class="one_line_source">[J Pharmacol Exp Ther.  1980]</span><div class="alt-note">
<div class="authors">Hunt CA, Jones RT</div>
<div class="citation">J Pharmacol Exp Ther. 1980 Oct; 215(1):35-44.</div>
</div>
</li>
<li class="two_line" reference_id="R77">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1323733/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users.</a><span class="one_line_source">[J Anal Toxicol.  1992]</span><div class="alt-note">
<div class="authors">Kelly P, Jones RT</div>
<div class="citation">J Anal Toxicol. 1992 Jul-Aug; 16(4):228-35.</div>
</div>
</li>
<li class="two_line" reference_id="R78">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/11955826/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Partition coefficient, blood to plasma ratio, protein binding and short-term stability of 11-nor-Delta(9)-carboxy tetrahydrocannabinol glucuronide.</a><span class="one_line_source">[Forensic Sci Int.  2002]</span><div class="alt-note">
<div class="authors">Skopp G, Pötsch L, Mauden M, Richter B</div>
<div class="citation">Forensic Sci Int. 2002 Mar 28; 126(1):17-23.</div>
</div>
</li>
<li class="two_line" reference_id="R70">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/12648025/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Pharmacokinetics and pharmacodynamics of cannabinoids.</a><span class="one_line_source">[Clin Pharmacokinet.  2003]</span><div class="alt-note">
<div class="authors">Grotenhermen F</div>
<div class="citation">Clin Pharmacokinet. 2003; 42(4):327-60.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P36" name="crb--P36" rid="P36" style="position: absolute; visibility: visible; width: 370px; top: 8577px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-47"><ul>
<li class="two_line" reference_id="R79">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/2997613/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Maternal-fetal transfer of abused substances: pharmacokinetic and pharmacodynamic data.</a><span class="one_line_source">[NIDA Res Monogr.  1985]</span><div class="alt-note">
<div class="authors">Lee CC, Chiang CN</div>
<div class="citation">NIDA Res Monogr. 1985; 60():110-47.</div>
</div>
</li>
<li class="two_line" reference_id="R80">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/2820086/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Fetal disposition of delta 9-tetrahydrocannabinol (THC) during late pregnancy in the rhesus monkey.</a><span class="one_line_source">[Toxicol Appl Pharmacol.  1987]</span><div class="alt-note">
<div class="authors">Bailey JR, Cunny HC, Paule MG, Slikker W Jr</div>
<div class="citation">Toxicol Appl Pharmacol. 1987 Sep 15; 90(2):315-21.</div>
</div>
</li>
<li class="two_line" reference_id="R81">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/897339/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">3H-delta9-tetrahydrocannabinol distribution in pregnant dogs and their fetuses.</a><span class="one_line_source">[Res Commun Chem Pathol Pharmacol.  1977]</span><div class="alt-note">
<div class="authors">Martin BR, Dewey WL, Harris LS, Beckner JS</div>
<div class="citation">Res Commun Chem Pathol Pharmacol. 1977 Jul; 17(3):457-70.</div>
</div>
</li>
<li class="two_line" reference_id="R82">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6088979/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Human placental transfer of cannabinoids.</a><span class="one_line_source">[N Engl J Med.  1984]</span><div class="alt-note">
<div class="authors">Blackard C, Tennes K</div>
<div class="citation">N Engl J Med. 1984 Sep 20; 311(12):797.</div>
</div>
</li>
<li class="two_line" reference_id="R83" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/3292101/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Drugs in human milk. Clinical pharmacokinetic considerations.</a><span class="one_line_source">[Clin Pharmacokinet.  1988]</span><div class="alt-note">
<div class="authors">Atkinson HC, Begg EJ, Darlow BA</div>
<div class="citation">Clin Pharmacokinet. 1988 Apr; 14(4):217-40.</div>
</div>
</li>
<li class="two_line" reference_id="R84" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6287261/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Presence of delta9-tetrahydrocannabinol in human milk.</a><span class="one_line_source">[N Engl J Med.  1982]</span><div class="alt-note">
<div class="authors">Perez-Reyes M, Wall ME</div>
<div class="citation">N Engl J Med. 1982 Sep 23; 307(13):819-20.</div>
</div>
</li>
</ul><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P37" name="crb--P37" rid="P37" style="position: absolute; visibility: visible; width: 370px; top: 8816px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-48"><ul>
<li class="two_line" reference_id="R85">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/5026162/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Isolation and characterization of two major urinary metabolites of   1 -tetrahydrocannabinol.</a><span class="one_line_source">[Science.  1972]</span><div class="alt-note">
<div class="authors">Burstein S, Rosenfeld J, Wittstruck T</div>
<div class="citation">Science. 1972 Apr 28; 176(4033):422-3.</div>
</div>
</li>
<li class="two_line" reference_id="R87">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/4855455/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">7-Oxo-delta1-tetrahydrocannabinol: a novel metabolite of delta1-tetrahydrocannabinol.</a><span class="one_line_source">[Res Commun Chem Pathol Pharmacol.  1974]</span><div class="alt-note">
<div class="authors">Ben-Zvi Z, Burstein S</div>
<div class="citation">Res Commun Chem Pathol Pharmacol. 1974 Jun; 8(2):223-9.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P38" name="crb--P38" rid="P38" style="position: absolute; visibility: visible; width: 370px; top: 9037px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-49"><ul>
<li class="two_line" reference_id="R89">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8839037/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes.</a><span class="one_line_source">[Chem Res Toxicol.  1996]</span><div class="alt-note">
<div class="authors">Iribarne C, Berthou F, Baird S, Dréano Y, Picart D, Bail JP, Beaune P, Ménez JF</div>
<div class="citation">Chem Res Toxicol. 1996 Mar; 9(2):365-73.</div>
</div>
</li>
<li class="two_line" reference_id="R90">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/7776836/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Metabolism of delta 9-tetrahydrocannabinol by cytochrome P450 isozymes purified from hepatic microsomes of monkeys.</a><span class="one_line_source">[Life Sci.  1995]</span><div class="alt-note">
<div class="authors">Matsunaga T, Iwawaki Y, Watanabe K, Yamamoto I, Kageyama T, Yoshimura H</div>
<div class="citation">Life Sci. 1995; 56(23-24):2089-95.</div>
</div>
</li>
<li class="two_line" reference_id="R64">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/5479011/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Marihuana: studies on the disposition and metabolism of delta-9-tetrahydrocannabinol in man.</a><span class="one_line_source">[Science.  1970]</span><div class="alt-note">
<div class="authors">Lemberger L, Silberstein SD, Axelrod J, Kopin IJ</div>
<div class="citation">Science. 1970 Dec 18; 170(3964):1320-2.</div>
</div>
</li>
<li class="two_line" reference_id="R70">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/12648025/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Pharmacokinetics and pharmacodynamics of cannabinoids.</a><span class="one_line_source">[Clin Pharmacokinet.  2003]</span><div class="alt-note">
<div class="authors">Grotenhermen F</div>
<div class="citation">Clin Pharmacokinet. 2003; 42(4):327-60.</div>
</div>
</li>
<li class="two_line" reference_id="R27">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6309462/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women.</a><span class="one_line_source">[Clin Pharmacol Ther.  1983]</span><div class="alt-note">
<div class="authors">Wall ME, Sadler BM, Brine D, Taylor H, Perez-Reyes M</div>
<div class="citation">Clin Pharmacol Ther. 1983 Sep; 34(3):352-63.</div>
</div>
</li>
<li class="two_line" reference_id="R14">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1338215/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.</a><span class="one_line_source">[J Anal Toxicol.  1992]</span><div class="alt-note">
<div class="authors">Huestis MA, Henningfield JE, Cone EJ</div>
<div class="citation">J Anal Toxicol. 1992 Sep-Oct; 16(5):276-82.</div>
</div>
</li>
<li class="two_line" reference_id="R92">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1352216/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Human hepatic microsomal metabolism of delta 1-tetrahydrocannabinol.</a><span class="one_line_source">[Drug Metab Dispos.  1992]</span><div class="alt-note">
<div class="authors">Bornheim LM, Lasker JM, Raucy JL</div>
<div class="citation">Drug Metab Dispos. 1992 Mar-Apr; 20(2):241-6.</div>
</div>
</li>
<li class="two_line" reference_id="R93">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/3009969/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">GC/MS and EMIT analyses for delta 9-tetrahydrocannabinol metabolites in plasma and urine of human subjects.</a><span class="one_line_source">[J Anal Toxicol.  1986]</span><div class="alt-note">
<div class="authors">McBurney LJ, Bobbie BA, Sepp LA</div>
<div class="citation">J Anal Toxicol. 1986 Mar-Apr; 10(2):56-64.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P39" name="crb--P39" rid="P39" style="position: absolute; visibility: visible; width: 370px; top: 9363px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-50"><ul>
<li class="two_line" reference_id="R64">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/5479011/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Marihuana: studies on the disposition and metabolism of delta-9-tetrahydrocannabinol in man.</a><span class="one_line_source">[Science.  1970]</span><div class="alt-note">
<div class="authors">Lemberger L, Silberstein SD, Axelrod J, Kopin IJ</div>
<div class="citation">Science. 1970 Dec 18; 170(3964):1320-2.</div>
</div>
</li>
<li class="two_line" reference_id="R94">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/4758913/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Delta 6-tetrahydrocannabinol-7-oic acid, a urinary delta 6-THC metabolite: isolation and synthesis.</a><span class="one_line_source">[Experientia.  1973]</span><div class="alt-note">
<div class="authors">Mechoulam R, BenZvi Z, Agurell S, Nilsson IM, Nilsson JL, Edery H, Grunfeld Y</div>
<div class="citation">Experientia. 1973 Oct 15; 29(10):1193-5.</div>
</div>
</li>
<li class="two_line" reference_id="R95" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6126323/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Identification of in vitro metabolites of delta 1-tetrahydrocannabinol formed by human livers.</a><span class="one_line_source">[Drug Metab Dispos.  1982]</span><div class="alt-note">
<div class="authors">Halldin MM, Widman M, V Bahr C, Lindgren JE, Martin BR</div>
<div class="citation">Drug Metab Dispos. 1982 Jul-Aug; 10(4):297-301.</div>
</div>
</li>
<li class="two_line" reference_id="R96" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/2993473/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabis: pharmacology and interpretation of effects.</a><span class="one_line_source">[J Forensic Sci.  1985]</span><div class="alt-note">
<div class="authors">Mason AP, McBay AJ</div>
<div class="citation">J Forensic Sci. 1985 Jul; 30(3):615-31.</div>
</div>
</li>
</ul><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P40" name="crb--P40" rid="P40" style="position: absolute; visibility: visible; width: 370px; top: 9500px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-51"><ul>
<li class="two_line" reference_id="R72">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6256518/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Tolerance and disposition of tetrahydrocannabinol in man.</a><span class="one_line_source">[J Pharmacol Exp Ther.  1980]</span><div class="alt-note">
<div class="authors">Hunt CA, Jones RT</div>
<div class="citation">J Pharmacol Exp Ther. 1980 Oct; 215(1):35-44.</div>
</div>
</li>
<li class="two_line" reference_id="R27">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6309462/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women.</a><span class="one_line_source">[Clin Pharmacol Ther.  1983]</span><div class="alt-note">
<div class="authors">Wall ME, Sadler BM, Brine D, Taylor H, Perez-Reyes M</div>
<div class="citation">Clin Pharmacol Ther. 1983 Sep; 34(3):352-63.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P41" name="crb--P41" rid="P41" style="position: absolute; visibility: visible; width: 370px; top: 9637px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-52"><ul>
<li class="two_line" reference_id="R98" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/845807/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pharmacokinetics of delta9-tetrahydrocannabinol in dogs.</a><span class="one_line_source">[J Pharm Sci.  1977]</span><div class="alt-note">
<div class="authors">Garrett ER, Hunt CA</div>
<div class="citation">J Pharm Sci. 1977 Mar; 66(3):395-407.</div>
</div>
</li>
<li class="two_line" reference_id="R99" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/5087483/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Delta-9-tetrahydrocannabinol: metabolism and disposition in long-term marihuana smokers.</a><span class="one_line_source">[Science.  1971]</span><div class="alt-note">
<div class="authors">Lemberger L, Tamarkin NR, Axelrod J, Kopin IJ</div>
<div class="citation">Science. 1971 Jul 2; 173(3991):72-4.</div>
</div>
</li>
<li class="two_line" reference_id="R8" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/3012605/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man.</a><span class="one_line_source">[Pharmacol Rev.  1986]</span><div class="alt-note">
<div class="authors">Agurell S, Halldin M, Lindgren JE, Ohlsson A, Widman M, Gillespie H, Hollister L</div>
<div class="citation">Pharmacol Rev. 1986 Mar; 38(1):21-43.</div>
</div>
</li>
</ul><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/" class="seemore">See links ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P42" name="crb--P42" rid="P42" style="position: absolute; visibility: visible; width: 370px; top: 9711px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-53"><ul><li class="two_line" reference_id="R100">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/2336840/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Metabolites of cannabidiol identified in human urine.</a><span class="one_line_source">[Xenobiotica.  1990]</span><div class="alt-note">
<div class="authors">Harvey DJ, Mechoulam R</div>
<div class="citation">Xenobiotica. 1990 Mar; 20(3):303-20.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P43" name="crb--P43" rid="P43" style="position: absolute; visibility: visible; width: 370px; top: 9765px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-54"><ul>
<li class="two_line" reference_id="R101">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/4813501/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Metabolism of tetrahydrocannabinol by the small intestine.</a><span class="one_line_source">[Gastroenterology.  1974]</span><div class="alt-note">
<div class="authors">Greene ML, Saunders DR</div>
<div class="citation">Gastroenterology. 1974 Mar; 66(3):365-72.</div>
</div>
</li>
<li class="two_line" reference_id="R104">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1493/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Metabolism of delta1-tetrahydrocannabinol by the isolated perfused dog lung. Comparison with in vitro liver metabolism.</a><span class="one_line_source">[J Pharm Pharmacol.  1975]</span><div class="alt-note">
<div class="authors">Widman M, Nordqvist M, Dollery CT, Briant RH</div>
<div class="citation">J Pharm Pharmacol. 1975 Nov; 27(11):842-8.</div>
</div>
</li>
<li class="two_line" reference_id="R102">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8162658/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Extrahepatic metabolism of drugs in humans.</a><span class="one_line_source">[Clin Pharmacokinet.  1994]</span><div class="alt-note">
<div class="authors">Krishna DR, Klotz U</div>
<div class="citation">Clin Pharmacokinet. 1994 Feb; 26(2):144-60.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P44" name="crb--P44" rid="P44" style="position: absolute; visibility: visible; width: 370px; top: 10028px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-55"><ul><li class="two_line" reference_id="R103">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/2848522/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Brain microsomal oxidation of delta 8- and delta 9-tetrahydrocannabinol.</a><span class="one_line_source">[Biochem Biophys Res Commun.  1988]</span><div class="alt-note">
<div class="authors">Watanabe K, Tanaka T, Yamamoto I, Yoshimura H</div>
<div class="citation">Biochem Biophys Res Commun. 1988 Nov 30; 157(1):75-80.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P45" name="crb--P45" rid="P45" style="position: absolute; visibility: visible; width: 370px; top: 10123px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-56"><ul>
<li class="two_line" reference_id="R8">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/3012605/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man.</a><span class="one_line_source">[Pharmacol Rev.  1986]</span><div class="alt-note">
<div class="authors">Agurell S, Halldin M, Lindgren JE, Ohlsson A, Widman M, Gillespie H, Hollister L</div>
<div class="citation">Pharmacol Rev. 1986 Mar; 38(1):21-43.</div>
</div>
</li>
<li class="two_line" reference_id="R100">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/2336840/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Metabolites of cannabidiol identified in human urine.</a><span class="one_line_source">[Xenobiotica.  1990]</span><div class="alt-note">
<div class="authors">Harvey DJ, Mechoulam R</div>
<div class="citation">Xenobiotica. 1990 Mar; 20(3):303-20.</div>
</div>
</li>
<li class="two_line" reference_id="R50">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/7389248/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Metabolic and psychophysiologic studies of cannabidiol-hexobarbital interaction.</a><span class="one_line_source">[Clin Pharmacol Ther.  1980]</span><div class="alt-note">
<div class="authors">Benowitz NL, Nguyen TL, Jones RT, Herning RI, Bachman J</div>
<div class="citation">Clin Pharmacol Ther. 1980 Jul; 28(1):115-20.</div>
</div>
</li>
<li class="two_line" reference_id="R106">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6270295/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Evidence that cannabidiol does not significantly alter the pharmacokinetics of tetrahydrocannabinol in man.</a><span class="one_line_source">[J Pharmacokinet Biopharm.  1981]</span><div class="alt-note">
<div class="authors">Hunt CA, Jones RT, Herning RI, Bachman J</div>
<div class="citation">J Pharmacokinet Biopharm. 1981 Jun; 9(3):245-60.</div>
</div>
</li>
<li class="two_line" reference_id="R107">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16306858/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract.</a><span class="one_line_source">[Ther Drug Monit.  2005]</span><div class="alt-note">
<div class="authors">Nadulski T, Pragst F, Weinberg G, Roser P, Schnelle M, Fronk EM, Stadelmann AM</div>
<div class="citation">Ther Drug Monit. 2005 Dec; 27(6):799-810.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P46" name="crb--P46" rid="P46" style="position: absolute; visibility: visible; width: 370px; top: 10467px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-57"><ul>
<li class="two_line" reference_id="R95">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6126323/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Identification of in vitro metabolites of delta 1-tetrahydrocannabinol formed by human livers.</a><span class="one_line_source">[Drug Metab Dispos.  1982]</span><div class="alt-note">
<div class="authors">Halldin MM, Widman M, V Bahr C, Lindgren JE, Martin BR</div>
<div class="citation">Drug Metab Dispos. 1982 Jul-Aug; 10(4):297-301.</div>
</div>
</li>
<li class="two_line" reference_id="R27">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6309462/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women.</a><span class="one_line_source">[Clin Pharmacol Ther.  1983]</span><div class="alt-note">
<div class="authors">Wall ME, Sadler BM, Brine D, Taylor H, Perez-Reyes M</div>
<div class="citation">Clin Pharmacol Ther. 1983 Sep; 34(3):352-63.</div>
</div>
</li>
<li class="two_line" reference_id="R108">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6105177/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Identification in human urine of delta 9-tetrahydrocannabinol-11-oic acid glucuronide: a tetrahydrocannabinol metabolite.</a><span class="one_line_source">[J Pharm Pharmacol.  1980]</span><div class="alt-note">
<div class="authors">Williams PL, Moffat AC</div>
<div class="citation">J Pharm Pharmacol. 1980 Jul; 32(7):445-8.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P47" name="crb--P47" rid="P47" style="position: absolute; visibility: visible; width: 370px; top: 10667px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-58"><ul>
<li class="two_line" reference_id="R109">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/2899638/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Prolonged apparent half-life of delta 1-tetrahydrocannabinol in plasma of chronic marijuana users.</a><span class="one_line_source">[J Pharm Pharmacol.  1988]</span><div class="alt-note">
<div class="authors">Johansson E, Agurell S, Hollister LE, Halldin MM</div>
<div class="citation">J Pharm Pharmacol. 1988 May; 40(5):374-5.</div>
</div>
</li>
<li class="two_line" reference_id="R98">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/845807/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pharmacokinetics of delta9-tetrahydrocannabinol in dogs.</a><span class="one_line_source">[J Pharm Sci.  1977]</span><div class="alt-note">
<div class="authors">Garrett ER, Hunt CA</div>
<div class="citation">J Pharm Sci. 1977 Mar; 66(3):395-407.</div>
</div>
</li>
<li class="two_line" reference_id="R110">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/2558889/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Terminal elimination plasma half-life of delta 1-tetrahydrocannabinol (delta 1-THC) in heavy users of marijuana.</a><span class="one_line_source">[Eur J Clin Pharmacol.  1989]</span><div class="alt-note">
<div class="authors">Johansson E, Halldin MM, Agurell S, Hollister LE, Gillespie HK</div>
<div class="citation">Eur J Clin Pharmacol. 1989; 37(3):273-7.</div>
</div>
</li>
<li class="two_line" reference_id="R111">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/2550702/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Urinary excretion half-life of delta 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.</a><span class="one_line_source">[J Anal Toxicol.  1989]</span><div class="alt-note">
<div class="authors">Johansson E, Halldin MM</div>
<div class="citation">J Anal Toxicol. 1989 Jul-Aug; 13(4):218-23.</div>
</div>
</li>
<li class="two_line" reference_id="R112">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/2830536/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Pharmacokinetics and disposition of cannabinoids.</a><span class="one_line_source">[NIDA Res Monogr.  1987]</span><div class="alt-note">
<div class="authors">Chiang CN, Rapaka RS</div>
<div class="citation">NIDA Res Monogr. 1987; 79():173-88.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P48" name="crb--P48" rid="P48" style="position: absolute; visibility: visible; width: 370px; top: 11014px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-59"><ul>
<li class="two_line" reference_id="R113">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8889681/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.</a><span class="one_line_source">[J Anal Toxicol.  1996]</span><div class="alt-note">
<div class="authors">Huestis MA, Mitchell JM, Cone EJ</div>
<div class="citation">J Anal Toxicol. 1996 Oct; 20(6):441-52.</div>
</div>
</li>
<li class="two_line" reference_id="R5">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6250760/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking.</a><span class="one_line_source">[Clin Pharmacol Ther.  1980]</span><div class="alt-note">
<div class="authors">Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK</div>
<div class="citation">Clin Pharmacol Ther. 1980 Sep; 28(3):409-16.</div>
</div>
</li>
<li class="two_line" reference_id="R17">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6271825/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The clinical pharmacology and dynamics of marihuana cigarette smoking.</a><span class="one_line_source">[J Clin Pharmacol.  1981]</span><div class="alt-note">
<div class="authors">Perez-Reyes M, Owens SM, Di Guiseppi S</div>
<div class="citation">J Clin Pharmacol. 1981 Aug-Sep; 21(8-9 Suppl):201S-207S.</div>
</div>
</li>
<li class="two_line" reference_id="R114">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6267648/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis.</a><span class="one_line_source">[Psychopharmacology (Berl).  1981]</span><div class="alt-note">
<div class="authors">Lindgren JE, Ohlsson A, Agurell S, Hollister L, Gillespie H</div>
<div class="citation">Psychopharmacology (Berl). 1981; 74(3):208-12.</div>
</div>
</li>
<li class="two_line" reference_id="R27">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6309462/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women.</a><span class="one_line_source">[Clin Pharmacol Ther.  1983]</span><div class="alt-note">
<div class="authors">Wall ME, Sadler BM, Brine D, Taylor H, Perez-Reyes M</div>
<div class="citation">Clin Pharmacol Ther. 1983 Sep; 34(3):352-63.</div>
</div>
</li>
<li class="two_line" reference_id="R115">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6271823/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The metabolism of delta 9-tetrahydrocannabinol and related cannabinoids in man.</a><span class="one_line_source">[J Clin Pharmacol.  1981]</span><div class="alt-note">
<div class="authors">Wall ME, Perez-Reyes M</div>
<div class="citation">J Clin Pharmacol. 1981 Aug-Sep; 21(8-9 Suppl):178S-189S.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P49" name="crb--P49" rid="P49" style="position: absolute; visibility: visible; width: 370px; top: 11424px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-60"><ul>
<li class="two_line" reference_id="R116">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/12816908/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Urinary cannabinoid detection times after controlled oral administration of delta9-tetrahydrocannabinol to humans.</a><span class="one_line_source">[Clin Chem.  2003]</span><div class="alt-note">
<div class="authors">Gustafson RA, Levine B, Stout PR, Klette KL, George MP, Moolchan ET, Huestis MA</div>
<div class="citation">Clin Chem. 2003 Jul; 49(7):1114-24.</div>
</div>
</li>
<li class="two_line" reference_id="R117">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/15107145/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Urinary pharmacokinetics of 11-nor-9-carboxy-delta9-tetrahydrocannabinol after controlled oral delta9-tetrahydrocannabinol administration.</a><span class="one_line_source">[J Anal Toxicol.  2004]</span><div class="alt-note">
<div class="authors">Gustafson RA, Kim I, Stout PR, Klette KL, George MP, Moolchan ET, Levine B, Huestis MA</div>
<div class="citation">J Anal Toxicol. 2004 Apr; 28(3):160-7.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P50" name="crb--P50" rid="P50" style="position: absolute; visibility: visible; width: 370px; top: 11709px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-61"><ul><li class="two_line" reference_id="R117">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/15107145/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Urinary pharmacokinetics of 11-nor-9-carboxy-delta9-tetrahydrocannabinol after controlled oral delta9-tetrahydrocannabinol administration.</a><span class="one_line_source">[J Anal Toxicol.  2004]</span><div class="alt-note">
<div class="authors">Gustafson RA, Kim I, Stout PR, Klette KL, George MP, Moolchan ET, Levine B, Huestis MA</div>
<div class="citation">J Anal Toxicol. 2004 Apr; 28(3):160-7.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P52" name="crb--P52" rid="P52" style="position: absolute; visibility: visible; width: 370px; top: 12068px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-62"><ul>
<li class="two_line" reference_id="R118">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/7500615/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabinoids in humans. II. The influence of three methods of hydrolysis on the concentration of THC and two metabolites in urine.</a><span class="one_line_source">[J Anal Toxicol.  1995]</span><div class="alt-note">
<div class="authors">Kemp PM, Abukhalaf IK, Manno JE, Manno BR, Alford DD, McWilliams ME, Nixon FE, Fitzgerald MJ, Reeves RR, Wood MJ</div>
<div class="citation">J Anal Toxicol. 1995 Sep; 19(5):292-8.</div>
</div>
</li>
<li class="two_line" reference_id="R119">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/7500614/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabinoids in humans. I. Analysis of delta 9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS.</a><span class="one_line_source">[J Anal Toxicol.  1995]</span><div class="alt-note">
<div class="authors">Kemp PM, Abukhalaf IK, Manno JE, Manno BR, Alford DD, Abusada GA</div>
<div class="citation">J Anal Toxicol. 1995 Sep; 19(5):285-91.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P53" name="crb--P53" rid="P53" style="position: absolute; visibility: visible; width: 370px; top: 12537px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-63"><ul>
<li class="two_line" reference_id="R120">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8394791/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Adsorption losses from urine-based cannabinoid calibrators during routine use.</a><span class="one_line_source">[Clin Chem.  1993]</span><div class="alt-note">
<div class="authors">Blanc JA, Manneh VA, Ernst R, Berger DE, de Keczer SA, Chase C, Centofanti JM, DeLizza AJ</div>
<div class="citation">Clin Chem. 1993 Aug; 39(8):1705-12.</div>
</div>
</li>
<li class="two_line" reference_id="R123">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1338115/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Surface adsorption of the urinary marijuana carboxy metabolite: the problem and a partial solution.</a><span class="one_line_source">[J Anal Toxicol.  1992]</span><div class="alt-note">
<div class="authors">Joern WA</div>
<div class="citation">J Anal Toxicol. 1992 Nov-Dec; 16(6):401.</div>
</div>
</li>
<li class="two_line" reference_id="R124">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/4853640/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Physiochemical properties, solubility, and protein binding of delta9-tetrahydrocannabinol.</a><span class="one_line_source">[J Pharm Sci.  1974]</span><div class="alt-note">
<div class="authors">Garrett ER, Hunt CA</div>
<div class="citation">J Pharm Sci. 1974 Jul; 63(7):1056-64.</div>
</div>
</li>
<li class="two_line" reference_id="R96">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/2993473/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabis: pharmacology and interpretation of effects.</a><span class="one_line_source">[J Forensic Sci.  1985]</span><div class="alt-note">
<div class="authors">Mason AP, McBay AJ</div>
<div class="citation">J Forensic Sci. 1985 Jul; 30(3):615-31.</div>
</div>
</li>
<li class="two_line" reference_id="R125" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/11599596/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Simultaneous determination of delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol in human plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry.</a><span class="one_line_source">[J Anal Toxicol.  2001]</span><div class="alt-note">
<div class="authors">Huang W, Moody DE, Andrenyak DM, Smith EK, Foltz RL, Huestis MA, Newton JF</div>
<div class="citation">J Anal Toxicol. 2001 Oct; 25(7):531-7.</div>
</div>
</li>
<li class="two_line" reference_id="R126" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6258825/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">125I radioimmunoassay of delta-9-tetrahydrocannabinol in blood and plasma with a solid-phase second-antibody separation method.</a><span class="one_line_source">[Clin Chem.  1981]</span><div class="alt-note">
<div class="authors">Owens SM, McBay AJ, Reisner HM, Perez-Reyes M</div>
<div class="citation">Clin Chem. 1981 Apr; 27(4):619-24.</div>
</div>
</li>
</ul><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P54" name="crb--P54" rid="P54" style="position: absolute; visibility: visible; width: 370px; top: 12737px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-64"><ul><li class="two_line" reference_id="R77">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1323733/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users.</a><span class="one_line_source">[J Anal Toxicol.  1992]</span><div class="alt-note">
<div class="authors">Kelly P, Jones RT</div>
<div class="citation">J Anal Toxicol. 1992 Jul-Aug; 16(4):228-35.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P55" name="crb--P55" rid="P55" style="position: absolute; visibility: visible; width: 370px; top: 12895px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-65"><ul>
<li class="two_line" reference_id="R93">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/3009969/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">GC/MS and EMIT analyses for delta 9-tetrahydrocannabinol metabolites in plasma and urine of human subjects.</a><span class="one_line_source">[J Anal Toxicol.  1986]</span><div class="alt-note">
<div class="authors">McBurney LJ, Bobbie BA, Sepp LA</div>
<div class="citation">J Anal Toxicol. 1986 Mar-Apr; 10(2):56-64.</div>
</div>
</li>
<li class="two_line" reference_id="R109">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/2899638/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Prolonged apparent half-life of delta 1-tetrahydrocannabinol in plasma of chronic marijuana users.</a><span class="one_line_source">[J Pharm Pharmacol.  1988]</span><div class="alt-note">
<div class="authors">Johansson E, Agurell S, Hollister LE, Halldin MM</div>
<div class="citation">J Pharm Pharmacol. 1988 May; 40(5):374-5.</div>
</div>
</li>
<li class="two_line" reference_id="R27" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6309462/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women.</a><span class="one_line_source">[Clin Pharmacol Ther.  1983]</span><div class="alt-note">
<div class="authors">Wall ME, Sadler BM, Brine D, Taylor H, Perez-Reyes M</div>
<div class="citation">Clin Pharmacol Ther. 1983 Sep; 34(3):352-63.</div>
</div>
</li>
<li class="two_line" reference_id="R127" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/5041775/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">11-hydroxy-  9 -tetrahydrocannabinol: pharmacology, disposition, and metabolism of a major metabolite of marihuana in man.</a><span class="one_line_source">[Science.  1972]</span><div class="alt-note">
<div class="authors">Lemberger L, Crabtree RE, Rowe HM</div>
<div class="citation">Science. 1972 Jul 7; 177(4043):62-4.</div>
</div>
</li>
</ul><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P56" name="crb--P56" rid="P56" style="position: absolute; visibility: visible; width: 370px; top: 13032px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-66"><ul><li class="two_line" reference_id="R14">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1338215/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.</a><span class="one_line_source">[J Anal Toxicol.  1992]</span><div class="alt-note">
<div class="authors">Huestis MA, Henningfield JE, Cone EJ</div>
<div class="citation">J Anal Toxicol. 1992 Sep-Oct; 16(5):276-82.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P57" name="crb--P57" rid="P57" style="position: absolute; visibility: visible; width: 370px; top: 13169px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-67"><ul>
<li class="two_line" reference_id="R14">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1338215/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.</a><span class="one_line_source">[J Anal Toxicol.  1992]</span><div class="alt-note">
<div class="authors">Huestis MA, Henningfield JE, Cone EJ</div>
<div class="citation">J Anal Toxicol. 1992 Sep-Oct; 16(5):276-82.</div>
</div>
</li>
<li class="two_line" reference_id="R128">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1324293/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Simultaneous quantitation of delta-9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta-9-tetrahydrocannabinol (THC-COOH) in serum by GC/MS using deuterated internal standards and its application to a smoking study and forensic cases.</a><span class="one_line_source">[J Forensic Sci.  1992]</span><div class="alt-note">
<div class="authors">Moeller MR, Doerr G, Warth S</div>
<div class="citation">J Forensic Sci. 1992 Jul; 37(4):969-83.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P58" name="crb--P58" rid="P58" style="position: absolute; visibility: visible; width: 370px; top: 13516px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-68"><ul>
<li class="two_line" reference_id="R24">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6145762/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin.</a><span class="one_line_source">[J Pharm Pharmacol.  1984]</span><div class="alt-note">
<div class="authors">Law B, Mason PA, Moffat AC, Gleadle RI, King LJ</div>
<div class="citation">J Pharm Pharmacol. 1984 May; 36(5):289-94.</div>
</div>
</li>
<li class="two_line" reference_id="R77">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1323733/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users.</a><span class="one_line_source">[J Anal Toxicol.  1992]</span><div class="alt-note">
<div class="authors">Kelly P, Jones RT</div>
<div class="citation">J Anal Toxicol. 1992 Jul-Aug; 16(4):228-35.</div>
</div>
</li>
<li class="two_line" reference_id="R93">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/3009969/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">GC/MS and EMIT analyses for delta 9-tetrahydrocannabinol metabolites in plasma and urine of human subjects.</a><span class="one_line_source">[J Anal Toxicol.  1986]</span><div class="alt-note">
<div class="authors">McBurney LJ, Bobbie BA, Sepp LA</div>
<div class="citation">J Anal Toxicol. 1986 Mar-Apr; 10(2):56-64.</div>
</div>
</li>
<li class="two_line" reference_id="R115" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6271823/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The metabolism of delta 9-tetrahydrocannabinol and related cannabinoids in man.</a><span class="one_line_source">[J Clin Pharmacol.  1981]</span><div class="alt-note">
<div class="authors">Wall ME, Perez-Reyes M</div>
<div class="citation">J Clin Pharmacol. 1981 Aug-Sep; 21(8-9 Suppl):178S-189S.</div>
</div>
</li>
<li class="two_line" reference_id="R118" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/7500615/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabinoids in humans. II. The influence of three methods of hydrolysis on the concentration of THC and two metabolites in urine.</a><span class="one_line_source">[J Anal Toxicol.  1995]</span><div class="alt-note">
<div class="authors">Kemp PM, Abukhalaf IK, Manno JE, Manno BR, Alford DD, McWilliams ME, Nixon FE, Fitzgerald MJ, Reeves RR, Wood MJ</div>
<div class="citation">J Anal Toxicol. 1995 Sep; 19(5):292-8.</div>
</div>
</li>
<li class="two_line" reference_id="R119" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/7500614/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabinoids in humans. I. Analysis of delta 9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS.</a><span class="one_line_source">[J Anal Toxicol.  1995]</span><div class="alt-note">
<div class="authors">Kemp PM, Abukhalaf IK, Manno JE, Manno BR, Alford DD, Abusada GA</div>
<div class="citation">J Anal Toxicol. 1995 Sep; 19(5):285-91.</div>
</div>
</li>
<li class="two_line" reference_id="R129" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/10999345/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Simultaneous analysis of delta9-THC and its major metabolites in urine, plasma, and meconium by GC-MS using an immunoaffinity extraction procedure.</a><span class="one_line_source">[J Anal Toxicol.  2000]</span><div class="alt-note">
<div class="authors">Feng S, ElSohly MA, Salamone S, Salem MY</div>
<div class="citation">J Anal Toxicol. 2000 Sep; 24(6):395-402.</div>
</div>
</li>
</ul><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P59" name="crb--P59" rid="P59" style="position: absolute; visibility: visible; width: 370px; top: 13674px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-69"><ul>
<li class="two_line" reference_id="R134">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1662560/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Ultrasensitive measurement of delta-9-tetrahydrocannabinol with a high energy dynode detector and electron-capture negative chemical-ionization mass spectrometry.</a><span class="one_line_source">[Clin Chem.  1991]</span><div class="alt-note">
<div class="authors">Shaw LM, Edling-Owens J, Mattes R</div>
<div class="citation">Clin Chem. 1991 Dec; 37(12):2062-8.</div>
</div>
</li>
<li class="two_line" reference_id="R42">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8897084/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The effect of orally and rectally administered delta 9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients.</a><span class="one_line_source">[Int J Clin Pharmacol Ther.  1996]</span><div class="alt-note">
<div class="authors">Brenneisen R, Egli A, Elsohly MA, Henn V, Spiess Y</div>
<div class="citation">Int J Clin Pharmacol Ther. 1996 Oct; 34(10):446-52.</div>
</div>
</li>
<li class="two_line" reference_id="R5">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6250760/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking.</a><span class="one_line_source">[Clin Pharmacol Ther.  1980]</span><div class="alt-note">
<div class="authors">Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK</div>
<div class="citation">Clin Pharmacol Ther. 1980 Sep; 28(3):409-16.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P60" name="crb--P60" rid="P60" style="position: absolute; visibility: visible; width: 370px; top: 13979px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-70"><ul><li class="two_line" reference_id="R109">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/2899638/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Prolonged apparent half-life of delta 1-tetrahydrocannabinol in plasma of chronic marijuana users.</a><span class="one_line_source">[J Pharm Pharmacol.  1988]</span><div class="alt-note">
<div class="authors">Johansson E, Agurell S, Hollister LE, Halldin MM</div>
<div class="citation">J Pharm Pharmacol. 1988 May; 40(5):374-5.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P61" name="crb--P61" rid="P61" style="position: absolute; visibility: visible; width: 370px; top: 14137px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-71"><ul>
<li class="two_line" reference_id="R16">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6280918/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Comparison of effects of marihuana cigarettes to three different potencies.</a><span class="one_line_source">[Clin Pharmacol Ther.  1982]</span><div class="alt-note">
<div class="authors">Perez-Reyes M, Di Guiseppi S, Davis KH, Schindler VH, Cook CE</div>
<div class="citation">Clin Pharmacol Ther. 1982 May; 31(5):617-24.</div>
</div>
</li>
<li class="two_line" reference_id="R17">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6271825/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The clinical pharmacology and dynamics of marihuana cigarette smoking.</a><span class="one_line_source">[J Clin Pharmacol.  1981]</span><div class="alt-note">
<div class="authors">Perez-Reyes M, Owens SM, Di Guiseppi S</div>
<div class="citation">J Clin Pharmacol. 1981 Aug-Sep; 21(8-9 Suppl):201S-207S.</div>
</div>
</li>
<li class="two_line" reference_id="R15">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1320536/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Characterization of the absorption phase of marijuana smoking.</a><span class="one_line_source">[Clin Pharmacol Ther.  1992]</span><div class="alt-note">
<div class="authors">Huestis MA, Sampson AH, Holicky BJ, Henningfield JE, Cone EJ</div>
<div class="citation">Clin Pharmacol Ther. 1992 Jul; 52(1):31-41.</div>
</div>
</li>
<li class="two_line" reference_id="R24">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6145762/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin.</a><span class="one_line_source">[J Pharm Pharmacol.  1984]</span><div class="alt-note">
<div class="authors">Law B, Mason PA, Moffat AC, Gleadle RI, King LJ</div>
<div class="citation">J Pharm Pharmacol. 1984 May; 36(5):289-94.</div>
</div>
</li>
<li class="two_line" reference_id="R137">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6304423/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Comparison of 3H- and 125I-radioimmunoassay and gas chromatography/mass spectrometry for the determination of delta 9-tetrahydrocannabinol and cannabinoids in blood and serum.</a><span class="one_line_source">[J Anal Toxicol.  1983]</span><div class="alt-note">
<div class="authors">Hanson VW, Buonarati MH, Baselt RC, Wade NA, Yep C, Biasotti AA, Reeve VC, Wong AS, Orbanowsky MW</div>
<div class="citation">J Anal Toxicol. 1983 Mar-Apr; 7(2):96-102.</div>
</div>
</li>
<li class="two_line" reference_id="R77">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1323733/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users.</a><span class="one_line_source">[J Anal Toxicol.  1992]</span><div class="alt-note">
<div class="authors">Kelly P, Jones RT</div>
<div class="citation">J Anal Toxicol. 1992 Jul-Aug; 16(4):228-35.</div>
</div>
</li>
<li class="two_line" reference_id="R96">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/2993473/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabis: pharmacology and interpretation of effects.</a><span class="one_line_source">[J Forensic Sci.  1985]</span><div class="alt-note">
<div class="authors">Mason AP, McBay AJ</div>
<div class="citation">J Forensic Sci. 1985 Jul; 30(3):615-31.</div>
</div>
</li>
<li class="two_line" reference_id="R14">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1338215/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.</a><span class="one_line_source">[J Anal Toxicol.  1992]</span><div class="alt-note">
<div class="authors">Huestis MA, Henningfield JE, Cone EJ</div>
<div class="citation">J Anal Toxicol. 1992 Sep-Oct; 16(5):276-82.</div>
</div>
</li>
<li class="two_line" reference_id="R138">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8357462/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Incidence of alcohol and drugs in fatally injured car drivers in Norway.</a><span class="one_line_source">[Accid Anal Prev.  1993]</span><div class="alt-note">
<div class="authors">Gjerde H, Beylich KM, Mørland J</div>
<div class="citation">Accid Anal Prev. 1993 Aug; 25(4):479-83.</div>
</div>
</li>
<li class="two_line" reference_id="R139">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6502125/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Ethanol, marijuana, and other drug use in 600 drivers killed in single-vehicle crashes in North Carolina, 1978-1981.</a><span class="one_line_source">[J Forensic Sci.  1984]</span><div class="alt-note">
<div class="authors">Mason AP, McBay AJ</div>
<div class="citation">J Forensic Sci. 1984 Oct; 29(4):987-1026.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P62" name="crb--P62" rid="P62" style="position: absolute; visibility: visible; width: 370px; top: 14547px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-72"><ul>
<li class="two_line" reference_id="R140">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1338216/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH)</a><span class="one_line_source">[J Anal Toxicol.  1992]</span><div class="alt-note">
<div class="authors">Huestis MA, Henningfield JE, Cone EJ</div>
<div class="citation">J Anal Toxicol. 1992 Sep-Oct; 16(5):283-90.</div>
</div>
</li>
<li class="two_line" reference_id="R132">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/11599597/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.</a><span class="one_line_source">[J Anal Toxicol.  2001]</span><div class="alt-note">
<div class="authors">Manno JE, Manno BR, Kemp PM, Alford DD, Abukhalaf IK, McWilliams ME, Hagaman FN, Fitzgerald MJ</div>
<div class="citation">J Anal Toxicol. 2001 Oct; 25(7):538-49.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P63" name="crb--P63" rid="P63" style="position: absolute; visibility: visible; width: 370px; top: 15011px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-73"><ul><li class="two_line" reference_id="R141">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16223887/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Estimating the time of last cannabis use from plasma delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol concentrations.</a><span class="one_line_source">[Clin Chem.  2005]</span><div class="alt-note">
<div class="authors">Huestis MA, Barnes A, Smith ML</div>
<div class="citation">Clin Chem. 2005 Dec; 51(12):2289-95.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P65" name="crb--P65" rid="P65" style="position: absolute; visibility: visible; width: 370px; top: 15661px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-74"><ul>
<li class="two_line" reference_id="R143">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/3902318/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Excretion patterns of cannabinoid metabolites after last use in a group of chronic users.</a><span class="one_line_source">[Clin Pharmacol Ther.  1985]</span><div class="alt-note">
<div class="authors">Ellis GM Jr, Mann MA, Judson BA, Schramm NT, Tashchian A</div>
<div class="citation">Clin Pharmacol Ther. 1985 Nov; 38(5):572-8.</div>
</div>
</li>
<li class="two_line" reference_id="R144">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8926739/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Detection times of marijuana metabolites in urine by immunoassay and GC-MS.</a><span class="one_line_source">[J Anal Toxicol.  1995]</span><div class="alt-note">
<div class="authors">Huestis MA, Mitchell JM, Cone EJ</div>
<div class="citation">J Anal Toxicol. 1995 Oct; 19(6):443-9.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P66" name="crb--P66" rid="P66" style="position: absolute; visibility: visible; width: 370px; top: 15861px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-75"><ul><li class="two_line" reference_id="R113">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8889681/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.</a><span class="one_line_source">[J Anal Toxicol.  1996]</span><div class="alt-note">
<div class="authors">Huestis MA, Mitchell JM, Cone EJ</div>
<div class="citation">J Anal Toxicol. 1996 Oct; 20(6):441-52.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P67" name="crb--P67" rid="P67" style="position: absolute; visibility: visible; width: 370px; top: 16208px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-76"><ul>
<li class="two_line" reference_id="R144">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8926739/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Detection times of marijuana metabolites in urine by immunoassay and GC-MS.</a><span class="one_line_source">[J Anal Toxicol.  1995]</span><div class="alt-note">
<div class="authors">Huestis MA, Mitchell JM, Cone EJ</div>
<div class="citation">J Anal Toxicol. 1995 Oct; 19(6):443-9.</div>
</div>
</li>
<li class="two_line" reference_id="R145">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8990229/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Lowering cutoffs for initial and confirmation testing for cocaine and marijuana: large-scale study of effects on the rates of drug-positive results.</a><span class="one_line_source">[Clin Chem.  1997]</span><div class="alt-note">
<div class="authors">Wingert WE</div>
<div class="citation">Clin Chem. 1997 Jan; 43(1):100-3.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P70" name="crb--P70" rid="P70" style="position: absolute; visibility: visible; width: 370px; top: 16892px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-77"><ul><li class="two_line" reference_id="R148">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9788519/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Differentiating new marijuana use from residual drug excretion in occasional marijuana users.</a><span class="one_line_source">[J Anal Toxicol.  1998]</span><div class="alt-note">
<div class="authors">Huestis MA, Cone EJ</div>
<div class="citation">J Anal Toxicol. 1998 Oct; 22(6):445-54.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P71" name="crb--P71" rid="P71" style="position: absolute; visibility: visible; width: 370px; top: 17147px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-78"><ul><li class="two_line" reference_id="R149">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9788521/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">In vivo adulteration: excess fluid ingestion causes false-negative marijuana and cocaine urine test results.</a><span class="one_line_source">[J Anal Toxicol.  1998]</span><div class="alt-note">
<div class="authors">Cone EJ, Lange R, Darwin WD</div>
<div class="citation">J Anal Toxicol. 1998 Oct; 22(6):460-73.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P72" name="crb--P72" rid="P72" style="position: absolute; visibility: visible; width: 370px; top: 17494px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-79"><ul><li class="two_line" reference_id="R150">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1934467/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Importance of creatinine analyses of urine when screening for abused drugs.</a><span class="one_line_source">[Clin Chem.  1991]</span><div class="alt-note">
<div class="authors">Lafolie P, Beck O, Blennow G, Boréus L, Borg S, Elwin CE, Karlsson L, Odelius G, Hjemdahl P</div>
<div class="citation">Clin Chem. 1991 Nov; 37(11):1927-31.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P73" name="crb--P73" rid="P73" style="position: absolute; visibility: visible; width: 370px; top: 17610px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-80"><ul>
<li class="two_line" reference_id="R151">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/14609657/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol. Study III. A Delta9-THC-COOH to creatinine ratio study.</a><span class="one_line_source">[Forensic Sci Int.  2003]</span><div class="alt-note">
<div class="authors">Fraser AD, Worth D</div>
<div class="citation">Forensic Sci Int. 2003 Nov 26; 137(2-3):196-202.</div>
</div>
</li>
<li class="two_line" reference_id="R153">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/15240035/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV.</a><span class="one_line_source">[Forensic Sci Int.  2004]</span><div class="alt-note">
<div class="authors">Fraser AD, Worth D</div>
<div class="citation">Forensic Sci Int. 2004 Jul 16; 143(2-3):147-52.</div>
</div>
</li>
<li class="two_line" reference_id="R148">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9788519/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Differentiating new marijuana use from residual drug excretion in occasional marijuana users.</a><span class="one_line_source">[J Anal Toxicol.  1998]</span><div class="alt-note">
<div class="authors">Huestis MA, Cone EJ</div>
<div class="citation">J Anal Toxicol. 1998 Oct; 22(6):445-54.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P74" name="crb--P74" rid="P74" style="position: absolute; visibility: visible; width: 370px; top: 17912px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-81"><ul>
<li class="two_line" reference_id="R154">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1851311/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Salivary THC following cannabis smoking correlates with subjective intoxication and heart rate.</a><span class="one_line_source">[Psychopharmacology (Berl).  1991]</span><div class="alt-note">
<div class="authors">Menkes DB, Howard RC, Spears GF, Cairns ER</div>
<div class="citation">Psychopharmacology (Berl). 1991; 103(2):277-9.</div>
</div>
</li>
<li class="two_line" reference_id="R159">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6294525/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Significant developments in radioimmune methods applied to delta 9-THC and its 9-substituted metabolites.</a><span class="one_line_source">[NIDA Res Monogr.  1982]</span><div class="alt-note">
<div class="authors">Soares JR, Grant JD, Gross SJ</div>
<div class="citation">NIDA Res Monogr. 1982; 42():44-55.</div>
</div>
</li>
<li class="two_line" reference_id="R160">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6294522/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The constituents of cannabis and the disposition and metabolism of cannabinoids.</a><span class="one_line_source">[NIDA Res Monogr.  1982]</span><div class="alt-note">
<div class="authors">Hawks RL</div>
<div class="citation">NIDA Res Monogr. 1982; 42():125-37.</div>
</div>
</li>
<li class="two_line" reference_id="R162">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/11043659/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Detection of cannabis in oral fluid (saliva) and forehead wipes (sweat) from impaired drivers.</a><span class="one_line_source">[J Anal Toxicol.  2000]</span><div class="alt-note">
<div class="authors">Kintz P, Cirimele V, Ludes B</div>
<div class="citation">J Anal Toxicol. 2000 Oct; 24(7):557-61.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P75" name="crb--P75" rid="P75" style="position: absolute; visibility: visible; width: 370px; top: 18196px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-82"><ul>
<li class="two_line" reference_id="R154">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1851311/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Salivary THC following cannabis smoking correlates with subjective intoxication and heart rate.</a><span class="one_line_source">[Psychopharmacology (Berl).  1991]</span><div class="alt-note">
<div class="authors">Menkes DB, Howard RC, Spears GF, Cairns ER</div>
<div class="citation">Psychopharmacology (Berl). 1991; 103(2):277-9.</div>
</div>
</li>
<li class="two_line" reference_id="R156">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/2984463/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Detection of recent cannabis use by saliva delta 9-THC radioimmunoassay.</a><span class="one_line_source">[J Anal Toxicol.  1985]</span><div class="alt-note">
<div class="authors">Gross SJ, Worthy TE, Nerder L, Zimmermann EG, Soares JR, Lomax P</div>
<div class="citation">J Anal Toxicol. 1985 Jan-Feb; 9(1):1-5.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P76" name="crb--P76" rid="P76" style="position: absolute; visibility: visible; width: 370px; top: 18313px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-83"><ul>
<li class="two_line" reference_id="R164">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/15516285/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.</a><span class="one_line_source">[J Anal Toxicol.  2004]</span><div class="alt-note">
<div class="authors">Huestis MA, Cone EJ</div>
<div class="citation">J Anal Toxicol. 2004 Sep; 28(6):394-9.</div>
</div>
</li>
<li class="two_line" reference_id="R165">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/11499881/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana.</a><span class="one_line_source">[J Anal Toxicol.  2001]</span><div class="alt-note">
<div class="authors">Niedbala RS, Kardos KW, Fritch DF, Kardos S, Fries T, Waga J, Robb J, Cone EJ</div>
<div class="citation">J Anal Toxicol. 2001 Jul-Aug; 25(5):289-303.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P77" name="crb--P77" rid="P77" style="position: absolute; visibility: visible; width: 370px; top: 18429px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-84"><ul><li class="two_line" reference_id="R166">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/6366113/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Detection of drugs in saliva of impaired drivers.</a><span class="one_line_source">[J Forensic Sci.  1984]</span><div class="alt-note">
<div class="authors">Peel HW, Perrigo BJ, Mikhael NZ</div>
<div class="citation">J Forensic Sci. 1984 Jan; 29(1):185-9.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P78" name="crb--P78" rid="P78" style="position: absolute; visibility: visible; width: 370px; top: 18608px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-85"><ul><li class="two_line" reference_id="R167">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16842950/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Correlation of Delta9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Dräger DrugTest.</a><span class="one_line_source">[Forensic Sci Int.  2006]</span><div class="alt-note">
<div class="authors">Laloup M, Del Mar Ramirez Fernandez M, Wood M, De Boeck G, Maes V, Samyn N</div>
<div class="citation">Forensic Sci Int. 2006 Sep 12; 161(2-3):175-9.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P79" name="crb--P79" rid="P79" style="position: absolute; visibility: visible; width: 370px; top: 18745px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-86"><ul>
<li class="two_line" reference_id="R165">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/11499881/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana.</a><span class="one_line_source">[J Anal Toxicol.  2001]</span><div class="alt-note">
<div class="authors">Niedbala RS, Kardos KW, Fritch DF, Kardos S, Fries T, Waga J, Robb J, Cone EJ</div>
<div class="citation">J Anal Toxicol. 2001 Jul-Aug; 25(5):289-303.</div>
</div>
</li>
<li class="two_line" reference_id="R168">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/11569567/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Blind trials of an onsite saliva drug test for marijuana and opiates.</a><span class="one_line_source">[J Forensic Sci.  2001]</span><div class="alt-note">
<div class="authors">Jehanli A, Brannan S, Moore L, Spiehler VR</div>
<div class="citation">J Forensic Sci. 2001 Sep; 46(5):1214-20.</div>
</div>
</li>
<li class="two_line" reference_id="R169">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9599579/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Determination of cannabinoids in water and human saliva by solid-phase microextraction and quadrupole ion trap gas chromatography/mass spectrometry.</a><span class="one_line_source">[Anal Chem.  1998]</span><div class="alt-note">
<div class="authors">Hall BJ, Satterfield-Doerr M, Parikh AR, Brodbelt JS</div>
<div class="citation">Anal Chem. 1998 May 1; 70(9):1788-96.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P80" name="crb--P80" rid="P80" style="position: absolute; visibility: visible; width: 370px; top: 18945px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-87"><ul>
<li class="two_line" reference_id="R170">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/14606995/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">An evaluation of rapid point-of-collection oral fluid drug-testing devices.</a><span class="one_line_source">[J Anal Toxicol.  2003]</span><div class="alt-note">
<div class="authors">Walsh JM, Flegel R, Crouch DJ, Cangianelli L, Baudys J</div>
<div class="citation">J Anal Toxicol. 2003 Oct; 27(7):429-39.</div>
</div>
</li>
<li class="two_line" reference_id="R173">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/17132261/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Recovery of drugs of abuse from the Immunalysis Quantisal oral fluid collection device.</a><span class="one_line_source">[J Anal Toxicol.  2006]</span><div class="alt-note">
<div class="authors">Quintela O, Crouch DJ, Andrenyak DM</div>
<div class="citation">J Anal Toxicol. 2006 Oct; 30(8):614-6.</div>
</div>
</li>
<li class="two_line" reference_id="R174">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/17137523/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Detection of THCA in oral fluid by GC-MS-MS.</a><span class="one_line_source">[J Anal Toxicol.  2006]</span><div class="alt-note">
<div class="authors">Day D, Kuntz DJ, Feldman M, Presley L</div>
<div class="citation">J Anal Toxicol. 2006 Nov-Dec; 30(9):645-50.</div>
</div>
</li>
<li class="two_line" reference_id="R175">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16959131/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Analytical procedure for the determination of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens.</a><span class="one_line_source">[J Anal Toxicol.  2006]</span><div class="alt-note">
<div class="authors">Moore C, Coulter C, Rana S, Vincent M, Soares J</div>
<div class="citation">J Anal Toxicol. 2006 Sep; 30(7):409-12.</div>
</div>
</li>
<li class="two_line" reference_id="R176">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16959132/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Detection of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens and its contribution to positive results in screening assays.</a><span class="one_line_source">[J Anal Toxicol.  2006]</span><div class="alt-note">
<div class="authors">Moore C, Ross W, Coulter C, Adams L, Rana S, Vincent M, Soares J</div>
<div class="citation">J Anal Toxicol. 2006 Sep; 30(7):413-8.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P81" name="crb--P81" rid="P81" style="position: absolute; visibility: visible; width: 370px; top: 19376px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-88"><ul><li class="two_line" reference_id="R177">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16419389/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.</a><span class="one_line_source">[J Anal Toxicol.  2005]</span><div class="alt-note">
<div class="authors">Niedbala RS, Kardos KW, Fritch DF, Kunsman KP, Blum KA, Newland GA, Waga J, Kurtz L, Bronsgeest M, Cone EJ</div>
<div class="citation">J Anal Toxicol. 2005 Oct; 29(7):607-15.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P82" name="crb--P82" rid="P82" style="position: absolute; visibility: visible; width: 370px; top: 19531px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-89"><ul>
<li class="two_line" reference_id="R178">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9700555/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Testing for drugs of abuse in saliva and sweat.</a><span class="one_line_source">[J Chromatogr B Biomed Sci Appl.  1998]</span><div class="alt-note">
<div class="authors">Kidwell DA, Holland JC, Athanaselis S</div>
<div class="citation">J Chromatogr B Biomed Sci Appl. 1998 Aug 21; 713(1):111-35.</div>
</div>
</li>
<li class="two_line" reference_id="R179">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/2241828/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">[Detection of drugs in sweat].</a><span class="one_line_source">[Beitr Gerichtl Med.  1990]</span><div class="alt-note">
<div class="authors">Balabanova S, Schneider E</div>
<div class="citation">Beitr Gerichtl Med. 1990; 48():45-9.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P83" name="crb--P83" rid="P83" style="position: absolute; visibility: visible; width: 370px; top: 19837px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-90"><ul>
<li class="two_line" reference_id="R157">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/10216980/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">[Evaluation of six rapid tests for screening of cannabis in sweat, saliva and tears].</a><span class="one_line_source">[Acta Clin Belg.  1999]</span><div class="alt-note">
<div class="authors">Mura P, Kintz P, Papet Y, Ruesch G, Piriou A</div>
<div class="citation">Acta Clin Belg. 1999; 53 Suppl 1():35-8.</div>
</div>
</li>
<li class="two_line" reference_id="R180">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/10876986/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users.</a><span class="one_line_source">[Int J Legal Med.  2000]</span><div class="alt-note">
<div class="authors">Samyn N, van Haeren C</div>
<div class="citation">Int J Legal Med. 2000; 113(3):150-4.</div>
</div>
</li>
<li class="two_line" reference_id="R181">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9166224/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Sweat testing for heroin and metabolites in a heroin maintenance program.</a><span class="one_line_source">[Clin Chem.  1997]</span><div class="alt-note">
<div class="authors">Kintz P, Brenneisen R, Bundeli P, Mangin P</div>
<div class="citation">Clin Chem. 1997 May; 43(5):736-9.</div>
</div>
</li>
<li class="two_line" reference_id="R162">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/11043659/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Detection of cannabis in oral fluid (saliva) and forehead wipes (sweat) from impaired drivers.</a><span class="one_line_source">[J Anal Toxicol.  2000]</span><div class="alt-note">
<div class="authors">Kintz P, Cirimele V, Ludes B</div>
<div class="citation">J Anal Toxicol. 2000 Oct; 24(7):557-61.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P84" name="crb--P84" rid="P84" style="position: absolute; visibility: visible; width: 370px; top: 20076px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-91"><ul><li class="two_line" reference_id="R186">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/11599599/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The determination of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) in hair using negative ion gas chromatography-mass spectrometry and high-volume injection.</a><span class="one_line_source">[J Anal Toxicol.  2001]</span><div class="alt-note">
<div class="authors">Moore C, Guzaldo F, Donahue T</div>
<div class="citation">J Anal Toxicol. 2001 Oct; 25(7):555-8.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P85" name="crb--P85" rid="P85" style="position: absolute; visibility: visible; width: 370px; top: 20255px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-92"><ul>
<li class="two_line" reference_id="R187">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16803651/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Application of two-dimensional gas chromatography with electron capture chemical ionization mass spectrometry to the detection of 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) in hair.</a><span class="one_line_source">[J Anal Toxicol.  2006]</span><div class="alt-note">
<div class="authors">Moore C, Rana S, Coulter C, Feyerherm F, Prest H</div>
<div class="citation">J Anal Toxicol. 2006 Apr; 30(3):171-7.</div>
</div>
</li>
<li class="two_line" reference_id="R188">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/8837945/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Testing human hair for Cannabis. III. rapid screening procedure for the simultaneous identification of delta 9-tetrahydrocannabinol, cannabinol, and cannabidiol.</a><span class="one_line_source">[J Anal Toxicol.  1996]</span><div class="alt-note">
<div class="authors">Cirimele V, Sachs H, Kintz P, Mangin P</div>
<div class="citation">J Anal Toxicol. 1996 Jan-Feb; 20(1):13-6.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P87" name="crb--P87" rid="P87" style="position: absolute; visibility: visible; width: 370px; top: 20592px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-93"><ul><li class="two_line" reference_id="R189">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16963215/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cannabinoid concentrations in hair from documented cannabis users.</a><span class="one_line_source">[Forensic Sci Int.  2007]</span><div class="alt-note">
<div class="authors">Huestis MA, Gustafson RA, Moolchan ET, Barnes A, Bourland JA, Sweeney SA, Hayes EF, Carpenter PM, Smith ML</div>
<div class="citation">Forensic Sci Int. 2007 Jul 4; 169(2-3):129-36.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p2" name="crb--__p2" rid="__p2" style="display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-94"><ul><li class="expanded" reference_id="R14">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1338215/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.</a><span class="one_line_source">[J Anal Toxicol.  1992]</span><div class="alt-note">
<div class="authors">Huestis MA, Henningfield JE, Cone EJ</div>
<div class="citation">J Anal Toxicol. 1992 Sep-Oct; 16(5):276-82.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p3" name="crb--__p3" rid="__p3" style="display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-95"><ul><li class="expanded" reference_id="R32">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/14630369/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Validated method for the simultaneous determination of Delta 9-tetrahydrocannabinol (THC), 11-hydroxy-THC and 11-nor-9-carboxy-THC in human plasma using solid phase extraction and gas chromatography-mass spectrometry with positive chemical ionization.</a><span class="one_line_source">[J Chromatogr B Analyt Technol Biomed Life Sci.  2003]</span><div class="alt-note">
<div class="authors">Gustafson RA, Moolchan ET, Barnes A, Levine B, Huestis MA</div>
<div class="citation">J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Dec 5; 798(1):145-54.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p4" name="crb--__p4" rid="__p4" style="display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-96"><ul><li class="expanded" reference_id="R140">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/1338216/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH)</a><span class="one_line_source">[J Anal Toxicol.  1992]</span><div class="alt-note">
<div class="authors">Huestis MA, Henningfield JE, Cone EJ</div>
<div class="citation">J Anal Toxicol. 1992 Sep-Oct; 16(5):283-90.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p5" name="crb--__p5" rid="__p5" style="display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-97"><ul><li class="expanded" reference_id="R148">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9788519/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Differentiating new marijuana use from residual drug excretion in occasional marijuana users.</a><span class="one_line_source">[J Anal Toxicol.  1998]</span><div class="alt-note">
<div class="authors">Huestis MA, Cone EJ</div>
<div class="citation">J Anal Toxicol. 1998 Oct; 22(6):445-54.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p6" name="crb--__p6" rid="__p6" style="display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-98"><ul><li class="expanded" reference_id="R164">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/15516285/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.</a><span class="one_line_source">[J Anal Toxicol.  2004]</span><div class="alt-note">
<div class="authors">Huestis MA, Cone EJ</div>
<div class="citation">J Anal Toxicol. 2004 Sep; 28(6):394-9.</div>
</div>
</li></ul></div>
</div>
</div>   
    </div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="./Human Cannabinoid Pharmacokinetics_files/jquery.scrollTo-1.4.2.js.download"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"><div id="body-link-popper-R1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Constituents of Cannabis sativa L. XVII. A review of the natural constituents.<div class="authors">Turner CE, Elsohly MA, Boeren EG</div><div class="citation">J Nat Prod. 1980 Mar-Apr; 43(2):169-234.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6991645/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R1">Ref list</a>]</p></div><div id="body-link-popper-R3" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">3. <span class="citation">ElSohly HN, Boeren EG, Turner CE, ElSohly MA.  In: <span class="ref-journal">The Cannabinoids: Chemical, Pharmacologic and Therapeutic Aspects.</span> Agurell S, Dewey WL, Willette RE, editors. Academic Press; Orlando: 1984. p. 89.</span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R3">Ref list</a>]</div><div id="body-link-popper-R4" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Marihuana chemistry.<div class="authors">Mechoulam R</div><div class="citation">Science. 1970 Jun 5; 168(3936):1159-66.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/4910003/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R4">Ref list</a>]</p></div><div id="body-link-popper-R5" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking.<div class="authors">Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK</div><div class="citation">Clin Pharmacol Ther. 1980 Sep; 28(3):409-16.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6250760/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R5">Ref list</a>]</p></div><div id="body-link-popper-R6" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Stability, transfer and absorption of cannabinoid constituents of cannabis (hashish) during smoking.<div class="authors">Agurell S, Leander K</div><div class="citation">Acta Pharm Suec. 1971 Sep; 8(4):391-402.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/5135173/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R6">Ref list</a>]</p></div><div id="body-link-popper-R9" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Single dose kinetics of deuterium labelled delta 1-tetrahydrocannabinol in heavy and light cannabis users.<div class="authors">Ohlsson A, Lindgren JE, Wahlén A, Agurell S, Hollister LE, Gillespie HK</div><div class="citation">Biomed Mass Spectrom. 1982 Jan; 9(1):6-10.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6277407/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R9">Ref list</a>]</p></div><div id="body-link-popper-R10" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Marijuana smoking: effect of varying delta 9-tetrahydrocannabinol content and number of puffs.<div class="authors">Azorlosa JL, Heishman SJ, Stitzer ML, Mahaffey JM</div><div class="citation">J Pharmacol Exp Ther. 1992 Apr; 261(1):114-22.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1313866/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R10">Ref list</a>]</p></div><div id="body-link-popper-R12" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Marijuana smoking: factors that influence the bioavailability of tetrahydrocannabinol.<div class="authors">Perez-Reyes M</div><div class="citation">NIDA Res Monogr. 1990; 99():42-62.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2176276/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R12">Ref list</a>]</p></div><div id="body-link-popper-R13" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Effect of subject expectancy on the THC intoxication and disposition from smoked hashish cigarettes.<div class="authors">Camí J, Guerra D, Ugena B, Segura J, de la Torre R</div><div class="citation">Pharmacol Biochem Behav. 1991 Sep; 40(1):115-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1664106/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R13">Ref list</a>]</p></div><div id="body-link-popper-R14" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.<div class="authors">Huestis MA, Henningfield JE, Cone EJ</div><div class="citation">J Anal Toxicol. 1992 Sep-Oct; 16(5):276-82.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1338215/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R14">Ref list</a>]</p></div><div id="body-link-popper-R15" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Characterization of the absorption phase of marijuana smoking.<div class="authors">Huestis MA, Sampson AH, Holicky BJ, Henningfield JE, Cone EJ</div><div class="citation">Clin Pharmacol Ther. 1992 Jul; 52(1):31-41.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1320536/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R15">Ref list</a>]</p></div><div id="body-link-popper-R16" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Comparison of effects of marihuana cigarettes to three different potencies.<div class="authors">Perez-Reyes M, Di Guiseppi S, Davis KH, Schindler VH, Cook CE</div><div class="citation">Clin Pharmacol Ther. 1982 May; 31(5):617-24.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6280918/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R16">Ref list</a>]</p></div><div id="body-link-popper-R17" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The clinical pharmacology and dynamics of marihuana cigarette smoking.<div class="authors">Perez-Reyes M, Owens SM, Di Guiseppi S</div><div class="citation">J Clin Pharmacol. 1981 Aug-Sep; 21(8-9 Suppl):201S-207S.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6271825/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R17">Ref list</a>]</p></div><div id="body-link-popper-R18" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Potency trends of delta9-THC and other cannabinoids in confiscated marijuana from 1980-1997.<div class="authors">ElSohly MA, Ross SA, Mehmedic Z, Arafat R, Yi B, Banahan BF 3rd</div><div class="citation">J Forensic Sci. 2000 Jan; 45(1):24-30.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/10641915/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R18">Ref list</a>]</p></div><div id="body-link-popper-R19" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Cannabis is more than simply delta(9)-tetrahydrocannabinol.<div class="authors">Russo EB, McPartland JM</div><div class="citation">Psychopharmacology (Berl). 2003 Feb; 165(4):431-2; author reply 433-4.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/12491031/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R19">Ref list</a>]</p></div><div id="body-link-popper-R20" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Characterization of cytochrome P450 3A inactivation by cannabidiol: possible involvement of cannabidiol-hydroxyquinone as a P450 inactivator.<div class="authors">Bornheim LM, Grillo MP</div><div class="citation">Chem Res Toxicol. 1998 Oct; 11(10):1209-16.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9778318/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R20">Ref list</a>]</p></div><div id="body-link-popper-R21" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">21. <span class="citation">Harvey DJ.  In: <span class="ref-journal">Marijuana and Medicine.</span> Nahas GG, Sutin KM, Harvey DJ, Agurell S, editors. Humana Press; Totowa: 2001. p. 91.</span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R21">Ref list</a>]</div><div id="body-link-popper-R22" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects.<div class="authors">Mechoulam R, Hanus L</div><div class="citation">Chem Phys Lipids. 2002 Dec 31; 121(1-2):35-43.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/12505688/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R22">Ref list</a>]</p></div><div id="body-link-popper-R23" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Concentration-effect relationship of delta-9-tetrahydrocannabiol and prediction of psychotropic effects after smoking marijuana.<div class="authors">Harder S, Rietbrock S</div><div class="citation">Int J Clin Pharmacol Ther. 1997 Apr; 35(4):155-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9112136/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R23">Ref list</a>]</p></div><div id="body-link-popper-R24" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin.<div class="authors">Law B, Mason PA, Moffat AC, Gleadle RI, King LJ</div><div class="citation">J Pharm Pharmacol. 1984 May; 36(5):289-94.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6145762/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R24">Ref list</a>]</p></div><div id="body-link-popper-R25" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Plasma levels of delta 9-tetrahydrocannabinol after intravenous, oral, and smoke administration.<div class="authors">Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK</div><div class="citation">NIDA Res Monogr. 1981 Feb; 34():250-6.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6261133/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R25">Ref list</a>]</p></div><div id="body-link-popper-R26" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Pharmacology of orally administered   9 -tetrahydrocannabinol.<div class="authors">Perez-Reyes M, Lipton MA, Timmons MC, Wall ME, Brine DR, Davis KH</div><div class="citation">Clin Pharmacol Ther. 1973 Jan-Feb; 14(1):48-55.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/4683071/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R26">Ref list</a>]</p></div><div id="body-link-popper-R27" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women.<div class="authors">Wall ME, Sadler BM, Brine D, Taylor H, Perez-Reyes M</div><div class="citation">Clin Pharmacol Ther. 1983 Sep; 34(3):352-63.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6309462/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R27">Ref list</a>]</p></div><div id="body-link-popper-R28" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Rapid screening for acidic non-steroidal anti-inflammatory drugs in urine by gas chromatography-mass spectrometry in the selected-ion monitoring mode.<div class="authors">Kim KR, Yoon HR</div><div class="citation">J Chromatogr B Biomed Appl. 1996 Jun 28; 682(1):55-66.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8832425/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R28">Ref list</a>]</p></div><div id="body-link-popper-R29" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Psychosis following ingestion of hemp in children.<div class="authors">Binitie A</div><div class="citation">Psychopharmacologia. 1975 Nov 21; 44(3):301-2.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1208765/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R29">Ref list</a>]</p></div><div id="body-link-popper-R30" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">[Cannabis poisoning after eating salad].<div class="authors">Meier H, Vonesch HJ</div><div class="citation">Schweiz Med Wochenschr. 1997 Feb 8; 127(6):214-8.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9157527/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R30">Ref list</a>]</p></div><div id="body-link-popper-R31" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.<div class="authors">Goodwin RS, Gustafson RA, Barnes A, Nebro W, Moolchan ET, Huestis MA</div><div class="citation">Ther Drug Monit. 2006 Aug; 28(4):545-51.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16885723/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R31">Ref list</a>]</p></div><div id="body-link-popper-R32" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Validated method for the simultaneous determination of Delta 9-tetrahydrocannabinol (THC), 11-hydroxy-THC and 11-nor-9-carboxy-THC in human plasma using solid phase extraction and gas chromatography-mass spectrometry with positive chemical ionization.<div class="authors">Gustafson RA, Moolchan ET, Barnes A, Levine B, Huestis MA</div><div class="citation">J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Dec 5; 798(1):145-54.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/14630369/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R32">Ref list</a>]</p></div><div id="body-link-popper-R33" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract.<div class="authors">Nadulski T, Sporkert F, Schnelle M, Stadelmann AM, Roser P, Schefter T, Pragst F</div><div class="citation">J Anal Toxicol. 2005 Nov-Dec; 29(8):782-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16356335/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R33">Ref list</a>]</p></div><div id="body-link-popper-R34" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Plant cannabinoids: a neglected pharmacological treasure trove.<div class="authors">Mechoulam R</div><div class="citation">Br J Pharmacol. 2005 Dec; 146(7):913-5.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16205721/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R34">Ref list</a>]</p></div><div id="body-link-popper-R35" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Early medical use of cannabis.<div class="authors">Zias J, Stark H, Sellgman J, Levy R, Werker E, Breuer A, Mechoulam R</div><div class="citation">Nature. 1993 May 20; 363(6426):215.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8387642/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R35">Ref list</a>]</p></div><div id="body-link-popper-R36" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol.<div class="authors">Russo E, Guy GW</div><div class="citation">Med Hypotheses. 2006; 66(2):234-46.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16209908/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R36">Ref list</a>]</p></div><div id="body-link-popper-R37" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">37. <span class="citation">Vaughan CW, Christie MJ.  In: <span class="ref-journal">Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential.</span> Grotenhermen F, Russo E, editors. The Haworth Integrative Healing Press; New York: 1984. p. 89.</span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R37">Ref list</a>]</div><div id="body-link-popper-R38" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">38. <span class="citation">Holdcroft A.  In: <span class="ref-journal">Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential.</span> Grotenhermen F, Russo E, editors. The Haworth Integrative Healing Press; New York: 1984. p. 181.</span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R38">Ref list</a>]</div><div id="body-link-popper-R39" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.<div class="authors">Zajicek J, Fox P, Sanders H, Wright D, Vickery J, Nunn A, Thompson A, UK MS Research Group.</div><div class="citation">Lancet. 2003 Nov 8; 362(9395):1517-26.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/14615106/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R39">Ref list</a>]</p></div><div id="body-link-popper-R40" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Bypassing the first-pass effect for the therapeutic use of cannabinoids.<div class="authors">Mattes RD, Shaw LM, Edling-Owens J, Engelman K, Elsohly MA</div><div class="citation">Pharmacol Biochem Behav. 1993 Mar; 44(3):745-7.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8383856/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R40">Ref list</a>]</p></div><div id="body-link-popper-R41" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Cannabinoids and appetite stimulation.<div class="authors">Mattes RD, Engelman K, Shaw LM, Elsohly MA</div><div class="citation">Pharmacol Biochem Behav. 1994 Sep; 49(1):187-95.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/7816872/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R41">Ref list</a>]</p></div><div id="body-link-popper-R42" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The effect of orally and rectally administered delta 9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients.<div class="authors">Brenneisen R, Egli A, Elsohly MA, Henn V, Spiess Y</div><div class="citation">Int J Clin Pharmacol Ther. 1996 Oct; 34(10):446-52.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8897084/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R42">Ref list</a>]</p></div><div id="body-link-popper-R43" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Human skin permeation of Delta8-tetrahydrocannabinol, cannabidiol and cannabinol.<div class="authors">Stinchcomb AL, Valiveti S, Hammell DC, Ramsey DR</div><div class="citation">J Pharm Pharmacol. 2004 Mar; 56(3):291-7.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15025853/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R43">Ref list</a>]</p></div><div id="body-link-popper-R44" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration.<div class="authors">Scheuplein RJ</div><div class="citation">J Invest Dermatol. 1967 Jan; 48(1):79-88.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6018244/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R44">Ref list</a>]</p></div><div id="body-link-popper-R45" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">In vitro experiment optimization for measuring tetrahydrocannabinol skin permeation.<div class="authors">Challapalli PV, Stinchcomb AL</div><div class="citation">Int J Pharm. 2002 Jul 25; 241(2):329-39.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/12100860/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R45">Ref list</a>]</p></div><div id="body-link-popper-R46" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">In vitro/in vivo correlation studies for transdermal delta 8-THC development.<div class="authors">Valiveti S, Hammell DC, Earles DC, Stinchcomb AL</div><div class="citation">J Pharm Sci. 2004 May; 93(5):1154-64.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15067692/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R46">Ref list</a>]</p></div><div id="body-link-popper-R47" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Inhalation marijuana as an antiemetic for cancer chemotherapy.<div class="authors">Vinciguerra V, Moore T, Brennan E</div><div class="citation">N Y State J Med. 1988 Oct; 88(10):525-7.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/3231372/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R47">Ref list</a>]</p></div><div id="body-link-popper-R48" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis.<div class="authors">D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieva R, Krystal JH</div><div class="citation">Neuropsychopharmacology. 2004 Aug; 29(8):1558-72.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15173844/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R48">Ref list</a>]</p></div><div id="body-link-popper-R49" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol.<div class="authors">Perez-Reyes M, Timmons MC, Davis KH, Wall EM</div><div class="citation">Experientia. 1973 Nov 15; 29(11):1368-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/4761242/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R49">Ref list</a>]</p></div><div id="body-link-popper-R50" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Metabolic and psychophysiologic studies of cannabidiol-hexobarbital interaction.<div class="authors">Benowitz NL, Nguyen TL, Jones RT, Herning RI, Bachman J</div><div class="citation">Clin Pharmacol Ther. 1980 Jul; 28(1):115-20.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/7389248/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R50">Ref list</a>]</p></div><div id="body-link-popper-R51" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.<div class="authors">Hampson AJ, Grimaldi M, Axelrod J, Wink D</div><div class="citation">Proc Natl Acad Sci U S A. 1998 Jul 7; 95(14):8268-73.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9653176/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R51">Ref list</a>]</p></div><div id="body-link-popper-R52" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial.<div class="authors">Karst M, Salim K, Burstein S, Conrad I, Hoy L, Schneider U</div><div class="citation">JAMA. 2003 Oct 1; 290(13):1757-62.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/14519710/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R52">Ref list</a>]</p></div><div id="body-link-popper-R53" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">53. <span class="citation">Melamede R.  In: <span class="ref-journal">Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential.</span> Grotenhermen F, Russo E, editors. The Haworth Integrative Healing Press; New York: 1984. p. 111.</span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R53">Ref list</a>]</div><div id="body-link-popper-R54" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">54. <span class="citation">Plasse T.  In: <span class="ref-journal">Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential.</span> Grotenhermen F, Russo E, editors. The Haworth Integrative Healing Press; New York: 1984. p. 165.</span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R54">Ref list</a>]</div><div id="body-link-popper-R55" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Cannabinoids control spasticity and tremor in a multiple sclerosis model.<div class="authors">Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Huffman JW, Layward L</div><div class="citation">Nature. 2000 Mar 2; 404(6773):84-7.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/10716447/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R55">Ref list</a>]</p></div><div id="body-link-popper-R56" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.<div class="authors">Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R, Feldmann M</div><div class="citation">Proc Natl Acad Sci U S A. 2000 Aug 15; 97(17):9561-6.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/10920191/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R56">Ref list</a>]</p></div><div id="body-link-popper-R57" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects.<div class="authors">Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG</div><div class="citation">Psychopharmacology (Berl). 1982; 76(3):245-50.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6285406/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R57">Ref list</a>]</p></div><div id="body-link-popper-R58" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">58. <span class="citation">McArdle K, Mackie P, Pertwee R, Guy G, Whittle B, Hawksworth G. <span><span class="ref-journal">Toxicology. </span>2001;<span class="ref-vol">168</span>:133.</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R58">Ref list</a>]</div><div id="body-link-popper-R59" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">59. <span class="citation">Agurell S, Gillespie H, Halldin M, Hollister LE, Johansson E, Lindgren JE, Ohlsson A, Szirmai M, Widman M.  In: <span class="ref-journal">Marihuana '84: Proceedings of the Oxford Symposium on Cannabis.</span> Harvey DJ, Paton WDM, Nahas GG, editors. IRL Press; Oxford: 1984. p. 49.</span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R59">Ref list</a>]</div><div id="body-link-popper-R60" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration.<div class="authors">Ohlsson A, Lindgren JE, Andersson S, Agurell S, Gillespie H, Hollister LE</div><div class="citation">Biomed Environ Mass Spectrom. 1986 Feb; 13(2):77-83.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2937482/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R60">Ref list</a>]</p></div><div id="body-link-popper-R61" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography.<div class="authors">Agurell S, Carlsson S, Lindgren JE, Ohlsson A, Gillespie H, Hollister L</div><div class="citation">Experientia. 1981 Oct 15; 37(10):1090-2.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6273208/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R61">Ref list</a>]</p></div><div id="body-link-popper-R62" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">62. <span class="citation">Guy GW, Robson PJ. <span><span class="ref-journal">J. Cannabis Ther. </span>2004;<span class="ref-vol">3</span>:121.</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R62">Ref list</a>]</div><div id="body-link-popper-R63" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">63. <span class="citation">Guy GW, Robson PJ. <span><span class="ref-journal">J. Cannabis Ther. </span>2004;<span class="ref-vol">3</span>:79.</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R63">Ref list</a>]</div><div id="body-link-popper-R64" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Marihuana: studies on the disposition and metabolism of delta-9-tetrahydrocannabinol in man.<div class="authors">Lemberger L, Silberstein SD, Axelrod J, Kopin IJ</div><div class="citation">Science. 1970 Dec 18; 170(3964):1320-2.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/5479011/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R64">Ref list</a>]</p></div><div id="body-link-popper-R65" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Pharmacokinetics of THC in brain and testis, male gametotoxicity and premature apoptosis of spermatozoa.<div class="authors">Nahas GG, Frick HC, Lattimer JK, Latour C, Harvey D</div><div class="citation">Hum Psychopharmacol. 2002 Mar; 17(2):103-13.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/12404700/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R65">Ref list</a>]</p></div><div id="body-link-popper-R66" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Delta-9-tetrahydrocannabinol: localization in body fat.<div class="authors">Kreuz DS, Axelrod J</div><div class="citation">Science. 1973 Jan 26; 179(4071):391-3.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/4682965/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R66">Ref list</a>]</p></div><div id="body-link-popper-R67" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Pharmacokinetics and disposition of delta 9-tetrahydrocannabinol and its metabolites.<div class="authors">Garrett ER</div><div class="citation">Adv Biosci. 1978 Jul 22-23; 22-23():105-21.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/756823/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R67">Ref list</a>]</p></div><div id="body-link-popper-R68" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">68. <span class="citation">Harvey DJ, Leuschner JTA, Paton WDM.  In: <span class="ref-journal">Marihuana '84: Proceedings of the Oxford Symposium on Cannabis.</span> Harvey DJ, Paton WDM, Nahas GG, editors. IRL Press; Oxford: 1984. p. 77.</span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R68">Ref list</a>]</div><div id="body-link-popper-R69" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Determination of delta 1-tetrahydrocannabinol in human fat biopsies from marihuana users by gas chromatography-mass spectrometry.<div class="authors">Johansson E, Norén K, Sjövall J, Halldin MM</div><div class="citation">Biomed Chromatogr. 1989 Jan; 3(1):35-8.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2539872/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R69">Ref list</a>]</p></div><div id="body-link-popper-R70" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Pharmacokinetics and pharmacodynamics of cannabinoids.<div class="authors">Grotenhermen F</div><div class="citation">Clin Pharmacokinet. 2003; 42(4):327-60.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/12648025/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R70">Ref list</a>]</p></div><div id="body-link-popper-R71" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Distribution of radioactivity in brain of tolerant and nontolerant pigeons treated with  3 H-  9 -tetrahydrocannabinol.<div class="authors">Dewey WL, McMillan DE, Harris LS, Turk RF</div><div class="citation">Biochem Pharmacol. 1973 Feb 1; 22(3):399-405.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/4687135/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R71">Ref list</a>]</p></div><div id="body-link-popper-R72" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Tolerance and disposition of tetrahydrocannabinol in man.<div class="authors">Hunt CA, Jones RT</div><div class="citation">J Pharmacol Exp Ther. 1980 Oct; 215(1):35-44.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6256518/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R72">Ref list</a>]</p></div><div id="body-link-popper-R73" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Cannabis: pharmacology and toxicology in animals and humans.<div class="authors">Adams IB, Martin BR</div><div class="citation">Addiction. 1996 Nov; 91(11):1585-614.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8972919/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R73">Ref list</a>]</p></div><div id="body-link-popper-R74" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">THC can be detected in brain while absent in blood.<div class="authors">Mura P, Kintz P, Dumestre V, Raul S, Hauet T</div><div class="citation">J Anal Toxicol. 2005 Nov-Dec; 29(8):842-3.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16356342/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R74">Ref list</a>]</p></div><div id="body-link-popper-R75" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Validation of Large White Pig as an animal model for the study of cannabinoids metabolism: application to the study of THC distribution in tissues.<div class="authors">Brunet B, Doucet C, Venisse N, Hauet T, Hébrard W, Papet Y, Mauco G, Mura P</div><div class="citation">Forensic Sci Int. 2006 Sep 12; 161(2-3):169-74.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16859848/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R75">Ref list</a>]</p></div><div id="body-link-popper-R76" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Intravenous injection in man of   9 -tetrahydrocannabinol and 11-OH-  9 -tetrahydrocannabinol.<div class="authors">Perez-Reyes M, Timmons MC, Lipton MA, Davis KH, Wall ME</div><div class="citation">Science. 1972 Aug 18; 177(4049):633-5.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/4558903/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R76">Ref list</a>]</p></div><div id="body-link-popper-R77" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users.<div class="authors">Kelly P, Jones RT</div><div class="citation">J Anal Toxicol. 1992 Jul-Aug; 16(4):228-35.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1323733/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R77">Ref list</a>]</p></div><div id="body-link-popper-R78" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Partition coefficient, blood to plasma ratio, protein binding and short-term stability of 11-nor-Delta(9)-carboxy tetrahydrocannabinol glucuronide.<div class="authors">Skopp G, Pötsch L, Mauden M, Richter B</div><div class="citation">Forensic Sci Int. 2002 Mar 28; 126(1):17-23.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/11955826/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R78">Ref list</a>]</p></div><div id="body-link-popper-R79" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Maternal-fetal transfer of abused substances: pharmacokinetic and pharmacodynamic data.<div class="authors">Lee CC, Chiang CN</div><div class="citation">NIDA Res Monogr. 1985; 60():110-47.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2997613/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R79">Ref list</a>]</p></div><div id="body-link-popper-R80" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Fetal disposition of delta 9-tetrahydrocannabinol (THC) during late pregnancy in the rhesus monkey.<div class="authors">Bailey JR, Cunny HC, Paule MG, Slikker W Jr</div><div class="citation">Toxicol Appl Pharmacol. 1987 Sep 15; 90(2):315-21.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2820086/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R80">Ref list</a>]</p></div><div id="body-link-popper-R81" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">3H-delta9-tetrahydrocannabinol distribution in pregnant dogs and their fetuses.<div class="authors">Martin BR, Dewey WL, Harris LS, Beckner JS</div><div class="citation">Res Commun Chem Pathol Pharmacol. 1977 Jul; 17(3):457-70.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/897339/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R81">Ref list</a>]</p></div><div id="body-link-popper-R82" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Human placental transfer of cannabinoids.<div class="authors">Blackard C, Tennes K</div><div class="citation">N Engl J Med. 1984 Sep 20; 311(12):797.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6088979/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R82">Ref list</a>]</p></div><div id="body-link-popper-R83" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Drugs in human milk. Clinical pharmacokinetic considerations.<div class="authors">Atkinson HC, Begg EJ, Darlow BA</div><div class="citation">Clin Pharmacokinet. 1988 Apr; 14(4):217-40.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/3292101/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R83">Ref list</a>]</p></div><div id="body-link-popper-R84" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Presence of delta9-tetrahydrocannabinol in human milk.<div class="authors">Perez-Reyes M, Wall ME</div><div class="citation">N Engl J Med. 1982 Sep 23; 307(13):819-20.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6287261/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R84">Ref list</a>]</p></div><div id="body-link-popper-R85" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Isolation and characterization of two major urinary metabolites of   1 -tetrahydrocannabinol.<div class="authors">Burstein S, Rosenfeld J, Wittstruck T</div><div class="citation">Science. 1972 Apr 28; 176(4033):422-3.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/5026162/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R85">Ref list</a>]</p></div><div id="body-link-popper-R87" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">7-Oxo-delta1-tetrahydrocannabinol: a novel metabolite of delta1-tetrahydrocannabinol.<div class="authors">Ben-Zvi Z, Burstein S</div><div class="citation">Res Commun Chem Pathol Pharmacol. 1974 Jun; 8(2):223-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/4855455/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R87">Ref list</a>]</p></div><div id="body-link-popper-R88" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">88. <span class="citation">Harvey DJ, Martin BR, Paton WDM.  In: <span class="ref-journal">Marijuana: Biological Effects.</span> Nahas GG, Paton WDM, editors. Pergamon Press; Oxford: 1979. p. 45.</span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R88">Ref list</a>]</div><div id="body-link-popper-R89" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes.<div class="authors">Iribarne C, Berthou F, Baird S, Dréano Y, Picart D, Bail JP, Beaune P, Ménez JF</div><div class="citation">Chem Res Toxicol. 1996 Mar; 9(2):365-73.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8839037/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R89">Ref list</a>]</p></div><div id="body-link-popper-R90" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Metabolism of delta 9-tetrahydrocannabinol by cytochrome P450 isozymes purified from hepatic microsomes of monkeys.<div class="authors">Matsunaga T, Iwawaki Y, Watanabe K, Yamamoto I, Kageyama T, Yoshimura H</div><div class="citation">Life Sci. 1995; 56(23-24):2089-95.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/7776836/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R90">Ref list</a>]</p></div><div id="body-link-popper-R91" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">91. <span class="citation">Harvey DJ, Paton WDM. <span><span class="ref-journal">Rev. Biochem. Toxicol. </span>1986;<span class="ref-vol">6</span>:221.</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R91">Ref list</a>]</div><div id="body-link-popper-R92" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Human hepatic microsomal metabolism of delta 1-tetrahydrocannabinol.<div class="authors">Bornheim LM, Lasker JM, Raucy JL</div><div class="citation">Drug Metab Dispos. 1992 Mar-Apr; 20(2):241-6.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1352216/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R92">Ref list</a>]</p></div><div id="body-link-popper-R93" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">GC/MS and EMIT analyses for delta 9-tetrahydrocannabinol metabolites in plasma and urine of human subjects.<div class="authors">McBurney LJ, Bobbie BA, Sepp LA</div><div class="citation">J Anal Toxicol. 1986 Mar-Apr; 10(2):56-64.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/3009969/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R93">Ref list</a>]</p></div><div id="body-link-popper-R94" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Delta 6-tetrahydrocannabinol-7-oic acid, a urinary delta 6-THC metabolite: isolation and synthesis.<div class="authors">Mechoulam R, BenZvi Z, Agurell S, Nilsson IM, Nilsson JL, Edery H, Grunfeld Y</div><div class="citation">Experientia. 1973 Oct 15; 29(10):1193-5.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/4758913/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R94">Ref list</a>]</p></div><div id="body-link-popper-R95" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Identification of in vitro metabolites of delta 1-tetrahydrocannabinol formed by human livers.<div class="authors">Halldin MM, Widman M, V Bahr C, Lindgren JE, Martin BR</div><div class="citation">Drug Metab Dispos. 1982 Jul-Aug; 10(4):297-301.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6126323/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R95">Ref list</a>]</p></div><div id="body-link-popper-R96" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Cannabis: pharmacology and interpretation of effects.<div class="authors">Mason AP, McBay AJ</div><div class="citation">J Forensic Sci. 1985 Jul; 30(3):615-31.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2993473/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R96">Ref list</a>]</p></div><div id="body-link-popper-R97" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">97. <span class="citation">Sporkert F, Pragst F, Ploner CJ, Tschirch A, Stadelmann AM. Annual Meeting of the International Association of Forensic Toxicologists (TIAFT); Prague, Czech Republic. August 26−30, 2001.p. 62.</span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R97">Ref list</a>]</div><div id="body-link-popper-R98" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Pharmacokinetics of delta9-tetrahydrocannabinol in dogs.<div class="authors">Garrett ER, Hunt CA</div><div class="citation">J Pharm Sci. 1977 Mar; 66(3):395-407.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/845807/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R98">Ref list</a>]</p></div><div id="body-link-popper-R99" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Delta-9-tetrahydrocannabinol: metabolism and disposition in long-term marihuana smokers.<div class="authors">Lemberger L, Tamarkin NR, Axelrod J, Kopin IJ</div><div class="citation">Science. 1971 Jul 2; 173(3991):72-4.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/5087483/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R99">Ref list</a>]</p></div><div id="body-link-popper-R8" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man.<div class="authors">Agurell S, Halldin M, Lindgren JE, Ohlsson A, Widman M, Gillespie H, Hollister L</div><div class="citation">Pharmacol Rev. 1986 Mar; 38(1):21-43.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/3012605/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R8">Ref list</a>]</p></div><div id="body-link-popper-R100" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Metabolites of cannabidiol identified in human urine.<div class="authors">Harvey DJ, Mechoulam R</div><div class="citation">Xenobiotica. 1990 Mar; 20(3):303-20.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2336840/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R100">Ref list</a>]</p></div><div id="body-link-popper-R86" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">86. <span class="citation">Ben-Zvi Z, Bergen JR, Burstein S, Sehgal PK, Varanelli C.  In: <span class="ref-journal">The Pharmacology of Marijuana.</span> Braude MC, Szara S, editors. Raven Press; New York: 1976. p. 63.</span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R86">Ref list</a>]</div><div id="body-link-popper-R101" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Metabolism of tetrahydrocannabinol by the small intestine.<div class="authors">Greene ML, Saunders DR</div><div class="citation">Gastroenterology. 1974 Mar; 66(3):365-72.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/4813501/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R101">Ref list</a>]</p></div><div id="body-link-popper-R104" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Metabolism of delta1-tetrahydrocannabinol by the isolated perfused dog lung. Comparison with in vitro liver metabolism.<div class="authors">Widman M, Nordqvist M, Dollery CT, Briant RH</div><div class="citation">J Pharm Pharmacol. 1975 Nov; 27(11):842-8.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1493/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R104">Ref list</a>]</p></div><div id="body-link-popper-R102" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Extrahepatic metabolism of drugs in humans.<div class="authors">Krishna DR, Klotz U</div><div class="citation">Clin Pharmacokinet. 1994 Feb; 26(2):144-60.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8162658/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R102">Ref list</a>]</p></div><div id="body-link-popper-R103" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Brain microsomal oxidation of delta 8- and delta 9-tetrahydrocannabinol.<div class="authors">Watanabe K, Tanaka T, Yamamoto I, Yoshimura H</div><div class="citation">Biochem Biophys Res Commun. 1988 Nov 30; 157(1):75-80.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2848522/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R103">Ref list</a>]</p></div><div id="body-link-popper-R105" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">105. <span class="citation">Wall ME, Brine DR, Perez-Reyes M.  In: <span class="ref-journal">The Pharmacology of Marihuana.</span> Braude MC, Szara S, editors. Raven Press; New York: 1976. p. 93.</span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R105">Ref list</a>]</div><div id="body-link-popper-R106" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Evidence that cannabidiol does not significantly alter the pharmacokinetics of tetrahydrocannabinol in man.<div class="authors">Hunt CA, Jones RT, Herning RI, Bachman J</div><div class="citation">J Pharmacokinet Biopharm. 1981 Jun; 9(3):245-60.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6270295/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R106">Ref list</a>]</p></div><div id="body-link-popper-R107" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract.<div class="authors">Nadulski T, Pragst F, Weinberg G, Roser P, Schnelle M, Fronk EM, Stadelmann AM</div><div class="citation">Ther Drug Monit. 2005 Dec; 27(6):799-810.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16306858/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R107">Ref list</a>]</p></div><div id="body-link-popper-R108" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Identification in human urine of delta 9-tetrahydrocannabinol-11-oic acid glucuronide: a tetrahydrocannabinol metabolite.<div class="authors">Williams PL, Moffat AC</div><div class="citation">J Pharm Pharmacol. 1980 Jul; 32(7):445-8.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6105177/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R108">Ref list</a>]</p></div><div id="body-link-popper-R109" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Prolonged apparent half-life of delta 1-tetrahydrocannabinol in plasma of chronic marijuana users.<div class="authors">Johansson E, Agurell S, Hollister LE, Halldin MM</div><div class="citation">J Pharm Pharmacol. 1988 May; 40(5):374-5.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2899638/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R109">Ref list</a>]</p></div><div id="body-link-popper-R110" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Terminal elimination plasma half-life of delta 1-tetrahydrocannabinol (delta 1-THC) in heavy users of marijuana.<div class="authors">Johansson E, Halldin MM, Agurell S, Hollister LE, Gillespie HK</div><div class="citation">Eur J Clin Pharmacol. 1989; 37(3):273-7.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2558889/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R110">Ref list</a>]</p></div><div id="body-link-popper-R111" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Urinary excretion half-life of delta 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.<div class="authors">Johansson E, Halldin MM</div><div class="citation">J Anal Toxicol. 1989 Jul-Aug; 13(4):218-23.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2550702/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R111">Ref list</a>]</p></div><div id="body-link-popper-R112" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Pharmacokinetics and disposition of cannabinoids.<div class="authors">Chiang CN, Rapaka RS</div><div class="citation">NIDA Res Monogr. 1987; 79():173-88.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2830536/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R112">Ref list</a>]</p></div><div id="body-link-popper-R113" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.<div class="authors">Huestis MA, Mitchell JM, Cone EJ</div><div class="citation">J Anal Toxicol. 1996 Oct; 20(6):441-52.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8889681/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R113">Ref list</a>]</p></div><div id="body-link-popper-R114" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis.<div class="authors">Lindgren JE, Ohlsson A, Agurell S, Hollister L, Gillespie H</div><div class="citation">Psychopharmacology (Berl). 1981; 74(3):208-12.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6267648/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R114">Ref list</a>]</p></div><div id="body-link-popper-R115" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The metabolism of delta 9-tetrahydrocannabinol and related cannabinoids in man.<div class="authors">Wall ME, Perez-Reyes M</div><div class="citation">J Clin Pharmacol. 1981 Aug-Sep; 21(8-9 Suppl):178S-189S.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6271823/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R115">Ref list</a>]</p></div><div id="body-link-popper-R116" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Urinary cannabinoid detection times after controlled oral administration of delta9-tetrahydrocannabinol to humans.<div class="authors">Gustafson RA, Levine B, Stout PR, Klette KL, George MP, Moolchan ET, Huestis MA</div><div class="citation">Clin Chem. 2003 Jul; 49(7):1114-24.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/12816908/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R116">Ref list</a>]</p></div><div id="body-link-popper-R117" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Urinary pharmacokinetics of 11-nor-9-carboxy-delta9-tetrahydrocannabinol after controlled oral delta9-tetrahydrocannabinol administration.<div class="authors">Gustafson RA, Kim I, Stout PR, Klette KL, George MP, Moolchan ET, Levine B, Huestis MA</div><div class="citation">J Anal Toxicol. 2004 Apr; 28(3):160-7.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15107145/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R117">Ref list</a>]</p></div><div id="body-link-popper-R118" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Cannabinoids in humans. II. The influence of three methods of hydrolysis on the concentration of THC and two metabolites in urine.<div class="authors">Kemp PM, Abukhalaf IK, Manno JE, Manno BR, Alford DD, McWilliams ME, Nixon FE, Fitzgerald MJ, Reeves RR, Wood MJ</div><div class="citation">J Anal Toxicol. 1995 Sep; 19(5):292-8.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/7500615/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R118">Ref list</a>]</p></div><div id="body-link-popper-R119" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Cannabinoids in humans. I. Analysis of delta 9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS.<div class="authors">Kemp PM, Abukhalaf IK, Manno JE, Manno BR, Alford DD, Abusada GA</div><div class="citation">J Anal Toxicol. 1995 Sep; 19(5):285-91.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/7500614/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R119">Ref list</a>]</p></div><div id="body-link-popper-R120" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Adsorption losses from urine-based cannabinoid calibrators during routine use.<div class="authors">Blanc JA, Manneh VA, Ernst R, Berger DE, de Keczer SA, Chase C, Centofanti JM, DeLizza AJ</div><div class="citation">Clin Chem. 1993 Aug; 39(8):1705-12.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8394791/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R120">Ref list</a>]</p></div><div id="body-link-popper-R123" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Surface adsorption of the urinary marijuana carboxy metabolite: the problem and a partial solution.<div class="authors">Joern WA</div><div class="citation">J Anal Toxicol. 1992 Nov-Dec; 16(6):401.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1338115/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R123">Ref list</a>]</p></div><div id="body-link-popper-R124" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Physiochemical properties, solubility, and protein binding of delta9-tetrahydrocannabinol.<div class="authors">Garrett ER, Hunt CA</div><div class="citation">J Pharm Sci. 1974 Jul; 63(7):1056-64.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/4853640/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R124">Ref list</a>]</p></div><div id="body-link-popper-R125" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Simultaneous determination of delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol in human plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry.<div class="authors">Huang W, Moody DE, Andrenyak DM, Smith EK, Foltz RL, Huestis MA, Newton JF</div><div class="citation">J Anal Toxicol. 2001 Oct; 25(7):531-7.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/11599596/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R125">Ref list</a>]</p></div><div id="body-link-popper-R126" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">125I radioimmunoassay of delta-9-tetrahydrocannabinol in blood and plasma with a solid-phase second-antibody separation method.<div class="authors">Owens SM, McBay AJ, Reisner HM, Perez-Reyes M</div><div class="citation">Clin Chem. 1981 Apr; 27(4):619-24.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6258825/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R126">Ref list</a>]</p></div><div id="body-link-popper-R127" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">11-hydroxy-  9 -tetrahydrocannabinol: pharmacology, disposition, and metabolism of a major metabolite of marihuana in man.<div class="authors">Lemberger L, Crabtree RE, Rowe HM</div><div class="citation">Science. 1972 Jul 7; 177(4043):62-4.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/5041775/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R127">Ref list</a>]</p></div><div id="body-link-popper-R128" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Simultaneous quantitation of delta-9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta-9-tetrahydrocannabinol (THC-COOH) in serum by GC/MS using deuterated internal standards and its application to a smoking study and forensic cases.<div class="authors">Moeller MR, Doerr G, Warth S</div><div class="citation">J Forensic Sci. 1992 Jul; 37(4):969-83.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1324293/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R128">Ref list</a>]</p></div><div id="body-link-popper-R129" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Simultaneous analysis of delta9-THC and its major metabolites in urine, plasma, and meconium by GC-MS using an immunoaffinity extraction procedure.<div class="authors">Feng S, ElSohly MA, Salamone S, Salem MY</div><div class="citation">J Anal Toxicol. 2000 Sep; 24(6):395-402.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/10999345/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R129">Ref list</a>]</p></div><div id="body-link-popper-R133" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">133. <span class="citation">Wall ME, Taylor HL.  In: <span class="ref-journal">Marihuana '84: Proceedings of the Oxford Symposium on Cannabis.</span> Harvey DJ, Paton SW, Nahas GG, editors. IRL Press; Oxford: 1984. p. 69.</span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R133">Ref list</a>]</div><div id="body-link-popper-R134" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Ultrasensitive measurement of delta-9-tetrahydrocannabinol with a high energy dynode detector and electron-capture negative chemical-ionization mass spectrometry.<div class="authors">Shaw LM, Edling-Owens J, Mattes R</div><div class="citation">Clin Chem. 1991 Dec; 37(12):2062-8.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1662560/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R134">Ref list</a>]</p></div><div id="body-link-popper-R135" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">135. <span class="citation">Nebro W, Barnes A, Gustafson R, Moolchan E, Huestis M. results presented at the FBI/SOFT/TIAFT Meeting; Washington DC. August 2004.</span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R135">Ref list</a>]</div><div id="body-link-popper-R136" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">136. <span class="citation">Peat MA.  In: <span class="ref-journal">Advances in Analytical Toxicology II.</span> Baselt RC, editor. Year Book Medical Publishers; Chicago: 1989. p. 186.</span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R136">Ref list</a>]</div><div id="body-link-popper-R137" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Comparison of 3H- and 125I-radioimmunoassay and gas chromatography/mass spectrometry for the determination of delta 9-tetrahydrocannabinol and cannabinoids in blood and serum.<div class="authors">Hanson VW, Buonarati MH, Baselt RC, Wade NA, Yep C, Biasotti AA, Reeve VC, Wong AS, Orbanowsky MW</div><div class="citation">J Anal Toxicol. 1983 Mar-Apr; 7(2):96-102.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6304423/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R137">Ref list</a>]</p></div><div id="body-link-popper-R138" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Incidence of alcohol and drugs in fatally injured car drivers in Norway.<div class="authors">Gjerde H, Beylich KM, Mørland J</div><div class="citation">Accid Anal Prev. 1993 Aug; 25(4):479-83.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8357462/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R138">Ref list</a>]</p></div><div id="body-link-popper-R139" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Ethanol, marijuana, and other drug use in 600 drivers killed in single-vehicle crashes in North Carolina, 1978-1981.<div class="authors">Mason AP, McBay AJ</div><div class="citation">J Forensic Sci. 1984 Oct; 29(4):987-1026.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6502125/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R139">Ref list</a>]</p></div><div id="body-link-popper-R140" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH)<div class="authors">Huestis MA, Henningfield JE, Cone EJ</div><div class="citation">J Anal Toxicol. 1992 Sep-Oct; 16(5):283-90.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1338216/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R140">Ref list</a>]</p></div><div id="body-link-popper-R132" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.<div class="authors">Manno JE, Manno BR, Kemp PM, Alford DD, Abukhalaf IK, McWilliams ME, Hagaman FN, Fitzgerald MJ</div><div class="citation">J Anal Toxicol. 2001 Oct; 25(7):538-49.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/11599597/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R132">Ref list</a>]</p></div><div id="body-link-popper-R141" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Estimating the time of last cannabis use from plasma delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol concentrations.<div class="authors">Huestis MA, Barnes A, Smith ML</div><div class="citation">Clin Chem. 2005 Dec; 51(12):2289-95.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16223887/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R141">Ref list</a>]</p></div><div id="body-link-popper-R142" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">142. <span class="citation">Smith M, Nebro W, Gustafson R, Huestis M. Annual Meeting of the International Association of Forensic Toxicologists (TIAFT); Seoul, Korea. August 29 – September 2, 2005.p. 1.</span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R142">Ref list</a>]</div><div id="body-link-popper-R143" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Excretion patterns of cannabinoid metabolites after last use in a group of chronic users.<div class="authors">Ellis GM Jr, Mann MA, Judson BA, Schramm NT, Tashchian A</div><div class="citation">Clin Pharmacol Ther. 1985 Nov; 38(5):572-8.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/3902318/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R143">Ref list</a>]</p></div><div id="body-link-popper-R144" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Detection times of marijuana metabolites in urine by immunoassay and GC-MS.<div class="authors">Huestis MA, Mitchell JM, Cone EJ</div><div class="citation">J Anal Toxicol. 1995 Oct; 19(6):443-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8926739/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R144">Ref list</a>]</p></div><div id="body-link-popper-R145" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Lowering cutoffs for initial and confirmation testing for cocaine and marijuana: large-scale study of effects on the rates of drug-positive results.<div class="authors">Wingert WE</div><div class="citation">Clin Chem. 1997 Jan; 43(1):100-3.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8990229/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R145">Ref list</a>]</p></div><div id="body-link-popper-R146" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">146. <span class="citation">Hawks RL.  In: <span class="ref-journal">The Cannabinoids: Chemical, Pharmacologic, and Therapeutic Aspects.</span> Agurell S, Dewey W, Willette R, editors. Academic Press; Rockville: 1983. p. 1.</span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R146">Ref list</a>]</div><div id="body-link-popper-R147" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">147. <span class="citation">Manno JE, Ferslew KE, Manno BR.  In: <span class="ref-journal">The Cannabinoids: Chemical, Pharmacologic, and Therapeutic Aspects.</span> Agurell S, Dewey WL, Willette RE, editors. Harcourt Brace Jonanovich; Orlando: 1984. p. 281.</span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R147">Ref list</a>]</div><div id="body-link-popper-R148" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Differentiating new marijuana use from residual drug excretion in occasional marijuana users.<div class="authors">Huestis MA, Cone EJ</div><div class="citation">J Anal Toxicol. 1998 Oct; 22(6):445-54.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9788519/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R148">Ref list</a>]</p></div><div id="body-link-popper-R149" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">In vivo adulteration: excess fluid ingestion causes false-negative marijuana and cocaine urine test results.<div class="authors">Cone EJ, Lange R, Darwin WD</div><div class="citation">J Anal Toxicol. 1998 Oct; 22(6):460-73.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9788521/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R149">Ref list</a>]</p></div><div id="body-link-popper-R150" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Importance of creatinine analyses of urine when screening for abused drugs.<div class="authors">Lafolie P, Beck O, Blennow G, Boréus L, Borg S, Elwin CE, Karlsson L, Odelius G, Hjemdahl P</div><div class="citation">Clin Chem. 1991 Nov; 37(11):1927-31.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1934467/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R150">Ref list</a>]</p></div><div id="body-link-popper-R151" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol. Study III. A Delta9-THC-COOH to creatinine ratio study.<div class="authors">Fraser AD, Worth D</div><div class="citation">Forensic Sci Int. 2003 Nov 26; 137(2-3):196-202.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/14609657/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R151">Ref list</a>]</p></div><div id="body-link-popper-R153" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV.<div class="authors">Fraser AD, Worth D</div><div class="citation">Forensic Sci Int. 2004 Jul 16; 143(2-3):147-52.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15240035/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R153">Ref list</a>]</p></div><div id="body-link-popper-R154" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Salivary THC following cannabis smoking correlates with subjective intoxication and heart rate.<div class="authors">Menkes DB, Howard RC, Spears GF, Cairns ER</div><div class="citation">Psychopharmacology (Berl). 1991; 103(2):277-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/1851311/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R154">Ref list</a>]</p></div><div id="body-link-popper-R159" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Significant developments in radioimmune methods applied to delta 9-THC and its 9-substituted metabolites.<div class="authors">Soares JR, Grant JD, Gross SJ</div><div class="citation">NIDA Res Monogr. 1982; 42():44-55.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6294525/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R159">Ref list</a>]</p></div><div id="body-link-popper-R160" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The constituents of cannabis and the disposition and metabolism of cannabinoids.<div class="authors">Hawks RL</div><div class="citation">NIDA Res Monogr. 1982; 42():125-37.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6294522/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R160">Ref list</a>]</p></div><div id="body-link-popper-R161" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">161. <span class="citation">Huestis MA, Cone EJ.  In: <span class="ref-journal">Drug Abuse Handbook.</span> Karch SB, editor. CRC Press; Boca Raton: 1998. p. 799.</span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R161">Ref list</a>]</div><div id="body-link-popper-R162" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Detection of cannabis in oral fluid (saliva) and forehead wipes (sweat) from impaired drivers.<div class="authors">Kintz P, Cirimele V, Ludes B</div><div class="citation">J Anal Toxicol. 2000 Oct; 24(7):557-61.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/11043659/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R162">Ref list</a>]</p></div><div id="body-link-popper-R156" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Detection of recent cannabis use by saliva delta 9-THC radioimmunoassay.<div class="authors">Gross SJ, Worthy TE, Nerder L, Zimmermann EG, Soares JR, Lomax P</div><div class="citation">J Anal Toxicol. 1985 Jan-Feb; 9(1):1-5.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2984463/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R156">Ref list</a>]</p></div><div id="body-link-popper-R163" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">163. <span class="citation">Huestis MA, Dickerson S, Cone EJ. <span><span class="ref-journal">Am. Acad. Forensic Sci. Annual Meeting. </span>1992:190.</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R163">Ref list</a>]</div><div id="body-link-popper-R164" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.<div class="authors">Huestis MA, Cone EJ</div><div class="citation">J Anal Toxicol. 2004 Sep; 28(6):394-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15516285/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R164">Ref list</a>]</p></div><div id="body-link-popper-R165" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana.<div class="authors">Niedbala RS, Kardos KW, Fritch DF, Kardos S, Fries T, Waga J, Robb J, Cone EJ</div><div class="citation">J Anal Toxicol. 2001 Jul-Aug; 25(5):289-303.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/11499881/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R165">Ref list</a>]</p></div><div id="body-link-popper-R166" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Detection of drugs in saliva of impaired drivers.<div class="authors">Peel HW, Perrigo BJ, Mikhael NZ</div><div class="citation">J Forensic Sci. 1984 Jan; 29(1):185-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/6366113/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R166">Ref list</a>]</p></div><div id="body-link-popper-R167" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Correlation of Delta9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Dräger DrugTest.<div class="authors">Laloup M, Del Mar Ramirez Fernandez M, Wood M, De Boeck G, Maes V, Samyn N</div><div class="citation">Forensic Sci Int. 2006 Sep 12; 161(2-3):175-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16842950/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R167">Ref list</a>]</p></div><div id="body-link-popper-R168" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Blind trials of an onsite saliva drug test for marijuana and opiates.<div class="authors">Jehanli A, Brannan S, Moore L, Spiehler VR</div><div class="citation">J Forensic Sci. 2001 Sep; 46(5):1214-20.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/11569567/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R168">Ref list</a>]</p></div><div id="body-link-popper-R169" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Determination of cannabinoids in water and human saliva by solid-phase microextraction and quadrupole ion trap gas chromatography/mass spectrometry.<div class="authors">Hall BJ, Satterfield-Doerr M, Parikh AR, Brodbelt JS</div><div class="citation">Anal Chem. 1998 May 1; 70(9):1788-96.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9599579/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R169">Ref list</a>]</p></div><div id="body-link-popper-R170" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">An evaluation of rapid point-of-collection oral fluid drug-testing devices.<div class="authors">Walsh JM, Flegel R, Crouch DJ, Cangianelli L, Baudys J</div><div class="citation">J Anal Toxicol. 2003 Oct; 27(7):429-39.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/14606995/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R170">Ref list</a>]</p></div><div id="body-link-popper-R173" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Recovery of drugs of abuse from the Immunalysis Quantisal oral fluid collection device.<div class="authors">Quintela O, Crouch DJ, Andrenyak DM</div><div class="citation">J Anal Toxicol. 2006 Oct; 30(8):614-6.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/17132261/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R173">Ref list</a>]</p></div><div id="body-link-popper-R174" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Detection of THCA in oral fluid by GC-MS-MS.<div class="authors">Day D, Kuntz DJ, Feldman M, Presley L</div><div class="citation">J Anal Toxicol. 2006 Nov-Dec; 30(9):645-50.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/17137523/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R174">Ref list</a>]</p></div><div id="body-link-popper-R175" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Analytical procedure for the determination of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens.<div class="authors">Moore C, Coulter C, Rana S, Vincent M, Soares J</div><div class="citation">J Anal Toxicol. 2006 Sep; 30(7):409-12.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16959131/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R175">Ref list</a>]</p></div><div id="body-link-popper-R176" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Detection of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens and its contribution to positive results in screening assays.<div class="authors">Moore C, Ross W, Coulter C, Adams L, Rana S, Vincent M, Soares J</div><div class="citation">J Anal Toxicol. 2006 Sep; 30(7):413-8.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16959132/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R176">Ref list</a>]</p></div><div id="body-link-popper-R177" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.<div class="authors">Niedbala RS, Kardos KW, Fritch DF, Kunsman KP, Blum KA, Newland GA, Waga J, Kurtz L, Bronsgeest M, Cone EJ</div><div class="citation">J Anal Toxicol. 2005 Oct; 29(7):607-15.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16419389/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R177">Ref list</a>]</p></div><div id="body-link-popper-R178" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Testing for drugs of abuse in saliva and sweat.<div class="authors">Kidwell DA, Holland JC, Athanaselis S</div><div class="citation">J Chromatogr B Biomed Sci Appl. 1998 Aug 21; 713(1):111-35.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9700555/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R178">Ref list</a>]</p></div><div id="body-link-popper-R179" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">[Detection of drugs in sweat].<div class="authors">Balabanova S, Schneider E</div><div class="citation">Beitr Gerichtl Med. 1990; 48():45-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/2241828/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R179">Ref list</a>]</p></div><div id="body-link-popper-R157" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">[Evaluation of six rapid tests for screening of cannabis in sweat, saliva and tears].<div class="authors">Mura P, Kintz P, Papet Y, Ruesch G, Piriou A</div><div class="citation">Acta Clin Belg. 1999; 53 Suppl 1():35-8.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/10216980/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R157">Ref list</a>]</p></div><div id="body-link-popper-R180" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users.<div class="authors">Samyn N, van Haeren C</div><div class="citation">Int J Legal Med. 2000; 113(3):150-4.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/10876986/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R180">Ref list</a>]</p></div><div id="body-link-popper-R181" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Sweat testing for heroin and metabolites in a heroin maintenance program.<div class="authors">Kintz P, Brenneisen R, Bundeli P, Mangin P</div><div class="citation">Clin Chem. 1997 May; 43(5):736-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9166224/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R181">Ref list</a>]</p></div><div id="body-link-popper-R182" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">182. <span class="citation">Ehorn C, Fretthold D, Maharaj M. Annual Meeting of the International Association of Forensic Toxicologists (TIAFT); Tampa, U.S.A.. October 31 – November 4, 1994.p. 11.</span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R182">Ref list</a>]</div><div id="body-link-popper-R183" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">183. <span class="citation">Cairns T, Kippenberger DJ, Scholtz H, Baumgartner WA. In: de Zeeuw RA, Al Hosani I, Al Munthiri S, Maqbool A, editors. Hair Analysis in Forensic Toxicology: Proceedings of the 1995 International Conference and Workshop; Abu Dhabi. 1995; Organizing Committee; p. 185.</span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R183">Ref list</a>]</div><div id="body-link-popper-R186" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The determination of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) in hair using negative ion gas chromatography-mass spectrometry and high-volume injection.<div class="authors">Moore C, Guzaldo F, Donahue T</div><div class="citation">J Anal Toxicol. 2001 Oct; 25(7):555-8.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/11599599/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R186">Ref list</a>]</p></div><div id="body-link-popper-R187" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Application of two-dimensional gas chromatography with electron capture chemical ionization mass spectrometry to the detection of 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) in hair.<div class="authors">Moore C, Rana S, Coulter C, Feyerherm F, Prest H</div><div class="citation">J Anal Toxicol. 2006 Apr; 30(3):171-7.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16803651/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R187">Ref list</a>]</p></div><div id="body-link-popper-R188" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Testing human hair for Cannabis. III. rapid screening procedure for the simultaneous identification of delta 9-tetrahydrocannabinol, cannabinol, and cannabidiol.<div class="authors">Cirimele V, Sachs H, Kintz P, Mangin P</div><div class="citation">J Anal Toxicol. 1996 Jan-Feb; 20(1):13-6.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/8837945/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R188">Ref list</a>]</p></div><div id="body-link-popper-R189" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Cannabinoid concentrations in hair from documented cannabis users.<div class="authors">Huestis MA, Gustafson RA, Moolchan ET, Barnes A, Bourland JA, Sweeney SA, Hayes EF, Carpenter PM, Smith ML</div><div class="citation">Forensic Sci Int. 2007 Jul 4; 169(2-3):129-36.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16963215/" ref="reftype=pubmed&amp;article-id=2689518&amp;issue-id=179191&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#R189">Ref list</a>]</p></div></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk jig-ncbihelpwindow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/">Support Center</a>
    <a id="help-desk-link" class="help_desk jig-ncbihelpwindow" target="_blank" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2017-06-07T21:16:38-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.45&amp;Host=ptpmc101&amp;ncbi_phid=8A1A7ABF938A4C2100000000008B0082&amp;ncbi_session=8A1A7ABF938A5761_0139SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2689518%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="./Human Cannabinoid Pharmacokinetics_files/preloaderWidget.js.download"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov/" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov/" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov/" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov/" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov/">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="https://www.ncbi.nlm.nih.gov/home/about/policies.shtml">Policies and Guidelines</a> | <a href="https://www.ncbi.nlm.nih.gov/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="./Human Cannabinoid Pharmacokinetics_files/InstrumentPageStarterJS.js.download"> </script>    
    <script type="text/javascript" src="./Human Cannabinoid Pharmacokinetics_files/hfjs2.js.download"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 63.5938px; left: 548.188px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div><script async="1" src="./Human Cannabinoid Pharmacokinetics_files/analytics.js.download"></script>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript>&lt;img alt="statistics" src="/stat?jsdisabled=true&amp;amp;ncbi_db=pmc&amp;amp;ncbi_pdid=article&amp;amp;ncbi_acc=&amp;amp;ncbi_domain=nihpa&amp;amp;ncbi_report=record&amp;amp;ncbi_type=fulltext&amp;amp;ncbi_objectid=&amp;amp;ncbi_pcid=/articles/PMC2689518/&amp;amp;ncbi_app=pmc" /&gt;</noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- 8A1A7ABF938A5761_0139SID /projects/PMC/PMCViewer@4.45 ptpmc101 v4.1.r526566 Fri, Feb 03 2017 14:27:04 -->

<script type="text/javascript" src="./Human Cannabinoid Pharmacokinetics_files/4065628.js.download" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1" style="display: none;"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div><ul class="print-log"><li></li></ul></body></html>